<!DOCTYPE HTML PUBLIC "-//W3C//DTD HTML 4.01 Transitional//EN"><HTML>
<HEAD>
<TITLE></TITLE>
</HEAD>
<BODY>
<A name=1></a>Scottish Diabetes Survey 2012<br>
Scottish Diabetes<br>
Survey 2012<br>
Scottish Diabetes Survey Monitoring Group<br>
1<br>
Scottish Diabetes Survey Monitoring Group<br>
<hr>
<A name=2></a>Scottish Diabetes Survey 2012<br>
Contents<br>
<A href="sds2012s.html#3">Foreword ....................................................................................................................................... 3</a><br>
<A href="sds2012s.html#5">Executive Summary....................................................................................................................... 5</a><br>
<A href="sds2012s.html#6">Prevalence..................................................................................................................................... 6</a><br>
<A href="sds2012s.html#12">Undiagnosed diabetes.......................................................................................................... 12</a><br>
<A href="sds2012s.html#13">Duration of Diabetes............................................................................................................. 13</a><br>
<A href="sds2012s.html#13">Sex........................................................................................................................................ 13</a><br>
<A href="sds2012s.html#13">Age ....................................................................................................................................... 13</a><br>
<A href="sds2012s.html#16">Mortality ............................................................................................................................... 16</a><br>
<A href="sds2012s.html#16">Type of diabetes ................................................................................................................... 16</a><br>
<A href="sds2012s.html#18">Ethnicity ................................................................................................................................ 18</a><br>
<A href="sds2012s.html#20">Body Mass Index .................................................................................................................. 20</a><br>
<A href="sds2012s.html#23">Glycaemic Control ................................................................................................................ 23</a><br>
<A href="sds2012s.html#34">Cardiovascular Risk..................................................................................................................... 34</a><br>
<A href="sds2012s.html#34">Blood Pressure ..................................................................................................................... 34</a><br>
<A href="sds2012s.html#45">Total cholesterol.................................................................................................................... 45</a><br>
<A href="sds2012s.html#50">Smoking status ..................................................................................................................... 50</a><br>
<A href="sds2012s.html#53">Complications of diabetes ........................................................................................................... 53</a><br>
<A href="sds2012s.html#53">Myocardial infarction............................................................................................................. 53</a><br>
<A href="sds2012s.html#55">Cardiac revascularisation ..................................................................................................... 55</a><br>
<A href="sds2012s.html#56">Stroke ................................................................................................................................... 56</a><br>
<A href="sds2012s.html#57">Kidney Disease..................................................................................................................... 57</a><br>
<A href="sds2012s.html#57">Serum creatinine............................................................................................................ 57</a><br>
<A href="sds2012s.html#59">Urinary microalbuminuria............................................................................................... 59</a><br>
<A href="sds2012s.html#61">End stage renal failure................................................................................................... 61</a><br>
<A href="sds2012s.html#62">Diabetic Eye Disease............................................................................................................ 62</a><br>
<A href="sds2012s.html#62">Diabetic retinal screening............................................................................................... 62</a><br>
<A href="sds2012s.html#66">Foot Complications .............................................................................................................. 66</a><br>
<A href="sds2012s.html#66">Peripheral pulses ........................................................................................................... 66</a><br>
<A href="sds2012s.html#67">Foot ulceration ............................................................................................................... 67</a><br>
<A href="sds2012s.html#69">Lower limb amputation................................................................................................... 69</a><br>
<A href="sds2012s.html#70">Foot risk calculation ....................................................................................................... 70</a><br>
<A href="sds2012s.html#71">Other statistics...................................................................................................................... 71</a><br>
<A href="sds2012s.html#71">My Diabetes My Way ..................................................................................................... 71</a><br>
<A href="sds2012s.html#72">Scottish Diabetes Research Network (SDRN) Research Register................................ 72</a><br>
<A href="sds2012s.html#73">Acknowledgements ..................................................................................................................... 73</a><br>
<A href="sds2012s.html#74">List of tables ................................................................................................................................ 74</a><br>
<A href="sds2012s.html#78">List of figures ............................................................................................................................... 78</a><br>
<A href="sds2012s.html#80">Appendix 1: SCI-DC Data Sources ............................................................................................. 80</a><br>
<A href="sds2012s.html#82">Appendix 2: Comparison with England........................................................................................ 82</a><br>
<A href="sds2012s.html#83">Appendix 3: Variability of HbA1c ................................................................................................. 83</a><br>
2<br>
Scottish Diabetes Survey Monitoring Group<br>
<hr>
<A name=3></a>Scottish Diabetes Survey 2012<br>
Foreword<br>
The Scottish Diabetes Survey 2012 data reflects many aspects of the quality of diabetes care<br>
across the whole of Scotland.<br>
The information in this Survey is a powerful tool for the diabetes community. The diabetes<br>
Managed Clinical Network in each NHS Board in particular, will find it useful in helping identify<br>
what is needed to further improve the quality of diabetes care.<br>
Research is also a key aspect of informing high quality diabetes care. The data collected will<br>
continue to be used for epidemiological research providing key information to help develop<br>
and plan services and improve outcomes for people living with diabetes across Scotland.<br>
Throughout 2011/2012 alone we have used these data to improve our understanding of the<br>
epidemiology of cardiovascular disease in Type 1 Diabetes, changes in amputation rates for<br>
those with diabetes and diabetic retinopathy in our population.<br>
The quality and the completeness of the data included within the Survey continues to improve.<br>
Most of the data contained in the Survey is extracted from our national award-winning diabetes<br>
IT system SCI-DC. Progress is gradually being made in the introduction of an updated version<br>
(SCI-Diabetes). Data on SCI-Diabetes can also be viewed by GP practices and hospitals and<br>
now, through our "My Diabetes My Way" website (<A href="http://www.mydiabetesmyway.scot.nhs.uk">http://www.mydiabetesmyway.scot.nhs.</a><br>
<A href="http://www.mydiabetesmyway.scot.nhs.uk">uk</a>), people who have registered can review their own data to support them self manage their<br>
diabetes.<br>
This year, the Survey now includes graphs that will enable each Board to quickly review their<br>
performance in comparison to 2011. As in last year's report, the Survey includes charts that<br>
will enable each NHS Board to review their information in comparison to the Scottish average.<br>
As in previous years, the Survey shows an ongoing increase in the prevalence of diabetes<br>
without a definite increase in the incidence of Type 2 Diabetes. The Survey also illustrates some<br>
significant improvements in diabetes care:<br>
 </span><span class="ft2">More people than ever before have had an HbA1c recorded and are accessing retinopathy<br>
screening.<br>
 </span><span class="ft2">There is an increase in the percentage of people with type 1 and type 2 diabetes with good<br>
blood pressure.<br>
The Survey also identifies a number of ongoing challenges for NHS Scotland:<br>
 </span><span class="ft2">The number of people with diabetes continues to increase by around 10,000 each year,<br>
presenting greater organisational and resource pressures.<br>
 </span><span class="ft2">The Survey reports that 39.3% of people with type 1 diabetes have poor glycaemic control.<br>
 </span><span class="ft2">While the overall screening for retinopathy has slightly improved, screening for retinopathy<br>
is better for people with type 2 diabetes, than for people with type 1 diabetes. Almost one<br>
in five people with type 1 diabetes do not have a record of eye screening within the last 15<br>
months.<br>
 </span><span class="ft2">There remains significant variation between different NHS Boards in the collection of Survey<br>
data and the outcomes achieved.<br>
NHS Boards will wish to address these issues through their diabetes Managed Clinical<br>
Networks where appropriate.<br>
3<br>
Scottish Diabetes Survey Monitoring Group<br>
<hr>
<A name=4></a>Scottish Diabetes Survey 2012<br>
We have also led an international comparison of Type 1 diabetes control that will be presented<br>
to the European Association for the Study of Diabetes to share learning and improve<br>
understanding with a view to improve services.<br>
The Survey will also assist the Scottish Diabetes Group to drive forward progress with the<br>
Scottish Diabetes Action Plan. We therefore expect to build on the messages the Survey gives<br>
us to further improve the quality of diabetes care in Scotland and help ensure that people with<br>
diabetes in Scotland receive world class safe and effective and person centred care.<br>
John A McKnight<br>
Chairman<br>
Scottish Diabetes Survey Monitoring Group<br>
4<br>
Scottish Diabetes Survey Monitoring Group<br>
<hr>
<A name=5></a>Scottish Diabetes Survey 2012<br>
Executive Summary<br>
This report presents the results of the 2012 Scottish Diabetes Survey. The survey</span><span class="ft3">1 </span><span class="ft2">collates<br>
information submitted by all 14 NHS Boards and provides data on the number of people with<br>
diabetes, the effects on their health, and the progress being made to improve the delivery and<br>
outcomes of care for diabetes. In this survey, we report separately on those with type 1 and type<br>
2 diabetes.<br>
In this Scottish Diabetes Survey 2012, we report that:<br>
 </span><span class="ft2">There were 258,570 people diagnosed with diabetes in Scotland recorded on local diabetes<br>
registers at the end of 2012. This represents 4.9% of the population;<br>
 </span><span class="ft2">Crude prevalence of diabetes ranged from 4.16% to 5.74% across NHS Boards (Table 1);<br>
 </span><span class="ft2">88.2% (227,967) of all people registered with diabetes had type 2 diabetes (Table 11);<br>
 </span><span class="ft2">11.2% of all registered people had type 1 diabetes. The number of people registered with<br>
type 1 diabetes increased from 26,294 in 2006 to 28,849 in 2013;<br>
 </span><span class="ft2">0.68% (1,754) were recorded as having "other" types of diabetes, including maturity onset<br>
diabetes of the young (MODY) and those with unknown diabetes type (Table 11);<br>
 </span><span class="ft2">38% of patients with a recorded BMI and type 1 diabetes and 31.6% of those with a recorded<br>
BMI and type 2 diabetes were overweight (BMI 25-30kg/m</span><span class="ft3">2</span><span class="ft2">), while 25.5% of those with type 1<br>
and 55.5% of those with type 2 were obese (BMI 30kg/m</span><span class="ft3">2 </span><span class="ft2">or above, tables 17and 18);<br>
 </span><span class="ft2">87.1% (type 1) and 92.8% (type 2) had an HbA recorded in the previous 15 months. Of<br>
1c<br>
these, 21.5% and 59.7% had a result &lt; 58mmol/mol (7.5%), the target reported in previous<br>
surveys (tables 19, 21 and 22);<br>
 </span><span class="ft2">85.2% of those with type 1 and 94.6% of those with type 2 diabetes had their blood pressure<br>
recorded in the previous 15 months. Of these, 47.6% and 32.6% respectively had a systolic<br>
BP measurement of  130/80 mmHg (tables 30, 33 and 35);<br>
 </span><span class="ft2">Cholesterol was recorded in 90.6% of patients within the previous 15 months, and the target<br>
of 5 mmol/l was achieved in 69.7% of those with type 1 and 80.5% of those with type 2<br>
diabetes (tables 39, 40 and 41);<br>
 </span><span class="ft2">23.8% (type 1) and 18.8% (type 2) were current smokers (tables 44 and 45);<br>
 </span><span class="ft2">1,049 (3.6%) of those with type 1 and 23,024 (10.1%) of those with type 2 diabetes have<br>
had a myocardial infarction and survived, and 2.5% and 7.2% respectively have undergone<br>
cardiac revascularisation (tables 47 and 49);<br>
 </span><span class="ft2">337 (1.2%) of those with type 1 and 1,167 (0.5%) of those with type 2 diabetes have a record<br>
of having end stage renal failure (Table 58);<br>
 </span><span class="ft2">86.1% of people with diabetes had had eye screening in the previous 15 months (Table 59);<br>
 </span><span class="ft2">55.9% of patients with type 1 diabetes and 71.8% of those with type 2 had their foot pulses<br>
checked in the previous 15 months (Table 62);<br>
 </span><span class="ft2">313 (1.1%) of those with type 1 and 1,541 (0.7%) of those with type 2 diabetes have a record<br>
of having had a lower limb amputation (Table 66).<br>
1 Full details of the 2012 survey questions are available at <A href="http://www.sci-diabetes.scot.nhs.uk/wp-content/uploads/2013/06/ScottishDiabetesSurvey2012GuidelinesFINAL.pdf">http://www.sci-diabetes.scot.nhs.uk/wp-content/</a><br>
<A href="http://www.sci-diabetes.scot.nhs.uk/wp-content/uploads/2013/06/ScottishDiabetesSurvey2012GuidelinesFINAL.pdf">uploads/2013/06/ScottishDiabetesSurvey2012GuidelinesFINAL.pdf</a><br>
5<br>
Scottish Diabetes Survey Monitoring Group<br>
<hr>
<A name=6></a>Scottish Diabetes Survey 2012<br>
Prevalence<br>
At the end of 2012 there were 258,570 people with known diabetes in Scotland recorded on<br>
local diabetes registers, which represents a crude prevalence of 4.92% of the population. In<br>
the 2011 Scottish Diabetes Survey, 247,278 people (4.74%) were known to have diabetes. The<br>
increase in reported prevalence depends on a number of factors, including:<br>
 </span><span class="ft2">demographic change - diabetes is more prevalent in older people so the increasing number<br>
of older people each year increases the prevalence of diabetes<br>
 </span><span class="ft2">an increase in the incidence of type 1 diabetes - we know that there has been a steady<br>
increase in the incidence of diabetes in Scottish children over the last 40 years<br>
 </span><span class="ft2">better survival partly because of improved control of blood glucose, blood pressure and<br>
cholesterol level<br>
 </span><span class="ft2">possibly better detection of diabetes in people with type 2 diabetes, many of whom have no<br>
symptoms<br>
Variation between health boards also depends on deprivation, the age and the ethnic<br>
distribution of the population of each board. However the broad similarity of reported<br>
prevalence, compared to some previous years, gives confidence in the completeness of<br>
recording. The increased prevalence in recent years is likely to be real rather than because of<br>
better reporting.<br>
Table 1.<br>
Crude and age-adjusted prevalence of diabetes (all types), 2012, Scotland, by NHS<br>
Board, ranked by age adjusted prevalence.<br>
NHS Board<br>
Population<br>
Number on<br>
Crude<br>
Age adjusted<br>
diabetes<br>
prevalence<br>
prevalence<br>
register at end<br>
of 2012<br>
Western Isles<br>
26,080<br>
1,259<br>
4.83%<br>
4.14%<br>
Highland<br>
311,960<br>
15,130<br>
4.85%<br>
4.31%<br>
Orkney<br>
20,160<br>
996<br>
4.94%<br>
4.39%<br>
Shetland<br>
22,500<br>
1,024<br>
4.55%<br>
4.44%<br>
Borders<br>
113,150<br>
5,831<br>
5.15%<br>
4.49%<br>
Lothian<br>
848,727<br>
35,288<br>
4.16%<br>
4.58%<br>
Grampian<br>
555,280<br>
25,275<br>
4.55%<br>
4.62%<br>
Dumfries &amp; Galloway<br>
148,060<br>
8,484<br>
5.73%<br>
4.78%<br>
Tayside<br>
405,721<br>
20,843<br>
5.14%<br>
4.81%<br>
Forth Valley<br>
295,541<br>
14,850<br>
5.02%<br>
5.05%<br>
Fife<br>
367,292<br>
19,097<br>
5.20%<br>
5.06%<br>
Greater Glasgow &amp; Clyde<br>
1,210,254<br>
59,121<br>
4.89%<br>
5.20%<br>
Ayrshire &amp; Arran<br>
366,890<br>
21,073<br>
5.74%<br>
5.26%<br>
Lanarkshire<br>
563,185<br>
30,299<br>
5.38%<br>
5.46%<br>
Scotland<br>
5,254,800<br>
258,570<br>
4.92%<br>
6<br>
Scottish Diabetes Survey Monitoring Group<br>
<hr>
<A name=7></a>Scottish Diabetes Survey 2012<br>
Table 2.<br>
Crude prevalence of diabetes for patients aged 65 and over (all types), 2012,<br>
Scotland, by NHS Board, ranked by prevalence.<br>
NHS Board<br>
Aged &gt;=65 (n)<br>
Aged &gt;=65 with<br>
Prevalence in those<br>
Diabetes<br>
aged &gt;=65<br>
Western Isles<br>
5,731<br>
696<br>
12.1%<br>
Shetland<br>
3,855<br>
509<br>
13.2%<br>
Highland<br>
62,246<br>
8,325<br>
13.4%<br>
Orkney<br>
4,053<br>
567<br>
14.0%<br>
Lothian<br>
126,006<br>
17,719<br>
14.1%<br>
Dumfries &amp; Galloway<br>
33,450<br>
4,825<br>
14.4%<br>
Grampian<br>
90,309<br>
13,134<br>
14.5%<br>
Borders<br>
23,277<br>
3,392<br>
14.6%<br>
Tayside<br>
78,157<br>
11,579<br>
14.8%<br>
Fife<br>
65,580<br>
10,128<br>
15.4%<br>
Greater Glasgow &amp; Clyde<br>
187,350<br>
28,920<br>
15.4%<br>
Ayrshire &amp; Arran<br>
71,351<br>
11,039<br>
15.5%<br>
Forth Valley<br>
49,469<br>
7,663<br>
15.5%<br>
Lanarkshire<br>
91,553<br>
14,953<br>
16.3%<br>
Scotland<br>
892,387<br>
133,449<br>
15.0%<br>
Age adjusted prevalence is based on direct age/sex standardisation using the Scottish<br>
population as the reference population structure. Population figures are based on mid-year<br>
population estimates published by National Records of Scotland (formerly GRO(S)). Because of<br>
publication dates surveys have in each case used population figures for the previous year - so<br>
that the 2012 survey uses diabetes data from 2012 but population estimates from 2011. This will<br>
lead to a very small overestimate of diabetes prevalence.<br>
Differences in prevalence are due to a number of factors. One is age - type 2 diabetes is more<br>
common in older age groups so the age structure of an area will affect the crude prevalence. A<br>
health board area with an older population will have a higher crude prevalence. For example,<br>
the crude (unadjusted) prevalence of diabetes in Dumfries &amp; Galloway is 16.5% above the<br>
Scottish average. However when the figure is adjusted for the age of the population, the<br>
Dumfries &amp; Galloway prevalence is actually lower than the Scottish average. Other reasons for<br>
differences in observed prevalence are given at the start of this section.<br>
Table 1 and figures 1 and 2 show both crude and age-adjusted figures for the prevalence of<br>
diabetes of all types in 2012. The age-adjusted figures take account of the fact that the average<br>
age differs between boards and that older populations have higher diabetes prevalence. Table 2<br>
shows that the prevalence of diabetes is particularly high among those aged 65 and over.<br>
7<br>
Scottish Diabetes Survey Monitoring Group<br>
<hr>
<A name=8></a>Scottish Diabetes Survey 2012<br>
Figure 1. Crude diabetes prevalence (all types) by NHS Health Board, Scotland, 2012.<br>
Vertical capped lines show 95% confidence intervals.<br>
8.0%<br>
7.0%<br>
NHS Board<br>
Scotland<br>
6.0%<br>
5.0%<br>
4.0%<br>
3.0%<br>
2.0%<br>
1.0%<br>
0.0%<br>
&amp;<br>
Fife<br>
&amp;<br>
Isles<br>
alley<br>
Arran<br>
Lothian<br>
Clyde<br>
Orkney<br>
V<br>
Shetland<br>
&amp;<br>
Tayside<br>
Borders<br>
Grampian<br>
Highland<br>
Glasqow<br>
Galloway<br>
estern<br>
Forth<br>
Lanarkshire<br>
Dumfries<br>
Ayrshire<br>
W<br>
Greater<br>
Figure 2. Age-adjusted diabetes prevalence (all types) by NHS Health Board, Scotland, 2012,<br>
ranked by prevalence. Vertical capped lines show 95% confidence intervals.<br>
8.0%<br>
7.0%<br>
NHS Board<br>
Scotland<br>
6.0%<br>
5.0%<br>
4.0%<br>
3.0%<br>
2.0%<br>
1.0%<br>
0.0%<br>
&amp;<br>
&amp;<br>
Isles<br>
Fife<br>
alleyV<br>
Clyde<br>
Arran<br>
Highland<br>
Borders<br>
Orkney<br>
Shetland<br>
Lothian<br>
Tayside<br>
Grampian<br>
Galloway<br>
Glasgow &amp;<br>
estern<br>
Dumfries<br>
Forth<br>
Ayrshire<br>
Lanarkshire<br>
W<br>
Greater<br>
8<br>
Scottish Diabetes Survey Monitoring Group<br>
<hr>
<A name=9></a>Scottish Diabetes Survey 2012<br>
Figure 3. Number of people with all types of diabetes in each NHS Health Board in 2012.<br>
70,000<br>
60,000<br>
50,000<br>
40,000<br>
30,000<br>
20,000<br>
10,000<br>
0<br>
&amp;<br>
&amp;<br>
Fife<br>
Isles<br>
alley<br>
Arran<br>
Orkney<br>
V<br>
Lothian<br>
Clyde<br>
Shetland<br>
Borders<br>
Tayside<br>
Galloway<br>
Highland<br>
&amp;<br>
Grampian<br>
Glasgow<br>
estern<br>
Dumfries<br>
Forth<br>
Ayrshire<br>
Lanarkshire<br>
W<br>
Greater<br>
Figure 4. Number of people recorded with diabetes (all types), Scotland 2001 ­ 2012.<br>
300,000<br>
250,000<br>
200,000<br>
150,000<br>
100,000<br>
50,000<br>
0<br>
2001<br>
2002<br>
2003<br>
2004<br>
2005<br>
2006<br>
2007<br>
2008<br>
2009<br>
2010<br>
2011<br>
2012<br>
9<br>
Scottish Diabetes Survey Monitoring Group<br>
<hr>
<A name=10></a>Scottish Diabetes Survey 2012<br>
Table 3.<br>
Number of people with diabetes, crude prevalence of diabetes and changes in<br>
numbers/proportions, compared to previous years (2007-2012).<br>
Survey<br>
Diabetes<br>
Crude<br>
Increase<br>
(%) Increase<br>
Absolute<br>
register<br>
prevalence<br>
increase<br>
2012<br>
258,570<br>
4.92%<br>
11,292<br>
4.57%<br>
0.18%<br>
2011<br>
247,278<br>
4.74%<br>
9,810<br>
4.13%<br>
0.16%<br>
2010<br>
237,468<br>
4.57%<br>
9,464<br>
4.15%<br>
0.16%<br>
2009<br>
228,004<br>
4.41%<br>
8,041<br>
3.66%<br>
0.14%<br>
2008<br>
219,963<br>
4.28%<br>
10,257<br>
4.89%<br>
0.18%<br>
2007<br>
209,706<br>
4.10%<br>
12,905<br>
6.56%<br>
0.24%<br>
Note: SCI-DC achieved complete coverage of Health Board areas in 2006.<br>
Between 2001 and 2006, the increase in numbers was partly due to improved recording as SCI-<br>
DC was being implemented. The increase observed since 2007 is more likely to reflect a real<br>
increase in numbers.<br>
Table 4.<br>
Type 1 diabetes: number of new cases and incidence rate (per 100,000 population<br>
per year) of by age, Scotland 2009-2012.<br>
Age<br>
2009<br>
2010<br>
2011<br>
2012<br>
Cases<br>
Rate<br>
Cases<br>
Rate<br>
Cases<br>
Rate Population Cases<br>
Rate<br>
0-4<br>
297,741<br>
66<br>
22<br>
148<br>
27<br>
145<br>
26<br>
166<br>
29<br>
5-9<br>
273,374<br>
137<br>
50<br>
10-14<br>
282,776<br>
152<br>
54<br>
258<br>
41<br>
268<br>
43<br>
244<br>
40<br>
15-19<br>
317,880<br>
110<br>
35<br>
20-29<br>
168<br>
24<br>
177<br>
25<br>
205<br>
29<br>
725,571<br>
172<br>
24<br>
30-39<br>
145<br>
22<br>
127<br>
20<br>
129<br>
20<br>
643,811<br>
118<br>
18<br>
40-49<br>
92<br>
12<br>
93<br>
12<br>
114<br>
14<br>
787,195<br>
96<br>
12<br>
50-59<br>
71<br>
11<br>
69<br>
10<br>
63<br>
9<br>
702,078<br>
66<br>
9<br>
60-69<br>
44<br>
8<br>
50<br>
9<br>
37<br>
6<br>
593,520<br>
43<br>
7<br>
70<br>
28<br>
5<br>
29<br>
5<br>
15<br>
2<br>
630,854<br>
18<br>
3<br>
Total<br>
954<br>
18<br>
958<br>
18<br>
973<br>
19 5,254,800<br>
978<br>
19<br>
Note: These are crude incidence figures that have been calculated retrospectively using SCI-DC data and therefore may<br>
be slightly affected by factors such as post-survey patient migration and on-going validation of diabetes classification. See<br>
also the note on population estimates after Table 1.<br>
10<br>
Scottish Diabetes Survey Monitoring Group<br>
<hr>
<A name=11></a>Scottish Diabetes Survey 2012<br>
Table 5.<br>
Type 2 diabetes: number of new cases and incidence rate (per 100,000 population<br>
per year) by age, Scotland 2009-2012.<br>
Age<br>
2009<br>
2010<br>
2011<br>
2012<br>
Cases<br>
Rate<br>
Cases<br>
Rate<br>
Cases<br>
Rate<br>
Population Cases<br>
Rate<br>
&lt;10<br>
2<br>
0<br>
0<br>
0<br>
0<br>
0<br>
571,115<br>
0<br>
0<br>
10-19<br>
22<br>
4<br>
18<br>
3<br>
10<br>
2<br>
600,656<br>
21<br>
3<br>
20-29<br>
164<br>
24<br>
166<br>
24<br>
163<br>
23<br>
725,571<br>
208<br>
29<br>
30-39<br>
797<br>
120<br>
755<br>
116<br>
730<br>
113<br>
643,811<br>
939<br>
146<br>
40-49<br>
2,667<br>
335<br>
2,555<br>
321<br>
2,552<br>
322<br>
787,195<br>
2,733<br>
347<br>
50-59<br>
4,411<br>
653<br>
4,287<br>
629<br>
4,106<br>
595<br>
702,078<br>
4,567<br>
650<br>
60-69<br>
5,286<br>
944<br>
4,870<br>
851<br>
4,741<br>
814<br>
593,520<br>
4,943<br>
833<br>
70<br>
5,278<br>
867<br>
4,925<br>
799<br>
4,667<br>
747<br>
630,854<br>
4,596<br>
729<br>
Total<br>
18,627<br>
360 17,576<br>
338 16,969<br>
325<br>
5,254,800 18,007<br>
343<br>
Note: These are crude incidence figures that have been calculated retrospectively using SCI-DC data and therefore may<br>
be slightly affected by factors such as post-survey patient migration and on-going validation of diabetes classification. See<br>
also the note on population estimates after Table 1.<br>
Table 6.<br>
Type 1 diabetes: number of new cases of and crude incidence rate for all ages<br>
(cases per 100,000 population per year) by NHS Board, 2009-2012, ranked by rate<br>
in 2012.<br>
Age<br>
2009<br>
2010<br>
2011<br>
2012<br>
Cases<br>
Rate<br>
Cases<br>
Rate<br>
Cases<br>
Rate<br>
Cases<br>
Rate<br>
Dumfries &amp; Galloway<br>
29<br>
20<br>
26<br>
18<br>
20<br>
13<br>
20<br>
14<br>
Orkney<br>
2<br>
10<br>
4<br>
20<br>
5<br>
25<br>
3<br>
15<br>
Highland<br>
69<br>
22<br>
53<br>
17<br>
74<br>
24<br>
49<br>
16<br>
Grampian<br>
115<br>
21<br>
123<br>
23<br>
117<br>
21<br>
90<br>
17<br>
Fife<br>
56<br>
16<br>
53<br>
15<br>
80<br>
22<br>
63<br>
17<br>
Shetland<br>
5<br>
23<br>
6<br>
27<br>
3<br>
13<br>
4<br>
18<br>
Borders<br>
16<br>
14<br>
20<br>
18<br>
17<br>
15<br>
20<br>
18<br>
Lothian<br>
136<br>
17<br>
155<br>
19<br>
136<br>
16<br>
153<br>
18<br>
Tayside<br>
57<br>
14<br>
71<br>
18<br>
58<br>
14<br>
73<br>
18<br>
Greater Glasgow &amp;<br>
Clyde<br>
218<br>
18<br>
205<br>
17<br>
221<br>
18<br>
228<br>
19<br>
Lanarkshire<br>
127<br>
23<br>
103<br>
18<br>
110<br>
20<br>
110<br>
20<br>
Ayrshire &amp; Arran<br>
70<br>
19<br>
69<br>
19<br>
68<br>
19<br>
79<br>
22<br>
Forth Valley<br>
50<br>
17<br>
64<br>
22<br>
61<br>
21<br>
70<br>
24<br>
Western Isles<br>
4<br>
15<br>
6<br>
23<br>
3<br>
11<br>
9<br>
35<br>
Scotland<br>
954<br>
18<br>
958<br>
18<br>
973<br>
19<br>
978<br>
19<br>
Note: These are crude incidence figures that have been calculated retrospectively using SCI-DC data and therefore may<br>
be slightly affected by factors such as post-survey patient migration and on-going validation of diabetes classification. See<br>
also the note on population estimates after Table 1.<br>
11<br>
Scottish Diabetes Survey Monitoring Group<br>
<hr>
<A name=12></a>Scottish Diabetes Survey 2012<br>
Table 7.<br>
Type 2 diabetes: number of new cases and crude incidence rate for all ages<br>
(cases per 100,000 population per year) by NHS Board, 2009-2012, ranked by rate<br>
in 2012.<br>
Age<br>
2009<br>
2010<br>
2011<br>
2012<br>
Cases<br>
Rate<br>
Cases<br>
Rate<br>
Cases<br>
Rate<br>
Cases<br>
Rate<br>
Shetland<br>
74<br>
337<br>
75<br>
338<br>
82<br>
366<br>
51<br>
227<br>
Lothian<br>
2,211<br>
270<br>
1,988<br>
241<br>
2,191<br>
262<br>
2,271<br>
268<br>
Western Isles<br>
96<br>
366<br>
101<br>
386<br>
71<br>
271<br>
75<br>
288<br>
Orkney<br>
67<br>
337<br>
59<br>
296<br>
85<br>
423<br>
61<br>
303<br>
Highland<br>
1,136<br>
367<br>
1,122<br>
361<br>
1,010<br>
325<br>
1,035<br>
332<br>
Greater Glasgow &amp;<br>
Clyde<br>
4,039<br>
338<br>
3,952<br>
330<br>
3,801<br>
316<br>
4,131<br>
341<br>
Grampian<br>
2,063<br>
382<br>
1,721<br>
316<br>
1,596<br>
290<br>
1,866<br>
336<br>
Tayside<br>
1,614<br>
407<br>
1,670<br>
418<br>
1,544<br>
383<br>
1,440<br>
355<br>
Forth Valley<br>
970<br>
334<br>
973<br>
334<br>
876<br>
299<br>
1,051<br>
356<br>
Lanarkshire<br>
2,302<br>
410<br>
2,081<br>
370<br>
1,976<br>
351<br>
2,083<br>
370<br>
Dumfries &amp; Galloway<br>
669<br>
450<br>
589<br>
397<br>
573<br>
387<br>
563<br>
380<br>
Fife<br>
1,315<br>
363<br>
1,296<br>
357<br>
1,235<br>
338<br>
1,363<br>
371<br>
Borders<br>
411<br>
366<br>
428<br>
380<br>
384<br>
340<br>
448<br>
396<br>
Ayrshire &amp; Arran<br>
1,660<br>
425<br>
1,521<br>
414<br>
1,545<br>
421<br>
1,570<br>
428<br>
Scotland<br>
18,627<br>
360 17,576<br>
338 16,969<br>
325 18,008<br>
343<br>
Note: These crude incidence figures have been calculated retrospectively using SCI-Diabetes data and present the<br>
number of patients in each health board within the relevant year regardless of subsequent mortality or migration off the<br>
CHI system. The results, therefore, may differ from the values displayed in the Duration of Diabetes &lt;1 year table which is<br>
limited to patients who were alive and actively registered to a practice in each heath board at the time of data extraction.<br>
Undiagnosed diabetes<br>
Estimates of undiagnosed diabetes in Scotland were included in the 2011 Scottish Diabetes<br>
Survey. These were based on the Association of Public Health Observatories (APHO)<br>
prevalence model. However the model does not provide updated figures for 2012, so the<br>
previously published estimates shown in the 2011 survey report should be used. More details<br>
are available at:<br>
<A href="http://www.scotpho.org.uk/health-wellbeing-and-disease/diabetes/data/undiagnosed-diabetes">http://www.scotpho.org.uk/health-wellbeing-and-disease/diabetes/data/undiagnosed-diabetes</a><br>
12<br>
Scottish Diabetes Survey Monitoring Group<br>
<hr>
<A name=13></a>Scottish Diabetes Survey 2012<br>
Duration of Diabetes<br>
The date of diagnosis was recorded for almost 100% of patients, of which 7% have had<br>
diabetes for less than one year and 9.6% have had diabetes for 20 years or more.<br>
Table 8.<br>
Duration of diabetes (years since diagnosis) by type of diabetes, Scotland, 2012.<br>
Duration<br>
Type 1 diabetes<br>
Type 2 diabetes<br>
T1 and T2 diabetes<br>
(Years)<br>
Number of<br>
Percentage<br>
Number of<br>
Percentage<br>
Total<br>
Total<br>
patients<br>
patients<br>
numbers<br>
percentage<br>
&lt; 1<br>
910<br>
3.2%<br>
16,983<br>
7.5%<br>
17,893<br>
7.0%<br>
1-4<br>
3,649<br>
12.7%<br>
66,987<br>
29.4%<br>
70,636<br>
27.5%<br>
5-9<br>
4,482<br>
15.6%<br>
68,940<br>
30.3%<br>
73,422<br>
28.6%<br>
10-14<br>
4,579<br>
15.9%<br>
43,925<br>
19.3%<br>
48,504<br>
18.9%<br>
15-19<br>
3,698<br>
12.8%<br>
17,954<br>
7.9%<br>
21,652<br>
8.4%<br>
20-24<br>
3,198<br>
11.1%<br>
7,813<br>
3.4%<br>
11,011<br>
4.3%<br>
25-29<br>
2,453<br>
8.5%<br>
3,064<br>
1.3%<br>
5,517<br>
2.2%<br>
30-34<br>
2,098<br>
7.3%<br>
1,071<br>
0.5%<br>
3,169<br>
1.2%<br>
35-39<br>
1,522<br>
5.3%<br>
447<br>
0.2%<br>
1,969<br>
0.8%<br>
40-44<br>
1,026<br>
3.6%<br>
225<br>
0.1%<br>
1,251<br>
0.5%<br>
45-49<br>
581<br>
2.0%<br>
117<br>
0.1%<br>
698<br>
0.3%<br>
50<br>
605<br>
2.1%<br>
152<br>
0.1%<br>
757<br>
0.3%<br>
Total<br>
28,801<br>
100.0%<br>
227,678<br>
100.0%<br>
256,479<br>
100.0%<br>
Note: Excludes patients where date of diagnosis not known (Type 1 = 48; Type 2 = 289).<br>
Sex<br>
A greater proportion of those with diagnosed diabetes are men; 56.2% compared with 43.8% in<br>
those with type 1 diabetes and 55.3% compared with 44.7% in those with type 2 diabetes. This<br>
ratio is relatively unchanged from 2001.<br>
Age<br>
Type 2 diabetes is more common in older people; 132,870 (51.8%) of all the people reported<br>
in the survey are aged 65 years or older. Figures 5 and 6 show the age distribution of people<br>
with diabetes compared with that of the general population; The possibility that type 2 diabetes<br>
is developing in people at a younger age is currently under investigation. This may have long-<br>
term implications for the NHS, because they will have diabetes for long enough to develop<br>
complications such as renal failure.<br>
13<br>
Scottish Diabetes Survey Monitoring Group<br>
<hr>
<A name=14></a>Scottish Diabetes Survey 2012<br>
Figure 5. Type 1 diabetes: age distribution of people recorded (right side) compared with<br>
age distribution of general population (left side), Scotland, 2012.<br>
Total Population<br>
Diabetes<br>
85+<br>
80-84<br>
75-79<br>
70-74<br>
65-69<br>
60-64<br>
55-59<br>
50-54<br>
45-49<br>
40-44<br>
35-39<br>
30-34<br>
25-29<br>
20-24<br>
15-19<br>
10-14<br>
5-9<br>
0-4<br>
15%<br>
10%<br>
5%<br>
0%<br>
0%<br>
5%<br>
10%<br>
15%<br>
Percentage of Total Population (left) and of Population with Diabetes (right) in each age group<br>
Figure 6. Type 2 diabetes: age distribution of people recorded (right side) compared with<br>
age distribution of general population (left side), Scotland, 2012.<br>
Total Population<br>
Diabetes<br>
85+<br>
80-84<br>
75-79<br>
70-74<br>
65-69<br>
60-64<br>
55-59<br>
50-54<br>
45-49<br>
40-44<br>
35-39<br>
30-34<br>
25-29<br>
20-24<br>
15-19<br>
10-14<br>
5-9<br>
0-4<br>
15%<br>
10%<br>
5%<br>
0%<br>
0%<br>
5%<br>
10%<br>
15%<br>
Percentage of Total Population (left) and of Population with Diabetes (right) in each age group<br>
14<br>
Scottish Diabetes Survey Monitoring Group<br>
<hr>
<A name=15></a>Scottish Diabetes Survey 2012<br>
Table 9.<br>
Age group of people recorded with type 1 or type 2 diabetes, percentage in each<br>
age group and cumulative percentage in each age group, by diabetes type.<br>
Age<br>
Type 1 diabetes<br>
Type 2 diabetes<br>
Number<br>
Percentage Cumulative<br>
Number<br>
Percentage Cumulative<br>
Percentage<br>
Percentage<br>
0-4<br>
114<br>
0.4%<br>
0.4%<br>
0<br>
0.0%<br>
0.0%<br>
5-9<br>
543<br>
1.9%<br>
2.3%<br>
3<br>
0.0%<br>
0.0%<br>
10-14<br>
1,235<br>
4.3%<br>
6.6%<br>
12<br>
0.0%<br>
0.0%<br>
15-19<br>
1,873<br>
6.5%<br>
13.1%<br>
47<br>
0.0%<br>
0.0%<br>
20-24<br>
2,258<br>
7.8%<br>
20.9%<br>
229<br>
0.1%<br>
0.1%<br>
25-29<br>
2,312<br>
8.0%<br>
28.9%<br>
576<br>
0.3%<br>
0.4%<br>
30-34<br>
2,234<br>
7.8%<br>
36.7%<br>
1,558<br>
0.7%<br>
1.1%<br>
35-39<br>
2,379<br>
8.3%<br>
44.9%<br>
2,943<br>
1.3%<br>
2.4%<br>
40-44<br>
2,889<br>
10.0%<br>
54.9%<br>
6,677<br>
2.9%<br>
5.3%<br>
45-49<br>
3,024<br>
10.5%<br>
65.4%<br>
12,287<br>
5.4%<br>
10.7%<br>
50-54<br>
2,711<br>
9.4%<br>
74.8%<br>
18,851<br>
8.3%<br>
19.0%<br>
55-59<br>
2,223<br>
7.7%<br>
82.6%<br>
24,899<br>
10.9%<br>
29.9%<br>
60-64<br>
1,666<br>
5.8%<br>
88.3%<br>
30,280<br>
13.3%<br>
43.2%<br>
65-69<br>
1,318<br>
4.6%<br>
92.9%<br>
34,666<br>
15.2%<br>
58.4%<br>
70-74<br>
873<br>
3.0%<br>
95.9%<br>
32,485<br>
14.3%<br>
72.6%<br>
75-79<br>
660<br>
2.3%<br>
98.2%<br>
29,309<br>
12.9%<br>
85.5%<br>
80-84<br>
361<br>
1.3%<br>
99.5%<br>
19,930<br>
8.7%<br>
94.2%<br>
85<br>
150<br>
0.5%<br>
100.0%<br>
13,118<br>
5.8%<br>
100.0%<br>
Scotland<br>
28,823<br>
100.0%<br>
100.0%<br>
227,870<br>
100.0%<br>
100.0%<br>
15<br>
Scottish Diabetes Survey Monitoring Group<br>
<hr>
<A name=16></a>Scottish Diabetes Survey 2012<br>
Mortality<br>
Table 10. The percentage of the diabetes population (all diabetes types) who have died<br>
within the last year, by NHS Board, Scotland 2012, ranked by mortality.<br>
NHS Board<br>
Deaths<br>
Total<br>
% of population<br>
Shetland<br>
30<br>
2.8%<br>
Highland<br>
521<br>
3.3%<br>
Lothian<br>
1,229<br>
3.4%<br>
Fife<br>
665<br>
3.4%<br>
Lanarkshire<br>
1,089<br>
3.5%<br>
Borders<br>
211<br>
3.5%<br>
Grampian<br>
940<br>
3.6%<br>
Ayrshire &amp; Arran<br>
795<br>
3.6%<br>
Greater Glasgow &amp; Clyde<br>
2,249<br>
3.7%<br>
Tayside<br>
813<br>
3.8%<br>
Forth Valley<br>
581<br>
3.8%<br>
Dumfries &amp; Galloway<br>
342<br>
3.9%<br>
Orkney<br>
42<br>
4.0%<br>
Western Isles<br>
58<br>
4.4%<br>
Scotland<br>
9,565<br>
3.6%<br>
Note: These data were calculated from all people with diabetes who died in the prior year expressed as a percentage of<br>
all people with diabetes still alive at the end of the year plus those who died during the year. This does not take account of<br>
the fact that as people die during the year the size of the population that remains and is still at risk of death becomes very<br>
slightly smaller. As a result these figures slightly underestimate the true mortality risk. Note that comparisons between<br>
NHS Boards do not take into account important differences in age structure which result in higher mortality in<br>
boards with older populations.<br>
Type of diabetes<br>
The majority of registered patients had type 2 diabetes (227,967 or 88.2%). The proportion<br>
of people with diabetes who have type 1 diabetes has fallen from 18.2% in 2002 to 11.2% in<br>
2012, probably largely due to relatively more complete recording of data from people with type<br>
1 diabetes than type 2 diabetes in earlier years. However, the absolute number of patients with<br>
type 1 diabetes continues to increase (22,597 in 2003; 28,849 in 2012). This reflects the rising<br>
incidence of type 1 diabetes in children over the last 40 years. We know from a series of studies<br>
of incidence that it has been rising by 2-3% a year since 1968.<br>
Other types of diabetes include Maturity Onset Diabetes of the Young (MODY), gestational<br>
diabetes and secondary diabetes. The remainder of this report focuses on type 1 and type 2<br>
diabetes and excludes other types.<br>
16<br>
Scottish Diabetes Survey Monitoring Group<br>
<hr>
<A name=17></a>Scottish Diabetes Survey 2012<br>
Figure 7<br>
Proportions of diabetes population by type<br>
0.7%<br>
11.2%<br>
Type 1<br>
Type 2<br>
Other<br>
88.2%<br>
Table 11. Numbers of people with diabetes and the distribution of diabetes type, by NHS<br>
board, Scotland 2012, ranked by the percentage with type 2 diabetes.<br>
NHS Board<br>
Type 1<br>
Type 2<br>
Other types<br>
Total<br>
of diabetes<br>
Number<br>
Percentage<br>
Number<br>
Percentage<br>
Western Isles<br>
185<br>
14.7%<br>
1,070<br>
85.0%<br>
4<br>
1,259<br>
Shetland<br>
128<br>
12.5%<br>
881<br>
86.0%<br>
15<br>
1,024<br>
Lothian<br>
4,282<br>
12.1%<br>
30,735<br>
87.1%<br>
271<br>
35,288<br>
Highland<br>
1,793<br>
11.9%<br>
13,190<br>
87.2%<br>
147<br>
15,130<br>
Grampian<br>
3,129<br>
12.4%<br>
22,037<br>
87.2%<br>
109<br>
25,275<br>
Lanarkshire<br>
3,585<br>
11.8%<br>
26,527<br>
87.6%<br>
187<br>
30,299<br>
Orkney<br>
119<br>
11.9%<br>
877<br>
88.1%<br>
0<br>
996<br>
Forth Valley<br>
1,648<br>
11.1%<br>
13,091<br>
88.2%<br>
111<br>
14,850<br>
Greater Glasgow<br>
&amp; Clyde<br>
6,366<br>
10.8%<br>
52,236<br>
88.4%<br>
519<br>
59,121<br>
Borders<br>
626<br>
10.7%<br>
5,160<br>
88.5%<br>
45<br>
5,831<br>
Dumfries &amp;<br>
Galloway<br>
889<br>
10.5%<br>
7,528<br>
88.7%<br>
67<br>
8,484<br>
Fife<br>
1,986<br>
10.4%<br>
17,030<br>
89.2%<br>
81<br>
19,097<br>
Ayrshire &amp; Arran<br>
2,212<br>
10.5%<br>
18,799<br>
89.2%<br>
62<br>
21,073<br>
Tayside<br>
1,901<br>
9.1%<br>
18,806<br>
90.2%<br>
136<br>
20,843<br>
Scotland<br>
28,849<br>
11.2%<br>
227,967<br>
88.2%<br>
1,754<br>
258,570<br>
Note: Percentages (of the total diabetes population) have been calculated for type 1 and type 2 diabetes only.<br>
17<br>
Scottish Diabetes Survey Monitoring Group<br>
<hr>
<A name=18></a>Scottish Diabetes Survey 2012<br>
Ethnicity<br>
Information on ethnic group was available for 77.7% of the registered diabetic population. The<br>
completeness of this information fell from 37% in 2002 to 24.4% in 2006, increased to 33.3% in<br>
2007 and again to 77.5% in 2011. Type 2 diabetes is much more common in South Asian than<br>
White ethnic groups and tends to present at an earlier age.<br>
Table 12. Type 1 diabetes: completeness of recording of ethnic group by NHS board,<br>
Scotland, 2012, ranked by completeness.<br>
NHS Board<br>
Ethnic group identified<br>
Number<br>
Percentage<br>
Dumfries &amp; Galloway<br>
810<br>
91.1%<br>
Greater Glasgow &amp; Clyde<br>
5,791<br>
91.0%<br>
Shetland<br>
116<br>
90.6%<br>
Forth Valley<br>
1,486<br>
90.2%<br>
Lothian<br>
3,772<br>
88.1%<br>
Lanarkshire<br>
3,062<br>
85.4%<br>
Fife<br>
1,690<br>
85.1%<br>
Highland<br>
1,519<br>
84.7%<br>
Tayside<br>
1,546<br>
81.3%<br>
Orkney<br>
90<br>
75.6%<br>
Western Isles<br>
128<br>
69.2%<br>
Borders<br>
428<br>
68.4%<br>
Grampian<br>
1,954<br>
62.4%<br>
Ayrshire &amp; Arran<br>
1,266<br>
57.2%<br>
Scotland<br>
23,658<br>
82.0%<br>
18<br>
Scottish Diabetes Survey Monitoring Group<br>
<hr>
<A name=19></a>Scottish Diabetes Survey 2012<br>
Table 13. Type 2 diabetes: completeness of recording of ethnic group by NHS board,<br>
Scotland, 2012, ranked by completeness.<br>
NHS Board<br>
Ethnic group identified<br>
Number<br>
Percentage<br>
Shetland<br>
834<br>
94.7%<br>
Greater Glasgow &amp; Clyde<br>
48,663<br>
93.2%<br>
Dumfries &amp; Galloway<br>
6,646<br>
88.3%<br>
Lanarkshire<br>
23,161<br>
87.3%<br>
Highland<br>
11,341<br>
86.0%<br>
Forth Valley<br>
11,150<br>
85.2%<br>
Lothian<br>
24,095<br>
78.4%<br>
Tayside<br>
14,544<br>
77.3%<br>
Orkney<br>
654<br>
74.6%<br>
Borders<br>
3,801<br>
73.7%<br>
Grampian<br>
12,958<br>
58.8%<br>
Fife<br>
9,085<br>
53.3%<br>
Ayrshire &amp; Arran<br>
8,523<br>
45.3%<br>
Western Isles<br>
474<br>
44.3%<br>
Scotland<br>
175,929<br>
77.2%<br>
Figure 8. Completeness of recording of ethnic group from 2011 to 2012: Arrows showing<br>
the direction of change have been added for all boards with more than 4% change<br>
between 2011 and 2012.<br>
98%<br>
SH<br>
Better<br>
GGC<br>
88%<br>
HI<br>
LA<br>
DG<br>
LO<br>
FV<br>
TA<br>
78%<br>
OR<br>
BO<br>
68%<br>
2012<br>
FI<br>
58%<br>
G<br>
AA<br>
48%<br>
WI<br>
Worse<br>
38%38%<br>
48%<br>
58%<br>
68%<br>
78%<br>
88%<br>
98%<br>
2011<br>
Note: Points in red indicate statistically significant change. The diagonal line shows no change between 2011 and 2012.<br>
19<br>
Scottish Diabetes Survey Monitoring Group<br>
<hr>
<A name=20></a>Scottish Diabetes Survey 2012<br>
Table 14. Completeness of recording of ethnic group, 2002-2012 (type 1 and type 2<br>
combined).<br>
Year<br>
Number identified<br>
Percentage identified<br>
2012<br>
199,587<br>
77.7%<br>
2011<br>
190,397<br>
77.5%<br>
2010<br>
164,370<br>
69.6%<br>
2009<br>
126,997<br>
56.0%<br>
2008<br>
94,925<br>
43.2%<br>
2007<br>
69,875<br>
33.3%<br>
2006<br>
48,035<br>
24.4%<br>
2005<br>
42,164<br>
25.0%<br>
2004<br>
44,695<br>
30.6%<br>
2003<br>
49,614<br>
37.0%<br>
2002<br>
32,036<br>
30.9%<br>
Body Mass Index<br>
Body Mass Index (BMI) was recorded for 89.2% of patients with type 1 or type 2 diabetes in the<br>
previous 15 months. This is an increase from 88.7% recorded in 2011 but a slight decrease from<br>
the 89.7% recorded in 2009. Of the 89.2% with a record of BMI, 32.3% were overweight (BMI<br>
25-29.9kg/m</span><span class="ft6">2</span><span class="ft3">) and 52.5% were obese (BMI 30kg/m</span><span class="ft6">2 </span><span class="ft3">or over).<br>
Despite type 2 diabetes being more prevalent in obese patients, 12.3% of those with type 2<br>
diabetes had normal weight (BMI 18.5-24.9kg/m²) and 31.6% were overweight (BMI 25-29.9 kg/<br>
m²).<br>
20<br>
Scottish Diabetes Survey Monitoring Group<br>
<hr>
<A name=21></a>Scottish Diabetes Survey 2012<br>
Table 15. Proportion of people with diabetes who had a record of BMI within the previous 15<br>
months, by NHS Board and diabetes type, 2012, ranked by completeness for type 2.<br>
NHS Board<br>
Type 1 diabetes Type 2 diabetes Total recorded<br>
Total not<br>
BMI percentage BMI percentage<br>
recorded<br>
recorded<br>
recorded<br>
Grampian<br>
90.8%<br>
92.3%<br>
22,863<br>
1,965<br>
Tayside<br>
88.9%<br>
92.2%<br>
18,841<br>
1,659<br>
Lothian<br>
91.4%<br>
91.6%<br>
31,739<br>
2,922<br>
Ayrshire &amp; Arran<br>
85.9%<br>
91.1%<br>
18,810<br>
1,942<br>
Orkney<br>
89.4%<br>
91.1%<br>
892<br>
89<br>
Highland<br>
87.8%<br>
90.5%<br>
13,339<br>
1,445<br>
Borders<br>
90.0%<br>
90.0%<br>
5,136<br>
572<br>
Dumfries &amp; Galloway<br>
88.2%<br>
89.5%<br>
7,447<br>
887<br>
Forth Valley<br>
88.5%<br>
89.1%<br>
12,953<br>
1,589<br>
Fife<br>
87.1%<br>
88.1%<br>
16,552<br>
2,251<br>
Greater Glasgow &amp; Clyde<br>
85.1%<br>
87.7%<br>
50,675<br>
7,276<br>
Lanarkshire<br>
77.2%<br>
86.7%<br>
25,359<br>
4,250<br>
Western Isles<br>
75.2%<br>
84.5%<br>
1,028<br>
207<br>
Shetland<br>
73.7%<br>
67.2%<br>
676<br>
319<br>
Scotland<br>
86.6%<br>
89.5%<br>
226,310<br>
27,373<br>
Note: Excludes patients under 18 years of age and patients whose date of birth has not been recorded (n = 3133).<br>
Figure 9. Proportion of people who had a record of BMI from 2011 to 2012: Arrows showing<br>
the direction of change have been added for all boards with more than 1.5%<br>
change between 2011 and 2012.<br>
94%<br>
Better<br>
92%<br>
AA<br>
GR<br>
TA<br>
OR<br>
HI<br>
LO<br>
90%<br>
DG<br>
FV<br>
BO<br>
FI<br>
88%<br>
2012<br>
GGC<br>
86%<br>
LA<br>
84%<br>
Worse<br>
WI<br>
82%82%<br>
84%<br>
86%<br>
88%<br>
90%<br>
92%<br>
94%<br>
2011<br>
Note: Points in red indicate statistically significant change. The diagonal line shows no change between 2011 and 2012.<br>
21<br>
Scottish Diabetes Survey Monitoring Group<br>
<hr>
<A name=22></a>Scottish Diabetes Survey 2012<br>
Table 16. Proportion of people with diabetes (types 1 and 2 combined) with a record of BMI<br>
in the previous 15 months, Scotland 2001 ­ 2012.<br>
Year<br>
BMI recorded<br>
2012<br>
89.2%<br>
2011<br>
88.7%<br>
2010<br>
82.0%<br>
2009<br>
89.7%<br>
2008<br>
87.4%<br>
2007<br>
85.3%<br>
2006<br>
84.8%<br>
2005<br>
69.1%<br>
2004<br>
66.1%<br>
2003<br>
58.9%<br>
2002<br>
52.3%<br>
2001<br>
39.8%<br>
Note: Excludes patients under 18 years of age and patients whose date of birth has not been recorded (n = 3133).<br>
Table 17. Type 1 diabetes: percentage of people with a record of BMI in the last 15 months<br>
who are in each BMI category (by NHS board), 2012, ranked by % with BMI 40.<br>
NHS<br>
BMI (kg/m</span><span class="ft6">2</span><span class="ft2">)<br>
Total<br>
Not<br>
Board<br>
recorded known<br>
&lt;18.5<br>
18.5-<br>
25-29.9<br>
30-34.9<br>
35-39.9<br>
40<br>
24.9<br>
Highland<br>
1.5%<br>
31.8% 39.8%<br>
18.8%<br>
6.2%<br>
1.9%<br>
1,401<br>
194<br>
Tayside<br>
1.5%<br>
35.2% 38.8%<br>
18.3%<br>
4.2%<br>
2.1%<br>
1,510<br>
189<br>
Grampian<br>
1.3%<br>
35.6% 39.5%<br>
15.9%<br>
5.5%<br>
2.1%<br>
2,536<br>
258<br>
Forth Valley<br>
3.5%<br>
36.2% 35.2%<br>
17.2%<br>
5.7%<br>
2.2%<br>
1,287<br>
168<br>
Lanarkshire<br>
2.0%<br>
34.0% 36.7%<br>
17.7%<br>
7.2%<br>
2.4%<br>
2,436<br>
721<br>
Western<br>
Isles<br>
0.8%<br>
36.3% 37.1%<br>
22.6%<br>
0.8%<br>
2.4%<br>
124<br>
41<br>
Lothian<br>
2.4%<br>
36.0% 37.7%<br>
16.1%<br>
5.3%<br>
2.4%<br>
3,592<br>
337<br>
Fife<br>
1.6%<br>
33.1% 37.9%<br>
18.4%<br>
6.5%<br>
2.5%<br>
1,553<br>
230<br>
Greater<br>
Glasgow &amp;<br>
2.1%<br>
35.3% 38.2%<br>
16.9%<br>
4.8%<br>
2.7%<br>
4,880<br>
857<br>
Clyde<br>
Ayrshire &amp;<br>
Arran<br>
2.2%<br>
33.1% 37.5%<br>
17.5%<br>
6.8%<br>
2.9%<br>
1,681<br>
275<br>
Orkney<br>
0.0%<br>
36.6% 40.9%<br>
8.6%<br>
10.8%<br>
3.2%<br>
93<br>
11<br>
Dumfries &amp;<br>
Galloway<br>
1.1%<br>
33.4% 37.4%<br>
19.2%<br>
5.5%<br>
3.4%<br>
713<br>
95<br>
Borders<br>
1.2%<br>
26.8% 40.4%<br>
19.3%<br>
8.2%<br>
4.0%<br>
497<br>
55<br>
Shetland<br>
1.2%<br>
23.8% 34.5%<br>
28.6%<br>
7.1%<br>
4.8%<br>
84<br>
30<br>
Scotland<br>
2.0%<br>
34.5% 38.0%<br>
17.3%<br>
5.7%<br>
2.5%<br>
22,387<br>
3,461<br>
Note: Excludes patients under 18 years of age and patients whose date of birth has not been recorded (n = 3,001).<br>
22<br>
Scottish Diabetes Survey Monitoring Group<br>
<hr>
<A name=23></a>Scottish Diabetes Survey 2012<br>
Table 18. Type 2 diabetes: proportion of people who are in each BMI category (by NHS<br>
board), 2012, ranked by % with BMI 40.<br>
NHS<br>
BMI (kg/m</span><span class="ft3">2</span><span class="ft2">)<br>
Total<br>
Not<br>
Board<br>
recorded known<br>
&lt;18.5<br>
18.5-<br>
25-29.9<br>
30-34.9<br>
35-39.9<br>
40<br>
24.9<br>
Western<br>
Isles<br>
0.7%<br>
10.8% 31.9%<br>
29.8%<br>
18.5%<br>
8.4%<br>
904<br>
166<br>
Grampian<br>
0.5%<br>
12.4% 32.5%<br>
30.0%<br>
14.9%<br>
9.8%<br>
20,327<br>
1,707<br>
Tayside<br>
0.6%<br>
12.2% 31.7%<br>
30.1%<br>
15.5%<br>
9.8%<br>
17,331<br>
1,470<br>
Highland<br>
0.5%<br>
12.0% 33.2%<br>
29.7%<br>
14.7%<br>
9.9%<br>
11,938<br>
1,251<br>
Dumfries &amp;<br>
Galloway<br>
0.7%<br>
11.6% 32.1%<br>
29.7%<br>
15.7%<br>
10.2%<br>
6,734<br>
792<br>
Greater<br>
Glasgow &amp;<br>
0.6%<br>
13.5% 32.2%<br>
29.1%<br>
14.5%<br>
10.2%<br>
45,795<br>
6,419<br>
Clyde<br>
Lanarkshire<br>
0.5%<br>
12.0% 30.8%<br>
30.1%<br>
16.2%<br>
10.3%<br>
22,923<br>
3,529<br>
Ayrshire &amp;<br>
Arran<br>
0.6%<br>
12.6% 31.9%<br>
29.6%<br>
14.8%<br>
10.5%<br>
17,129<br>
1,667<br>
Borders<br>
0.8%<br>
11.8% 31.7%<br>
29.2%<br>
16.1%<br>
10.5%<br>
4,639<br>
517<br>
Lothian<br>
0.6%<br>
12.3% 30.9%<br>
29.6%<br>
16.0%<br>
10.6%<br>
28,147<br>
2,585<br>
Forth Valley<br>
0.7%<br>
11.2% 30.4%<br>
29.9%<br>
16.6%<br>
11.2%<br>
11,666<br>
1,421<br>
Orkney<br>
0.4%<br>
8.9% 31.0%<br>
32.2%<br>
16.0%<br>
11.5%<br>
799<br>
78<br>
Fife<br>
0.5%<br>
11.0% 30.7%<br>
28.8%<br>
17.1%<br>
11.9%<br>
14,999<br>
2,021<br>
Shetland<br>
0.3%<br>
9.5% 30.1%<br>
25.7%<br>
22.0%<br>
12.5%<br>
592<br>
289<br>
Scotland<br>
0.6%<br>
12.3% 31.6%<br>
29.6%<br>
15.5%<br>
10.4% 203,923<br>
23,912<br>
Note: Excludes children under 12 years of age (n = 132).<br>
Glycaemic Control<br>
92.1% of patients had an HbA recorded in the previous 15 months (table 20). In 55.6% of<br>
1c<br>
patients with a recorded result, HbA was less than 58mmol/mol (7.5%), suggesting reasonable<br>
1c<br>
control of diabetes. While all laboratories in Scotland are using a standardised (IFCC aligned)<br>
HbA assay, there are some slight differences in actual results between laboratories and<br>
1c<br>
some concern remains about the comparability of results between laboratries. This should be<br>
considered when comparing results from different health board areas. It should be noted that<br>
HbA is higher in the winter with an average variability of around 6mmol/mol (0.5%). This is<br>
1c<br>
described in more detail in Appendix 3.<br>
23<br>
Scottish Diabetes Survey Monitoring Group<br>
<hr>
<A name=24></a>Scottish Diabetes Survey 2012<br>
Figure 10. Percentage of patients with diabetes with a recording of HbA1c within the previous<br>
15 months by NHS Board and diabetes type, Scotland, 2012 (horizontal lines show<br>
figures for Scotland as a whole and bars are ranked by figures for type 2 diabetes).<br>
100%<br>
Type 1<br>
90%<br>
Type 2<br>
80%<br>
Scotland -<br>
70%<br>
Type 1<br>
60%<br>
Scotland -<br>
Type 2<br>
50%<br>
40%<br>
30%<br>
20%<br>
10%<br>
0%<br>
&amp;<br>
Fife<br>
Isles<br>
alley<br>
Orkney<br>
Arran<br>
Tayside<br>
V<br>
Clyde<br>
Ayrshire &amp;<br>
Lothian<br>
Shetland<br>
&amp;<br>
Borders<br>
Grampian<br>
Galloway<br>
Highland<br>
Glasgow<br>
estern<br>
Dumfries<br>
Forth<br>
Lanarkshire<br>
W<br>
Greater<br>
Figure 11. Proportion of people with type 1 diabetes who had a record of HbA1c from 2011 to<br>
2012: Arrows showing the direction of change have been added for all boards with<br>
more than 3.5% change between 2011 and 2012<br>
100%<br>
SH<br>
Better<br>
WE<br>
OR<br>
95%<br>
TA<br>
LO<br>
AA<br>
90%<br>
FI<br>
FV<br>
BO<br>
GR<br>
HI<br>
85%<br>
GGC<br>
2012<br>
DG<br>
80%<br>
LA<br>
75%<br>
Worse<br>
70%<br>
75%<br>
80%<br>
85%<br>
90%<br>
95%<br>
100%<br>
2011<br>
Note: Points in red indicate statistically significant change. The diagonal line shows no change between 2011 and 2012.<br>
24<br>
Scottish Diabetes Survey Monitoring Group<br>
<hr>
<A name=25></a>Scottish Diabetes Survey 2012<br>
Figure 12. Proportion of people with type 2 diabetes who had a record of HbA1c from 2011 to<br>
2012: Arrows showing the direction of change have been added for all boards with<br>
more than 1.5% change between 2011 and 2012<br>
Better<br>
99%<br>
OR<br>
97%<br>
WE<br>
TA<br>
FI<br>
95%<br>
AA<br>
SH<br>
LO<br>
DG<br>
93%<br>
GR<br>
FV<br>
GGC<br>
2012<br>
HI<br>
91%<br>
LA<br>
89%<br>
BO<br>
87%<br>
Worse<br>
85%<br>
85%<br>
87%<br>
89%<br>
91%<br>
93%<br>
95%<br>
97%<br>
99%<br>
2011<br>
Note: Points in red indicate statistically significant change. The diagonal line shows no change between 2011 and 2012.<br>
25<br>
Scottish Diabetes Survey Monitoring Group<br>
<hr>
<A name=26></a>Scottish Diabetes Survey 2012<br>
Table 19. Percentage of people with diabetes who had a record of HbA within the previous<br>
1c<br>
15 months, by diabetes type and NHS board, 2012, ranked by figures for type 2.<br>
NHS Board<br>
Type 1 diabetes<br>
Type 2 diabetes<br>
Total<br>
recorded<br>
Recorded within<br>
Not<br>
Recorded within<br>
Not<br>
previous 15 months recorded previous 15 months<br>
recorded<br>
Number Percentage<br>
Number Percentage<br>
Orkney<br>
116<br>
97.5%<br>
3<br>
854<br>
97.4%<br>
23<br>
970<br>
Western Isles<br>
180<br>
97.3%<br>
5<br>
1,028<br>
96.1%<br>
42<br>
1,208<br>
Tayside<br>
1781<br>
93.7%<br>
120<br>
18,044<br>
95.9%<br>
762<br>
19,825<br>
Ayrshire &amp;<br>
Arran<br>
1,990<br>
90.0%<br>
222<br>
17,937<br>
95.4%<br>
862<br>
19,927<br>
Fife<br>
1,767<br>
89.0%<br>
219<br>
16,097<br>
94.5%<br>
933<br>
17,864<br>
Shetland<br>
125<br>
97.7%<br>
3<br>
829<br>
94.1%<br>
52<br>
954<br>
Grampian<br>
2,734<br>
87.4%<br>
395<br>
20,623<br>
93.6%<br>
1,414<br>
23,357<br>
Lothian<br>
3,930<br>
91.8%<br>
352<br>
28,675<br>
93.3%<br>
2,060<br>
32,605<br>
Dumfries &amp;<br>
Galloway<br>
742<br>
83.5%<br>
147<br>
7,001<br>
93.0%<br>
527<br>
7,743<br>
Forth Valley<br>
1,464<br>
88.8%<br>
184<br>
12,110<br>
92.5%<br>
981<br>
13,574<br>
Highland<br>
1514<br>
84.4%<br>
279<br>
12141<br>
92.0%<br>
1,049<br>
13,655<br>
Greater<br>
Glasgow &amp;<br>
5467<br>
85.9%<br>
899<br>
47629<br>
91.2%<br>
4,607<br>
53,096<br>
Clyde<br>
Lanarkshire<br>
2,765<br>
77.1%<br>
820<br>
23,921<br>
90.2%<br>
2,606<br>
26,686<br>
Borders<br>
543<br>
86.7%<br>
83<br>
4,574<br>
88.6%<br>
586<br>
5,117<br>
Scotland<br>
25,118<br>
87.1%<br>
3,731<br>
211,463<br>
92.8%<br>
16,504<br>
236,581<br>
Table 20. Percentage of people with diabetes (type 1 and type 2 combined) with a record of<br>
HbA in previous 15 months, Scotland, 2004-2012.<br>
1c<br>
Year<br>
Recorded within<br>
previous 15 months<br>
2012<br>
92.1%<br>
2011<br>
91.1%<br>
2010<br>
91.4%<br>
2009<br>
89.5%<br>
2008<br>
89.8%<br>
2007<br>
88.7%<br>
2006<br>
87.0%<br>
2005<br>
84.0%<br>
2004<br>
73.6%<br>
26<br>
Scottish Diabetes Survey Monitoring Group<br>
<hr>
<A name=27></a>Scottish Diabetes Survey 2012<br>
Figure 13. Type 1 diabetes: percentage of people in each HbA category for HbA recorded<br>
1c<br>
1c<br>
in the previous 15 months, by NHS Board, 2012, ranked by proportion with HbA</span><span class="ft2">1c<br>
over 75 mmol/mol (9%).<br>
Scotland<br>
HbA1c &lt; 58<br>
HbA1c 58-75<br>
Shetland<br>
HbA1c &gt; 75<br>
Lothian<br>
Not recorded<br>
Lanarkshire<br>
Greater Glasgow &amp; Clyde<br>
Dumfries &amp; Galloway<br>
Highland<br>
Borders<br>
Ayrshire &amp; Arran<br>
Orkney<br>
Fife<br>
Western Isles<br>
Forth Valley<br>
Tayside<br>
Grampian<br>
0%<br>
20%<br>
40%<br>
60%<br>
80%<br>
100%<br>
Figure 14. Type 2 diabetes: percentage of people in each HbA category for HbA recorded<br>
1c<br>
1c<br>
in the previous 15 months, ranked by percentage with HbA over 75mmol/mol<br>
1c<br>
(9%).<br>
Scotland<br>
HbA</span><span class="ft5">1c </span><span class="ft3">&lt; 58<br>
Borders<br>
HbA</span><span class="ft5">1c </span><span class="ft3">58-75<br>
HbA</span><span class="ft5">1c </span><span class="ft3">&gt; 75<br>
Shetland<br>
Not recorded<br>
Lothian<br>
Dumfries &amp; Galloway<br>
Ayrshire &amp; Arran<br>
Fife<br>
Highland<br>
Forth Valley<br>
Tayside<br>
Lanarkshire<br>
Greater Glasgow &amp; Clyde<br>
Grampian<br>
Orkney<br>
Western Isles<br>
0%<br>
20%<br>
40%<br>
60%<br>
80%<br>
100%<br>
27<br>
Scottish Diabetes Survey Monitoring Group<br>
<hr>
<A name=28></a>Scottish Diabetes Survey 2012<br>
Table 21. Type 1 diabetes: HbA category as a percentage of patients with HbA recorded in<br>
1c<br>
1c<br>
previous 15 months, by NHS Board, ranked by proportion with HbA over 75mmol/<br>
1c<br>
mol (9%).<br>
NHS Board<br>
HbA &lt; 58 mmol/<br>
HbA 58 -75<br>
HbA &gt;75 mmol/<br>
Total<br>
Not<br>
1c<br>
1c<br>
1c<br>
mol (7.5%)<br>
mmol/mol (7.5 -<br>
mol (9%)<br>
recorded recorded<br>
9.0%)<br>
Shetland<br>
37<br>
29.6%<br>
59<br>
47.2%<br>
29<br>
23.2%<br>
125<br>
3<br>
Lothian<br>
883<br>
22.5%<br>
1,737<br>
44.2%<br>
1,310<br>
33.3%<br>
3,930<br>
352<br>
Greater Glasgow<br>
&amp; Clyde<br>
1,491<br>
27.3%<br>
2,004<br>
36.7%<br>
1,972<br>
36.1%<br>
5,467<br>
899<br>
Orkney<br>
18<br>
15.5%<br>
56<br>
48.3%<br>
42<br>
36.2%<br>
116<br>
3<br>
Borders<br>
103<br>
19.0%<br>
243<br>
44.8%<br>
197<br>
36.3%<br>
543<br>
83<br>
Highland<br>
324<br>
21.4%<br>
633<br>
41.8%<br>
557<br>
36.8%<br>
1,514<br>
279<br>
Dumfries &amp;<br>
Galloway<br>
154<br>
20.8%<br>
312<br>
42.0%<br>
276<br>
37.2%<br>
742<br>
147<br>
Ayrshire &amp; Arran<br>
428<br>
21.5%<br>
789<br>
39.6%<br>
773<br>
38.8%<br>
1,990<br>
222<br>
Western Isles<br>
26<br>
14.4%<br>
83<br>
46.1%<br>
71<br>
39.4%<br>
180<br>
5<br>
Lanarkshire<br>
563<br>
20.4%<br>
1,093<br>
39.5%<br>
1,109<br>
40.1%<br>
2,765<br>
820<br>
Fife<br>
336<br>
19.0%<br>
679<br>
38.4%<br>
752<br>
42.6%<br>
1,767<br>
219<br>
Forth Valley<br>
304<br>
20.8%<br>
506<br>
34.6%<br>
654<br>
44.7%<br>
1,464<br>
184<br>
Tayside<br>
356<br>
20.0%<br>
624<br>
35.0%<br>
801<br>
45.0%<br>
1,781<br>
120<br>
Grampian<br>
384<br>
14.0%<br>
1,012<br>
37.0%<br>
1,338<br>
48.9%<br>
2,734<br>
395<br>
Scotland<br>
5,407<br>
21.5%<br>
9,830<br>
39.1%<br>
9,881<br>
39.3%<br>
25,118<br>
3,731<br>
28<br>
Scottish Diabetes Survey Monitoring Group<br>
<hr>
<A name=29></a>Scottish Diabetes Survey 2012<br>
Table 22. Type 2 diabetes: HbA category as percentage of patients with HbA recorded in<br>
1c<br>
1c<br>
previous 15 months, by NHS Board, ranked by proportion with HbA over 75mmol/<br>
1c<br>
mol (9%).<br>
NHS Board<br>
HbA &lt; 58 mmol/<br>
HbA 58 -75<br>
HbA &gt;75 mmol/<br>
Total<br>
Not<br>
1c<br>
1c<br>
1c<br>
mol (7.5%)<br>
mmol/mol (7.5 -<br>
mol (9%)<br>
recorded recorded<br>
9.0%)<br>
Borders<br>
2,787<br>
60.9%<br>
1,214<br>
26.5%<br>
573<br>
12.5%<br>
4,574<br>
586<br>
Shetland<br>
553<br>
66.7%<br>
172<br>
20.7%<br>
104<br>
12.5%<br>
829<br>
52<br>
Lothian<br>
17,484<br>
61.0%<br>
7,355<br>
25.6%<br>
3,836<br>
13.4%<br>
28,675<br>
2060<br>
Dumfries &amp;<br>
Galloway<br>
4,201<br>
60.0%<br>
1,844<br>
26.3%<br>
956<br>
13.7%<br>
7,001<br>
527<br>
Ayrshire &amp; Arran<br>
11,282<br>
62.9%<br>
4,148<br>
23.1%<br>
2,507<br>
14.0%<br>
17,937<br>
862<br>
Fife<br>
10,195<br>
63.3%<br>
3,622<br>
22.5%<br>
2,280<br>
14.2%<br>
16,097<br>
933<br>
Tayside<br>
11,145<br>
61.8%<br>
4,183<br>
23.2%<br>
2,716<br>
15.1%<br>
18,044<br>
762<br>
Highland<br>
6,913<br>
56.9%<br>
3,368<br>
27.7%<br>
1,860<br>
15.3%<br>
12,141<br>
1049<br>
Forth Valley<br>
7,124<br>
58.8%<br>
3,124<br>
25.8%<br>
1,862<br>
15.4%<br>
12,110<br>
981<br>
Greater Glasgow<br>
&amp; Clyde<br>
28,420<br>
59.7% 11,280<br>
23.7%<br>
7,929<br>
16.6%<br>
47,629<br>
4607<br>
Lanarkshire<br>
13,814<br>
57.7%<br>
6,102<br>
25.5%<br>
4,005<br>
16.7%<br>
23,921<br>
2606<br>
Orkney<br>
447<br>
52.3%<br>
256<br>
30.0%<br>
151<br>
17.7%<br>
854<br>
23<br>
Grampian<br>
11,259<br>
54.6%<br>
5,590<br>
27.1%<br>
3,774<br>
18.3%<br>
20,623<br>
1414<br>
Western Isles<br>
517<br>
50.3%<br>
289<br>
28.1%<br>
222<br>
21.6%<br>
1,028<br>
42<br>
Scotland<br>
126,141<br>
59.7% 52,547<br>
24.8%<br>
32,775<br>
15.5%<br>
211,463<br>
16,504<br>
Table 23. Type 1 diabetes: number and percentage of people with a record of HbA in each<br>
1c<br>
HbA category, Scotland, 2009-2012.<br>
1c<br>
Year<br>
HbA &lt; 58 (7.5%)<br>
HbA 58-75 (7.5-<br>
HbA &gt;75 (9.0%)<br>
Total<br>
Not<br>
1c<br>
1c<br>
1c<br>
9.0%)<br>
recorded known<br>
Number Percentage Number Percentage Number Percentage<br>
2012<br>
5,407<br>
21.5%<br>
9,830<br>
39.1%<br>
9,881<br>
39.3%<br>
25,118<br>
3,731<br>
2011<br>
5,345<br>
22.0%<br>
9,893<br>
40.7%<br>
9,071<br>
37.3%<br>
24,309<br>
3,963<br>
2010<br>
5,337<br>
21.8%<br>
9,754<br>
39.9%<br>
9,375<br>
38.3%<br>
24,466<br>
3,444<br>
2009<br>
5,194<br>
21.8%<br>
9,556<br>
40.1%<br>
9,096<br>
38.1%<br>
23,846<br>
3,521<br>
Table 24. Type 2 diabetes: number and percentage of people with a record of HbA in each<br>
1c<br>
HbA category, Scotland, 2009-2012.<br>
1c<br>
Year<br>
HbA &lt; 58 (7.5%)<br>
HbA 58-75 (7.5-<br>
HbA &gt;75 (9.0%)<br>
Total<br>
Not<br>
1c<br>
1c<br>
1c<br>
9.0%)<br>
recorded known<br>
Number Percentage Number Percentage Number Percentage<br>
2012 </span><span class="ft6">126,141<br>
59.7%<br>
52,547<br>
24.8%<br>
32,775<br>
15.5%<br>
211,463<br>
16,504<br>
2011 </span><span class="ft6">123,974<br>
62.1%<br>
46,475<br>
23.3%<br>
29,177<br>
14.6%<br>
199,626<br>
17,888<br>
2010 </span><span class="ft6">122,563<br>
64.0%<br>
42,603<br>
22.3%<br>
26,264<br>
13.7%<br>
191,430<br>
16,849<br>
2009 </span><span class="ft6">114,281<br>
63.8%<br>
40,537<br>
22.6%<br>
24,234<br>
13.5%<br>
179,052<br>
20,212<br>
29<br>
Scottish Diabetes Survey Monitoring Group<br>
<hr>
<A name=30></a>Scottish Diabetes Survey 2012<br>
Table 25. Type 1 diabetes: HbA category as percent of all those with HbA recorded in<br>
1c<br>
1c<br>
the previous 15 months (HbA in mmol/mol), by NHS Board, 2011, ranked by<br>
1c<br>
proportion with HbA over 75mmol/mol.<br>
1c<br>
NHS<br>
HbA<br>
HbA<br>
HbA<br>
HbA<br>
HbA<br>
HbA<br>
Total<br>
Not<br>
1c<br>
1c<br>
1c<br>
1c<br>
1c<br>
1c<br>
Board<br>
&lt;53<br>
53-57<br>
58-63<br>
64-68<br>
69-75<br>
&gt;75<br>
recorded recorded<br>
Shetland<br>
12.8%<br>
16.8%<br>
14.4%<br>
15.2%<br>
17.6%<br>
23.2%<br>
125<br>
3<br>
Lothian<br>
13.2%<br>
9.3%<br>
15.8%<br>
13.2%<br>
15.2%<br>
33.3%<br>
3,930<br>
352<br>
Greater<br>
Glasgow &amp;<br>
19.2%<br>
8.1%<br>
12.4%<br>
11.5%<br>
12.8%<br>
36.1%<br>
5,467<br>
899<br>
Clyde<br>
Orkney<br>
8.6%<br>
6.9%<br>
17.2%<br>
10.3%<br>
20.7%<br>
36.2%<br>
116<br>
3<br>
Borders<br>
13.4%<br>
5.5%<br>
12.5%<br>
16.4%<br>
15.8%<br>
36.3%<br>
543<br>
83<br>
Highland<br>
11.6%<br>
9.8%<br>
13.8%<br>
12.8%<br>
15.2%<br>
36.8%<br>
1,514<br>
279<br>
Dumfries &amp;<br>
Galloway<br>
11.3%<br>
9.4%<br>
12.1%<br>
13.2%<br>
16.7%<br>
37.2%<br>
742<br>
147<br>
Ayrshire &amp;<br>
Arran<br>
12.6%<br>
8.9%<br>
12.3%<br>
13.8%<br>
13.6%<br>
38.8%<br>
1,990<br>
222<br>
Western<br>
Isles<br>
7.8%<br>
6.7%<br>
16.1%<br>
14.4%<br>
15.6%<br>
39.4%<br>
180<br>
5<br>
Lanarkshire<br>
12.2%<br>
8.2%<br>
13.5%<br>
11.5%<br>
14.5%<br>
40.1%<br>
2,765<br>
820<br>
Fife<br>
10.2%<br>
8.8%<br>
11.4%<br>
14.6%<br>
12.5%<br>
42.6%<br>
1,767<br>
219<br>
Forth Valley<br>
12.5%<br>
8.3%<br>
12.4%<br>
10.3%<br>
11.8%<br>
44.7%<br>
1,464<br>
184<br>
Tayside<br>
10.5%<br>
9.5%<br>
9.8%<br>
12.7%<br>
12.5%<br>
45.0%<br>
1,781<br>
120<br>
Grampian<br>
6.8%<br>
7.3%<br>
11.4%<br>
12.6%<br>
13.0%<br>
48.9%<br>
2,734<br>
395<br>
Scotland<br>
13.0%<br>
8.5%<br>
12.8%<br>
12.6%<br>
13.8%<br>
39.3%<br>
25,118<br>
3,731<br>
30<br>
Scottish Diabetes Survey Monitoring Group<br>
<hr>
<A name=31></a>Scottish Diabetes Survey 2012<br>
Table 26. Type 2 diabetes: HbA category as percent of all those with HbA recorded in<br>
1c<br>
1c<br>
the previous 15 months (HbA in mmol/mol), by NHS Board, 2011, ranked by<br>
1c<br>
proportion with HbA over 75 mmol/mol (9%).<br>
1c<br>
NHS<br>
HbA<br>
HbA<br>
HbA<br>
HbA<br>
HbA<br>
HbA<br>
Total<br>
Not<br>
1c<br>
1c<br>
1c<br>
1c<br>
1c<br>
1c<br>
Board<br>
&lt;53<br>
53-57<br>
58-63<br>
64-68<br>
69-75<br>
&gt;75<br>
recorded recorded<br>
Borders<br>
43.1%<br>
17.8%<br>
13.5%<br>
7.5%<br>
5.6%<br>
12.5%<br>
4,574<br>
586<br>
Shetland<br>
52.8%<br>
13.9%<br>
9.4%<br>
6.3%<br>
5.1%<br>
12.6%<br>
829<br>
52<br>
Lothian<br>
45.9%<br>
15.1%<br>
12.5%<br>
7.0%<br>
6.2%<br>
13.4%<br>
28,675<br>
2,060<br>
Dumfries &amp;<br>
Galloway<br>
45.9%<br>
14.1%<br>
13.4%<br>
7.1%<br>
5.9%<br>
13.7%<br>
7,001<br>
527<br>
Ayrshire &amp;<br>
Arran<br>
46.9%<br>
16.1%<br>
11.0%<br>
6.9%<br>
5.2%<br>
14.0%<br>
17,937<br>
862<br>
Fife<br>
46.8%<br>
16.5%<br>
10.2%<br>
7.2%<br>
5.1%<br>
14.2%<br>
16,097<br>
933<br>
Tayside<br>
45.9%<br>
15.9%<br>
11.1%<br>
7.1%<br>
5.0%<br>
15.1%<br>
18,044<br>
762<br>
Highland<br>
40.2%<br>
16.7%<br>
13.7%<br>
7.7%<br>
6.4%<br>
15.3%<br>
12,141<br>
1,049<br>
Forth Valley<br>
43.5%<br>
15.4%<br>
12.5%<br>
7.1%<br>
6.2%<br>
15.4%<br>
12,110<br>
981<br>
Greater<br>
Glasgow &amp;<br>
45.8%<br>
13.9%<br>
11.3%<br>
6.4%<br>
6.0%<br>
16.7%<br>
47,629<br>
4,607<br>
Clyde<br>
Lanarkshire<br>
42.7%<br>
15.1%<br>
12.2%<br>
6.9%<br>
6.4%<br>
16.7%<br>
23,921<br>
2,606<br>
Orkney<br>
36.4%<br>
15.9%<br>
12.9%<br>
9.1%<br>
8.0%<br>
17.7%<br>
854<br>
23<br>
Grampian<br>
37.1%<br>
17.5%<br>
12.4%<br>
8.9%<br>
5.8%<br>
18.3%<br>
20,623<br>
1,414<br>
Western<br>
Isles<br>
35.4%<br>
14.9%<br>
13.6%<br>
7.9%<br>
6.6%<br>
21.6%<br>
1,028<br>
42<br>
Scotland<br>
44.2%<br>
15.4%<br>
11.9%<br>
7.1%<br>
5.9%<br>
15.5% 211,463<br>
16,504<br>
31<br>
Scottish Diabetes Survey Monitoring Group<br>
<hr>
<A name=32></a>Scottish Diabetes Survey 2012<br>
Table 27. Mean HbA (mmol/mol) recorded in the previous 15 months, by NHS Board, for<br>
1c<br>
people with type 1 diabetes by age and for type 2 diabetes (all ages combined),<br>
ranked by mean HbA for those with type 2 diabetes.<br>
1c<br>
NHS<br>
Type 1 diabetes; age in years<br>
Type 2<br>
Board<br>
diabetes<br>
0-4<br>
5-9 10-14 15-<br>
20-<br>
25-<br>
30-<br>
40-<br>
50-<br>
60-<br>
&gt;79 All ages<br>
19<br>
24<br>
29<br>
39<br>
49<br>
59<br>
79<br>
Shetland<br>
74<br>
71<br>
65<br>
83<br>
52<br>
65<br>
68<br>
70<br>
62<br>
60<br>
-<br>
56<br>
Ayrshire &amp;<br>
Arran<br>
72<br>
68<br>
76<br>
77<br>
79<br>
72<br>
70<br>
71<br>
70<br>
67<br>
66<br>
57<br>
Fife<br>
73<br>
69<br>
74<br>
80<br>
78<br>
74<br>
72<br>
74<br>
73<br>
70<br>
66<br>
57<br>
Lothian<br>
65<br>
65<br>
71<br>
79<br>
74<br>
71<br>
68<br>
70<br>
69<br>
65<br>
68<br>
57<br>
Borders<br>
-<br>
79<br>
67<br>
78<br>
76<br>
71<br>
72<br>
72<br>
71<br>
65<br>
64<br>
58<br>
Dumfries &amp;<br>
Galloway<br>
-<br>
72<br>
67<br>
81<br>
82<br>
78<br>
72<br>
72<br>
71<br>
65<br>
68<br>
58<br>
Forth Valley<br>
70<br>
62<br>
72<br>
81<br>
85<br>
78<br>
75<br>
71<br>
71<br>
65<br>
63<br>
58<br>
Greater<br>
Glasgow &amp;<br>
57<br>
59<br>
63<br>
70<br>
72<br>
69<br>
65<br>
69<br>
65<br>
64<br>
65<br>
58<br>
Clyde<br>
Tayside<br>
69<br>
68<br>
73<br>
82<br>
84<br>
80<br>
74<br>
72<br>
73<br>
68<br>
59<br>
58<br>
Highland<br>
74<br>
58<br>
68<br>
76<br>
82<br>
76<br>
74<br>
71<br>
70<br>
65<br>
66<br>
59<br>
Lanarkshire<br>
72<br>
67<br>
72<br>
80<br>
79<br>
75<br>
70<br>
71<br>
70<br>
68<br>
65<br>
59<br>
Orkney<br>
64<br>
76<br>
81<br>
91<br>
88<br>
74<br>
70<br>
70<br>
72<br>
63<br>
72<br>
60<br>
Grampian<br>
81<br>
78<br>
81<br>
87<br>
81<br>
76<br>
74<br>
75<br>
75<br>
72<br>
82<br>
61<br>
Western<br>
Isles<br>
56<br>
73<br>
63<br>
85<br>
82<br>
81<br>
71<br>
75<br>
70<br>
65<br>
79<br>
62<br>
32<br>
Scottish Diabetes Survey Monitoring Group<br>
<hr>
<A name=33></a>Scottish Diabetes Survey 2012<br>
Table 28. Numbers (and percentages) of people aged under 18 with type 1 diabetes on<br>
insulin pumps by age and NHS Board, December 2012.<br>
NHS Board<br>
Type 1 population<br>
Number of patients<br>
Percentage<br>
Ayrshire &amp; Arran<br>
257<br>
39<br>
15.2%<br>
Borders<br>
70<br>
22<br>
31.4%<br>
Dumfries &amp; Galloway<br>
80<br>
10<br>
12.5%<br>
Fife<br>
200<br>
33<br>
16.5%<br>
Forth Valley<br>
176<br>
25<br>
14.2%<br>
Grampian<br>
326<br>
38<br>
11.7%<br>
Greater Glasgow &amp; Clyde<br>
635<br>
72<br>
11.3%<br>
Highland<br>
232<br>
6<br>
2.6%<br>
Lanarkshire<br>
399<br>
15<br>
3.8%<br>
Lothian<br>
378<br>
59<br>
15.6%<br>
Orkney<br>
15<br>
3<br>
20.0%<br>
Shetland<br>
14<br>
2<br>
14.3%<br>
Tayside<br>
203<br>
63<br>
31.0%<br>
Western Isles<br>
20<br>
0<br>
0.0%<br>
Scotland<br>
3,005<br>
387<br>
12.9%<br>
Note: These figures are those provided by MCNs to the Scottish Government in December 2012.<br>
Table 29. Numbers (and percentages) of people aged over 18 with type 1 diabetes on insulin<br>
pumps by age and NHS Board, December 2012.<br>
NHS Board<br>
Type 1 population<br>
Number of patients<br>
Percentage<br>
Ayrshire &amp; Arran<br>
1,973<br>
42<br>
2.1%<br>
Borders<br>
541<br>
36<br>
6.7%<br>
Dumfries &amp; Galloway<br>
893<br>
26<br>
2.9%<br>
Fife<br>
1,769<br>
110<br>
6.2%<br>
Forth Valley<br>
1,449<br>
55<br>
3.8%<br>
Grampian<br>
2,779<br>
58<br>
2.1%<br>
Greater Glasgow &amp; Clyde<br>
5,648<br>
88<br>
1.6%<br>
Highland<br>
1,585<br>
40<br>
2.5%<br>
Lanarkshire<br>
3,145<br>
61<br>
1.9%<br>
Lothian<br>
3,799<br>
195<br>
5.1%<br>
Orkney<br>
103<br>
3<br>
2.9%<br>
Shetland<br>
110<br>
3<br>
2.7%<br>
Tayside<br>
1,691<br>
78<br>
4.6%<br>
Western Isles<br>
166<br>
2<br>
1.2%<br>
Scotland<br>
25,651<br>
797<br>
3.1%<br>
Note: These figures are those provided by MCNs to the Scottish Government in December 2012.<br>
33<br>
Scottish Diabetes Survey Monitoring Group<br>
<hr>
<A name=34></a>Scottish Diabetes Survey 2012<br>
Cardiovascular Risk<br>
Diabetes is associated with an increased risk of cardiovascular disease and it is therefore<br>
important to address cardiovascular risk factors such as blood pressure (BP), cholesterol and<br>
smoking.<br>
Blood Pressure<br>
93.6% of people with diabetes had their BP recorded within the previous 15 months, of which<br>
77.5% had a systolic BP less than or equal to 140mmHg, suggesting reasonable control of<br>
blood pressure. However, this target level is under review.<br>
There has been little recent change in the completeness of blood pressure recording (table 31).<br>
However, the proportion with a systolic blood pressure of 140mmHq or greater has fallen (table<br>
37) reflecting better blood pressure control overall.<br>
Figure 15. Percentage of people with diabetes (by diabetes type) with a recording of BP in the<br>
previous 15 months, by NHS Board (horizontal lines show levels for Scotland as a<br>
whole); ranked by figures for type 2 (Note that Y axis is interrupted at 50%).<br>
100%<br>
Type 1<br>
Type 2<br>
90%<br>
Scotland<br>
-<br>
Type 1<br>
80%<br>
Scotland<br>
-<br>
Type 2<br>
70%<br>
60%<br>
50%<br>
&amp;<br>
alley<br>
Fife<br>
Isles<br>
Orkney<br>
Arran<br>
Borders<br>
V<br>
Clyde<br>
Ayrshire &amp;<br>
Tayside<br>
Lothian<br>
&amp;<br>
Grampian<br>
Highland<br>
Galloway<br>
Glasgow<br>
Shetland<br>
Forth<br>
estern<br>
Dumfries<br>
Lanarkshire<br>
W<br>
Greater<br>
34<br>
Scottish Diabetes Survey Monitoring Group<br>
<hr>
<A name=35></a>Scottish Diabetes Survey 2012<br>
Table 30. Percentage of people with diabetes with a recording of BP in the previous 15<br>
months, by NHS Board and diabetes type, ranked by figures for type 2 diabetes.<br>
NHS Board<br>
Recorded within previous 15 months<br>
Type 1 diabetes<br>
Type 2 diabetes<br>
Number<br>
Percentage<br>
Number<br>
Percentage<br>
Orkney<br>
105<br>
88.2%<br>
860<br>
98.1%<br>
Borders<br>
556<br>
88.8%<br>
4,982<br>
96.6%<br>
Grampian<br>
2,674<br>
85.5%<br>
21,266<br>
96.5%<br>
Ayrshire &amp; Arran<br>
1,808<br>
81.7%<br>
18,106<br>
96.3%<br>
Tayside<br>
1,666<br>
87.6%<br>
18,056<br>
96.0%<br>
Lothian<br>
3,789<br>
88.5%<br>
29,487<br>
95.9%<br>
Forth Valley<br>
1,396<br>
84.7%<br>
12,417<br>
94.9%<br>
Western Isles<br>
149<br>
80.5%<br>
1,012<br>
94.6%<br>
Highland<br>
1,488<br>
83.0%<br>
12,462<br>
94.5%<br>
Fife<br>
1,671<br>
84.1%<br>
16,072<br>
94.4%<br>
Dumfries &amp; Galloway<br>
764<br>
85.9%<br>
7,070<br>
93.9%<br>
Greater Glasgow &amp; Clyde<br>
5,509<br>
86.5%<br>
48,849<br>
93.5%<br>
Lanarkshire<br>
2,910<br>
81.2%<br>
24,441<br>
92.1%<br>
Shetland<br>
89<br>
69.5%<br>
622<br>
70.6%<br>
Scotland<br>
24,574<br>
85.2%<br>
215,702<br>
94.6%<br>
Note: The numbers in this Table relate to all ages.<br>
Table 31. Percentage of people with Type 1 or Type 2 diabetes with a record of BP within the<br>
previous 15 months, Scotland, 2009-2012.<br>
Type 1<br>
Year<br>
Type 1 population<br>
BP Recorded (n)<br>
BP (%)<br>
2012<br>
28,849<br>
24,574<br>
85.2%<br>
2011<br>
28,272<br>
24,165<br>
85.5%<br>
2010<br>
27,910<br>
23,977<br>
85.9%<br>
2009<br>
27,367<br>
23,568<br>
86.1%<br>
Type 2<br>
Year<br>
Type 2 population<br>
BP Recorded (n)<br>
BP (%)<br>
2012<br>
227,967<br>
215,702<br>
94.6%<br>
2011<br>
217,514<br>
204,782<br>
94.1%<br>
2010<br>
208,279<br>
196,638<br>
94.4%<br>
2009<br>
199,264<br>
189,289<br>
95.0%<br>
35<br>
Scottish Diabetes Survey Monitoring Group<br>
<hr>
<A name=36></a>Scottish Diabetes Survey 2012<br>
Figure 16. Type 1 diabetes : percentage of people with most recent systolic blood pressure<br>
(SBP) &lt; 140 mmHg in the last 15 months by NHS Board. Horizontal line indicates<br>
level for Scotland as a whole.<br>
100%<br>
Systolic BP  140<br>
90%<br>
80%<br>
70%<br>
60%<br>
50%<br>
40%<br>
30%<br>
20%<br>
10%<br>
0%<br>
&amp;<br>
&amp;<br>
Fife<br>
Arran<br>
alley<br>
Isles<br>
Orkney<br>
Lothian<br>
Clyde<br>
V<br>
Shetland<br>
Tayside<br>
Borders<br>
Ayrshire<br>
Grampian<br>
Highland<br>
Glasgow &amp;<br>
Galloway<br>
Lanarkshire<br>
Dumfries<br>
Forth<br>
esternW<br>
Greater<br>
Figure 17. Type 1 diabetes :percentage of people with most recent blood pressure in the<br>
last 15 months &lt; 130 mmHg (systolic) and &lt;80mmHg (diastolic), by NHS Board.<br>
Horizontal line indicates level for Scotland as a whole.<br>
100%<br>
BP  130/80<br>
90%<br>
Scotland  130<br>
80%<br>
70%<br>
60%<br>
50%<br>
40%<br>
30%<br>
20%<br>
10%<br>
0%<br>
&amp;<br>
&amp;<br>
Arran<br>
Isles<br>
alley<br>
Fife<br>
Orkney<br>
Clyde&amp;<br>
Lothian<br>
V<br>
Tayside<br>
Grampian<br>
Ayrshire<br>
Highland<br>
Glasgow<br>
Shetland<br>
Galloway<br>
Borders<br>
estern<br>
Lanarkshire<br>
Forth<br>
Dumfries<br>
W<br>
Greater<br>
36<br>
Scottish Diabetes Survey Monitoring Group<br>
<hr>
<A name=37></a>Scottish Diabetes Survey 2012<br>
Figure 18. Type 2 diabetes: percentage of people with most recent systolic blood pressure<br>
(SBP) &lt; 140 mmHg in the last 15 months by NHS Board. Horizontal line indicates<br>
level for Scotland as a whole.<br>
100%<br>
90%<br>
Systolic BP  140<br>
80%<br>
Scotland  140<br>
70%<br>
60%<br>
50%<br>
40%<br>
30%<br>
20%<br>
10%<br>
0%<br>
&amp;<br>
&amp;<br>
alley<br>
Fife<br>
Clyde<br>
Arran<br>
Isles<br>
Lothian<br>
V<br>
Orkney<br>
Glasgow &amp;<br>
Galloway<br>
Shetland<br>
Borders<br>
Grampian<br>
Highland<br>
Tayside<br>
Lanarkshire<br>
Ayrshire<br>
Forth<br>
Dumfries<br>
esternW<br>
Greater<br>
Figure 19. Type 2 diabetes: percentage of people with most recent blood pressure in the<br>
last 15 months &lt; 130 mmHg (systolic) and &lt;80mmHg (diastolic), by NHS Board.<br>
Horizontal line indicates level for Scotland as a whole.<br>
100%<br>
BP  130/80<br>
90%<br>
Scotland  130<br>
80%<br>
70%<br>
60%<br>
50%<br>
40%<br>
30%<br>
20%<br>
10%<br>
0%<br>
&amp;<br>
&amp;<br>
alley<br>
Fife<br>
Clyde<br>
Arran<br>
Isles<br>
&amp;<br>
Lothian<br>
V<br>
Orkney<br>
Glasgow<br>
Tayside<br>
Borders<br>
Grampian<br>
Shetland<br>
Ayrshire<br>
Highland<br>
Galloway<br>
Lanarkshire<br>
Forth<br>
estern<br>
Dumfries<br>
W<br>
Greater<br>
37<br>
Scottish Diabetes Survey Monitoring Group<br>
<hr>
<A name=38></a>Scottish Diabetes Survey 2012<br>
Table 32. Type 1 diabetes : percentage of people with systolic blood pressure (SBP) &lt; 140<br>
mmHg by NHS Board, ranked by percentage &gt; 140.<br>
NHS<br>
Systolic BP  140<br>
Systolic BP &gt; 140<br>
Total<br>
Not recorded (n,%)<br>
Board<br>
recorded<br>
Number Percentage Number Percentage<br>
Number Percentage<br>
Orkney<br>
89<br>
84.8%<br>
16<br>
15.2%<br>
105<br>
14<br>
11.8%<br>
Ayrshire &amp;<br>
Arran<br>
1,527<br>
84.5%<br>
281<br>
15.5%<br>
1,808<br>
404<br>
18.3%<br>
Shetland<br>
75<br>
84.3%<br>
14<br>
15.7%<br>
89<br>
39<br>
30.5%<br>
Lanarkshire<br>
2,449<br>
84.2%<br>
461<br>
15.8%<br>
2,910<br>
675<br>
18.8%<br>
Grampian<br>
2,246<br>
84.0%<br>
428<br>
16.0%<br>
2,674<br>
455<br>
14.5%<br>
Highland<br>
1,214<br>
81.6%<br>
274<br>
18.4%<br>
1,488<br>
305<br>
17.0%<br>
Lothian<br>
3,090<br>
81.6%<br>
699<br>
18.4%<br>
3,789<br>
493<br>
11.5%<br>
Greater<br>
Glasgow &amp;<br>
4,405<br>
80.0%<br>
1,104<br>
20.0%<br>
5,509<br>
857<br>
13.5%<br>
Clyde<br>
Dumfries &amp;<br>
Galloway<br>
603<br>
78.9%<br>
161<br>
21.1%<br>
764<br>
125<br>
14.1%<br>
Forth Valley<br>
1,101<br>
78.9%<br>
295<br>
21.1%<br>
1,396<br>
252<br>
15.3%<br>
Western<br>
Isles<br>
117<br>
78.5%<br>
32<br>
21.5%<br>
149<br>
36<br>
19.5%<br>
Tayside<br>
1,291<br>
77.5%<br>
375<br>
22.5%<br>
1,666<br>
235<br>
12.4%<br>
Fife<br>
1,264<br>
75.6%<br>
407<br>
24.4%<br>
1,671<br>
315<br>
15.9%<br>
Borders<br>
367<br>
66.0%<br>
189<br>
34.0%<br>
556<br>
70<br>
11.2%<br>
Scotland<br>
19,838<br>
80.7%<br>
4,736<br>
19.3%<br>
24,574<br>
4,275<br>
14.8%<br>
Note: Restricted to most recent value recorded in the previous 15 months ­ those recorded longer ago than that were<br>
classed as missing (not recorded).<br>
38<br>
Scottish Diabetes Survey Monitoring Group<br>
<hr>
<A name=39></a>Scottish Diabetes Survey 2012<br>
Figure 20. Type 1 diabetes: percentage of people with SBP  140mmHg from 2011 to 2012:<br>
Arrows showing the direction of change have been added for all boards with more<br>
than 2.5% change between 2011 and 2012.<br>
86%<br>
FV<br>
Better<br>
LA<br>
GR LA<br>
84%<br>
SH<br>
82%<br>
HI<br>
OR<br>
GGC<br>
80%<br>
AA<br>
DG<br>
2012 78%<br>
TA<br>
WI<br>
76%<br>
FI<br>
74%<br>
Worse<br>
72%72%<br>
74%<br>
76%<br>
78%<br>
80%<br>
82%<br>
84%<br>
86%<br>
2011<br>
Note: Points in red indicate statistically significant change. The diagonal line shows no change between 2011 and 2012.<br>
39<br>
Scottish Diabetes Survey Monitoring Group<br>
<hr>
<A name=40></a>Scottish Diabetes Survey 2012<br>
Table 33. Type 1 diabetes: percentage of people with systolic blood pressure (SBP) &lt;130<br>
mmHg AND diastolic blood pressure (DBP) &lt;80mmHg, by NHS Board (denominator<br>
those with recording of SBP and DBP within the previous 15 months), ranked by<br>
percentage &gt; 130/80.<br>
NHS<br>
BP  130/80<br>
BP &gt; 130/80<br>
Total<br>
Not recorded<br>
Board<br>
recorded<br>
Number Percentage Number Percentage<br>
Number Percentage<br>
Grampian<br>
1,507<br>
56.4%<br>
1,167<br>
43.6%<br>
2,674<br>
455<br>
14.5%<br>
Ayrshire &amp;<br>
Arran<br>
962<br>
53.2%<br>
846<br>
46.8%<br>
1,808<br>
404<br>
18.3%<br>
Western<br>
Isles<br>
77<br>
51.7%<br>
72<br>
48.3%<br>
149<br>
36<br>
19.5%<br>
Lanarkshire<br>
1,471<br>
50.6%<br>
1,439<br>
49.5%<br>
2,910<br>
675<br>
18.8%<br>
Orkney<br>
51<br>
48.6%<br>
54<br>
51.4%<br>
105<br>
14<br>
11.8%<br>
Highland<br>
708<br>
47.6%<br>
780<br>
52.4%<br>
1,488<br>
305<br>
17.0%<br>
Greater<br>
Glasgow &amp;<br>
2,592<br>
47.1%<br>
2,917<br>
52.9%<br>
5,509<br>
857<br>
13.5%<br>
Clyde<br>
Lothian<br>
1,767<br>
46.6%<br>
2,022<br>
53.4%<br>
3,789<br>
493<br>
11.5%<br>
Shetland<br>
40<br>
44.9%<br>
49<br>
55.1%<br>
89<br>
39<br>
30.5%<br>
Forth Valley<br>
618<br>
44.3%<br>
778<br>
55.7%<br>
1,396<br>
252<br>
15.3%<br>
Fife<br>
710<br>
42.5%<br>
961<br>
57.5%<br>
1,671<br>
315<br>
15.9%<br>
Tayside<br>
695<br>
41.7%<br>
971<br>
58.3%<br>
1,666<br>
235<br>
12.4%<br>
Dumfries &amp;<br>
Galloway<br>
300<br>
39.3%<br>
464<br>
60.7%<br>
764<br>
125<br>
14.1%<br>
Borders<br>
207<br>
37.2%<br>
349<br>
62.8%<br>
556<br>
70<br>
11.2%<br>
Scotland<br>
11,705<br>
47.6%<br>
12,869<br>
52.4%<br>
24,574<br>
4,275<br>
14.8%<br>
Note: Restricted to most recent value recorded in the previous 15 months ­ those recorded longer ago than that were<br>
classed as missing (not recorded).<br>
40<br>
Scottish Diabetes Survey Monitoring Group<br>
<hr>
<A name=41></a>Scottish Diabetes Survey 2012<br>
Table 34. Type 2 diabetes: percentage of people with systolic blood pressure (SBP) &lt;<br>
140 mmHg by NHS Board (denominator those with recording of SBP within the<br>
previous 15 months), ranked by percentage &gt; 140.<br>
NHS<br>
Systolic BP  140<br>
Systolic BP &gt; 140<br>
Total<br>
Not recorded<br>
Board<br>
recorded<br>
Number Percentage Number Percentage<br>
Number Percentage<br>
Lanarkshire<br>
19,780<br>
80.9%<br>
4,661<br>
19.1%<br>
24,441<br>
2086<br>
7.9%<br>
Greater<br>
Glasgow &amp;<br>
38454<br>
78.7%<br>
10395<br>
21.3%<br>
48,849<br>
3387<br>
6.5%<br>
Clyde<br>
Lothian<br>
22941<br>
77.8%<br>
6546<br>
22.2%<br>
29,487<br>
1248<br>
4.1%<br>
Ayrshire &amp;<br>
Arran<br>
14,031<br>
77.5%<br>
4,075<br>
22.5%<br>
18,106<br>
693<br>
3.7%<br>
Forth Valley<br>
9593<br>
77.3%<br>
2824<br>
22.7%<br>
12,417<br>
674<br>
5.1%<br>
Dumfries &amp;<br>
Galloway<br>
5411<br>
76.5%<br>
1659<br>
23.5%<br>
7,070<br>
458<br>
6.1%<br>
Shetland<br>
475<br>
76.4%<br>
147<br>
23.6%<br>
622<br>
259<br>
29.4%<br>
Grampian<br>
15,998<br>
75.2%<br>
5,268<br>
24.8%<br>
21,266<br>
771<br>
3.5%<br>
Fife<br>
12069<br>
75.1%<br>
4003<br>
24.9%<br>
16,072<br>
958<br>
5.6%<br>
Borders<br>
3739<br>
75.1%<br>
1243<br>
24.9%<br>
4,982<br>
178<br>
3.4%<br>
Highland<br>
9289<br>
74.5%<br>
3173<br>
25.5%<br>
12,462<br>
728<br>
5.5%<br>
Tayside<br>
13301<br>
73.7%<br>
4755<br>
26.3%<br>
18,056<br>
750<br>
4.0%<br>
Western<br>
Isles<br>
740<br>
73.1%<br>
272<br>
26.9%<br>
1,012<br>
58<br>
5.4%<br>
Orkney<br>
625<br>
72.7%<br>
235<br>
27.3%<br>
860<br>
17<br>
1.9%<br>
Scotland<br>
166,446<br>
77.2%<br>
49,256<br>
22.8%<br>
215,702<br>
12,265<br>
5.4%<br>
Note: Restricted to most recent value recorded in the previous 15 months ­ those recorded longer ago than that were<br>
classed as missing (not recorded).<br>
41<br>
Scottish Diabetes Survey Monitoring Group<br>
<hr>
<A name=42></a>Scottish Diabetes Survey 2012<br>
Figure 21. Type 2 diabetes: percentage of people with SBP  140mmHg from 2011 to 2012:<br>
Arrows showing the direction of change have been added for all boards with more<br>
than 1.5% change between 2011 and 2012.<br>
82%<br>
Better<br>
LA<br>
80%<br>
GGC<br>
AA<br>
LO<br>
78%<br>
FV<br>
SH<br>
DG<br>
76%<br>
GR<br>
HI<br>
FI<br>
BO<br>
2012<br>
TA<br>
74%<br>
OR<br>
WI<br>
72%<br>
70%<br>
Worse<br>
68%68%<br>
70%<br>
72%<br>
74%<br>
76%<br>
78%<br>
80%<br>
2011<br>
Note: Points in red indicate statistically significant change. The diagonal line shows no change between 2011 and 2012.<br>
42<br>
Scottish Diabetes Survey Monitoring Group<br>
<hr>
<A name=43></a>Scottish Diabetes Survey 2012<br>
Table 35. Type 2 diabetes: percentage of people with systolic blood pressure (SBP) &lt;130<br>
mmHg AND diastolic blood pressure (DBP) &lt;80mmHg, by NHS Board (denominator<br>
those with recording of SBP and DBP within the previous 15 months), ranked by<br>
percentage &gt; 130/80.<br>
NHS<br>
BP  130/80<br>
BP &gt; 130/80<br>
Total<br>
Not recorded<br>
Board<br>
recorded<br>
Number Percentage Number Percentage<br>
Number Percentage<br>
Greater<br>
Glasgow &amp;<br>
17,262<br>
35.3%<br>
31,587<br>
64.7%<br>
48,849<br>
3387<br>
6.5%<br>
Clyde<br>
Lanarkshire<br>
8365<br>
34.2%<br>
16076<br>
65.8%<br>
24,441<br>
2086<br>
7.9%<br>
Lothian<br>
9647<br>
32.7%<br>
19840<br>
67.3%<br>
29,487<br>
1248<br>
4.1%<br>
Forth Valley<br>
4,029<br>
32.4%<br>
8,388<br>
67.6%<br>
12,417<br>
674<br>
5.1%<br>
Grampian<br>
6851<br>
32.2%<br>
14415<br>
67.8%<br>
21,266<br>
771<br>
3.5%<br>
Fife<br>
5176<br>
32.2%<br>
10896<br>
67.8%<br>
16,072<br>
958<br>
5.6%<br>
Shetland<br>
195<br>
31.4%<br>
427<br>
68.7%<br>
622<br>
259<br>
29.4%<br>
Ayrshire &amp;<br>
Arran<br>
5,667<br>
31.3%<br>
12,439<br>
68.7%<br>
18,106<br>
693<br>
3.7%<br>
Western<br>
Isles<br>
315<br>
31.1%<br>
697<br>
68.9%<br>
1,012<br>
58<br>
5.4%<br>
Tayside<br>
5518<br>
30.6%<br>
12538<br>
69.4%<br>
18,056<br>
750<br>
4.0%<br>
Borders<br>
1485<br>
29.8%<br>
3497<br>
70.2%<br>
4,982<br>
178<br>
3.5%<br>
Highland<br>
3689<br>
29.6%<br>
8773<br>
70.4%<br>
12,462<br>
728<br>
5.5%<br>
Dumfries &amp;<br>
Galloway<br>
1991<br>
28.2%<br>
5079<br>
71.8%<br>
7,070<br>
458<br>
6.1%<br>
Orkney<br>
231<br>
26.9%<br>
629<br>
73.1%<br>
860<br>
17<br>
1.9%<br>
Scotland<br>
70,421<br>
32.6% 145,281<br>
67.4%<br>
215,702<br>
12,265<br>
5.4%<br>
Note. Restricted to most recent value recorded in the previous 15 months ­ those recorded longer ago than that were<br>
classed as missing (not recorded).<br>
Table 36. Percentage of people with diabetes (type 1 and type 2 combined) with systolic<br>
blood pressure (SBP) &lt; 140 mmHg (denominator those with recording of SBP<br>
within the previous 15 months), Scotland, 2005-2012.<br>
Year<br>
Total<br>
Systolic BP  140 Systolic BP &gt; 140<br>
Not recorded<br>
2012<br>
256,816<br>
77.5%<br>
22.5%<br>
6.4%<br>
2011<br>
228,948<br>
76.0%<br>
24.0%<br>
6.9%<br>
2010<br>
220,615<br>
74.9%<br>
25.1%<br>
6.6%<br>
2009<br>
212,857<br>
75.1%<br>
24.9%<br>
6.1%<br>
2008<br>
199,650<br>
73.3%<br>
26.7%<br>
9.2%<br>
2007<br>
204,166<br>
73.0%<br>
27.0%<br>
2.6%<br>
2006<br>
188,424<br>
71.1%<br>
28.9%<br>
4.3%<br>
2005<br>
155,269<br>
69.2%<br>
30.8%<br>
7.9%<br>
Note: From 2008 onwards, there was a requirement that BP should be in previous 15 months. In 2004 to 2007, older<br>
results could be included if there was no recent result.<br>
43<br>
Scottish Diabetes Survey Monitoring Group<br>
<hr>
<A name=44></a>Scottish Diabetes Survey 2012<br>
Table 37. Type 1 diabetes: mean BP (mmHg) recorded in previous 15 months in people aged<br>
&lt;40 years, by NHS Board, 2012, ranked by mean systolic BP.<br>
NHS Board<br>
Mean systolic BP<br>
Mean diastolic BP<br>
Grampian<br>
119<br>
70<br>
Ayrshire &amp; Arran<br>
119<br>
72<br>
Western Isles<br>
119<br>
72<br>
Orkney<br>
120<br>
70<br>
Highland<br>
121<br>
73<br>
Lanarkshire<br>
122<br>
74<br>
Lothian<br>
123<br>
75<br>
Greater Glasgow &amp; Clyde<br>
124<br>
74<br>
Shetland<br>
125<br>
72<br>
Forth Valley<br>
125<br>
73<br>
Dumfries &amp; Galloway<br>
125<br>
75<br>
Tayside<br>
125<br>
75<br>
Fife<br>
125<br>
77<br>
Borders<br>
127<br>
74<br>
Table 38. Type 2 diabetes: mean BP recorded in previous 15 months in people aged 50-60<br>
years, by NHS Board, 2012, ranked by mean systolic BP.<br>
NHS Board<br>
Mean systolic BP<br>
Mean diastolic BP<br>
Lothian<br>
131<br>
78<br>
Dumfries &amp; Galloway<br>
132<br>
78<br>
Forth Valley<br>
132<br>
78<br>
Greater Glasgow &amp; Clyde<br>
132<br>
78<br>
Lanarkshire<br>
132<br>
78<br>
Ayrshire &amp; Arran<br>
133<br>
78<br>
Borders<br>
133<br>
78<br>
Grampian<br>
133<br>
78<br>
Highland<br>
133<br>
78<br>
Fife<br>
133<br>
79<br>
Tayside<br>
133<br>
79<br>
Western Isles<br>
133<br>
79<br>
Orkney<br>
134<br>
79<br>
Shetland<br>
134<br>
80<br>
44<br>
Scottish Diabetes Survey Monitoring Group<br>
<hr>
<A name=45></a>Scottish Diabetes Survey 2012<br>
Total cholesterol<br>
Cholesterol was recorded in 90.6% of people with type 1 or type 2 diabetes within the previous<br>
15 months. Total cholesterol was less than or equal to 5.0mmol/l in 79.5% of patients with a<br>
recorded result.<br>
Figure 22. Percentage of people with diabetes with a record of cholesterol within the previous<br>
15 months by diabetes type and NHS Board, 2012. Horizontal lines indicate figures<br>
for Scotland as a whole.<br>
100%<br>
Type 1<br>
90%<br>
80%<br>
Type 2<br>
70%<br>
Scotland<br>
Type 1<br>
60%<br>
Scotland<br>
50%<br>
Type 2<br>
40%<br>
30%<br>
20%<br>
10%<br>
0%<br>
&amp;<br>
&amp;<br>
Fife<br>
Arran<br>
Isles<br>
alley<br>
Orkney<br>
Tayside<br>
Lothian<br>
Borders<br>
Clyde<br>
V<br>
&amp;<br>
Grampian<br>
Highland<br>
Ayrshire<br>
Galloway<br>
Shetland<br>
Dumfries<br>
Glasgow<br>
estern<br>
Lanarkshire<br>
Forth<br>
W<br>
Greater<br>
Note: Excludes children under 12 years (n=986).<br>
45<br>
Scottish Diabetes Survey Monitoring Group<br>
<hr>
<A name=46></a>Scottish Diabetes Survey 2012<br>
Figure 23. Percentage of people with diabetes (type 1 and type 2 combined) with a record<br>
of cholesterol within the previous 15 months from 2011 to 2012: Arrows showing<br>
the direction of change have been added for all boards with more than 1% change<br>
between 2011 and 2012.<br>
98%<br>
Better<br>
96%<br>
OR<br>
94%<br>
AA<br>
FI<br>
GR<br>
TA<br>
92%<br>
LO<br>
SH<br>
BO<br>
2012<br>
HI<br>
WI<br>
DG<br>
90%<br>
GGC<br>
LA<br>
FV<br>
88%<br>
86%<br>
Worse<br>
84%84%<br>
86%<br>
88%<br>
90%<br>
92%<br>
94%<br>
96%<br>
98%<br>
2011<br>
Note: Points in red indicate statistically significant change. The diagonal line shows no change between 2011 and 2012.<br>
Table 39. Percentage of people with diabetes (Type 1 and Type 2 combined) with a record of<br>
cholesterol within the previous 15 months, Scotland, 2002-2012.<br>
Year<br>
Recorded within previous 15 months<br>
2012<br>
90.6%<br>
2011<br>
89.2%<br>
2010<br>
89.6%<br>
2009<br>
86.5%<br>
2008<br>
90.1%<br>
2007<br>
88.4%<br>
2006<br>
85.5%<br>
2005<br>
79.2%<br>
2004<br>
69.0%<br>
2003<br>
40.2%<br>
2002<br>
60.5%<br>
Note: Excludes patients under 18 years of age and patients whose date of birth has not been recorded (n = 3133).<br>
46<br>
Scottish Diabetes Survey Monitoring Group<br>
<hr>
<A name=47></a>Scottish Diabetes Survey 2012<br>
Figure 24. Type 1 diabetes: percentage of people with cholesterol 5mmol/l, by NHS Board<br>
(denominator those with recording of cholesterol within the previous 15 months).<br>
Horizontal line indicates level for Scotland as a whole.<br>
100%<br>
Chol &lt;= 5<br>
90%<br>
mmol/l<br>
80%<br>
Scotland<br>
70%<br>
60%<br>
50%<br>
40%<br>
30%<br>
20%<br>
10%<br>
0%<br>
Fife<br>
Arran<br>
Clyde<br>
alley<br>
Isles<br>
Orkney<br>
Tayside<br>
&amp;<br>
&amp;<br>
V<br>
Lothian<br>
Grampian<br>
Highland<br>
Borders<br>
Galloway<br>
Shetland<br>
Forth<br>
estern<br>
&amp;<br>
Lanarkshire<br>
W<br>
Ayrshire<br>
Glasgow<br>
Dumfries<br>
Greater<br>
Note: Excludes children under 12 years (n=980).<br>
Figure 25. Type 2 diabetes: percentage of people with cholesterol 5mmol/l, by NHS Board<br>
(denominator those with recording of cholesterol within the previous 15 months).<br>
Horizontal line indicates level for Scotland as a whole.<br>
100%<br>
Chol &lt;= 5<br>
90%<br>
mmol/l<br>
Scotland<br>
80%<br>
70%<br>
60%<br>
50%<br>
40%<br>
30%<br>
20%<br>
10%<br>
0%<br>
&amp;<br>
&amp;<br>
Fife<br>
Arran<br>
alley<br>
Isles<br>
Lothian<br>
Tayside<br>
Clyde<br>
Borders<br>
&amp;<br>
V<br>
Orkney<br>
Grampian<br>
Glasgow<br>
yrshireA<br>
Galloway<br>
Highland<br>
Shetland<br>
Forth<br>
Lanarkshire<br>
Dumfries<br>
esternW<br>
Greater<br>
Note: Excludes children under 12 years (n= 6).<br>
47<br>
Scottish Diabetes Survey Monitoring Group<br>
<hr>
<A name=48></a>Scottish Diabetes Survey 2012<br>
Figure 26. Percentage of people with diabetes (type 1 and type 2 combined) with cholesterol<br>
 5 mmol/l within the previous 15 months from 2011 to 2012: Arrows showing the<br>
direction of change have been added for all boards with more than 1.5% change<br>
between 2011 and 2012.<br>
68%<br>
TA<br>
Better<br>
66%<br>
GGC<br>
GR<br>
LO<br>
64%<br>
FV<br>
AA<br>
OR<br>
BO<br>
62%<br>
FI<br>
60%<br>
LA<br>
2012<br>
HI<br>
58%<br>
DG<br>
56%<br>
54%<br>
WI<br>
SH<br>
52%<br>
Worse<br>
50%54%<br>
56%<br>
58%<br>
60%<br>
62%<br>
64%<br>
66%<br>
68%<br>
2011<br>
Note: Points in red indicate statistically significant change. The diagonal line shows no change between 2011 and 2012.<br>
Table 40. Type 1 diabetes : percentage of people with cholesterol 5mmol/l, by NHS Board<br>
(denominator those with recording of cholesterol within the previous 15 months),<br>
ranked by percentage.<br>
NHS Board<br>
Total recorded<br>
Total cholesterol  5<br>
Not recorded<br>
Orkney<br>
99<br>
76.8%<br>
4.8%<br>
Tayside<br>
1,337<br>
74.0%<br>
21.3%<br>
Grampian<br>
2,277<br>
73.9%<br>
18.5%<br>
Highland<br>
1,348<br>
72.3%<br>
15.5%<br>
Borders<br>
487<br>
71.5%<br>
11.8%<br>
Ayrshire &amp; Arran<br>
1,626<br>
70.3%<br>
16.9%<br>
Fife<br>
1,450<br>
70.0%<br>
18.7%<br>
Greater Glasgow &amp; Clyde<br>
4,474<br>
69.3%<br>
22.0%<br>
Forth Valley<br>
1,247<br>
69.3%<br>
14.3%<br>
Lothian<br>
3,295<br>
68.3%<br>
16.1%<br>
Western Isles<br>
150<br>
66.7%<br>
9.1%<br>
Dumfries &amp; Galloway<br>
672<br>
65.6%<br>
16.8%<br>
Lanarkshire<br>
2,430<br>
64.9%<br>
23.0%<br>
Shetland<br>
101<br>
61.4%<br>
11.4%<br>
Scotland<br>
20,993<br>
69.7%<br>
18.8%<br>
Note: Excludes patients under 18 years of age and patients whose date of birth has not been recorded (n = 3001).<br>
48<br>
Scottish Diabetes Survey Monitoring Group<br>
<hr>
<A name=49></a>Scottish Diabetes Survey 2012<br>
Table 41. Type 2 diabetes: percentage of people with cholesterol 5mmol/l, by NHS Board<br>
(denominator those with recording of cholesterol within the previous 15 months),<br>
ranked by percentage.<br>
NHS Board<br>
Total recorded<br>
Total cholesterol  5<br>
Not recorded<br>
Grampian<br>
20,777<br>
82.5%<br>
5.7%<br>
Lothian<br>
28,409<br>
81.9%<br>
7.6%<br>
Tayside<br>
17,837<br>
81.9%<br>
5.1%<br>
Fife<br>
15,964<br>
81.6%<br>
6.2%<br>
Borders<br>
4,742<br>
80.5%<br>
8.0%<br>
Greater Glasgow &amp; Clyde<br>
46,706<br>
80.4%<br>
10.5%<br>
Ayrshire &amp; Arran<br>
17,713<br>
80.0%<br>
5.8%<br>
Forth Valley<br>
11,583<br>
80.0%<br>
11.5%<br>
Orkney<br>
841<br>
79.7%<br>
4.1%<br>
Lanarkshire<br>
23,579<br>
78.9%<br>
10.8%<br>
Dumfries &amp; Galloway<br>
6,885<br>
77.2%<br>
8.5%<br>
Highland<br>
11,977<br>
77.1%<br>
9.2%<br>
Shetland<br>
805<br>
75.8%<br>
8.6%<br>
Western Isles<br>
977<br>
75.0%<br>
8.7%<br>
Scotland<br>
208,795<br>
80.5%<br>
8.4%<br>
Note: Excludes patients under 18 years of age and patients whose date of birth has not been recorded (n = 132).<br>
Table 42. Percentage of people with diabetes (type 1 and type 2 combined) with cholesterol<br>
5mmol/l, by NHS Board (denominator those with recording of cholesterol within<br>
the previous 15 months).<br>
Year<br>
Cholesterol  5<br>
Cholesterol &gt; 5<br>
Not known<br>
Total<br>
Number Percentage Number Percentage Number Percentage<br>
2012<br>
182,643<br>
79.5%<br>
47,145<br>
20.5%<br>
23,895<br>
9.4%<br>
253,683<br>
2011<br>
174,832<br>
79.8%<br>
44,364<br>
20.2%<br>
25,604<br>
10.4%<br>
245,786<br>
2010<br>
169,367<br>
80.4%<br>
41,391<br>
19.6%<br>
24,440<br>
10.4%<br>
235,198<br>
2009<br>
157,434<br>
80.7%<br>
37,650<br>
19.3%<br>
30,551<br>
13.5%<br>
225,635<br>
2008<br>
157,938<br>
80.1%<br>
39,107<br>
19.9%<br>
21,858<br>
10.0%<br>
218,903<br>
2007<br>
159,843<br>
79.8%<br>
40,552<br>
20.2%<br>
8,257<br>
4.0%<br>
208,652<br>
2006<br>
143,999<br>
78.9%<br>
38,614<br>
21.1%<br>
13,104<br>
6.7%<br>
195,717<br>
2005<br>
113,542<br>
75.1%<br>
37,631<br>
24.9%<br>
16,680<br>
9.9%<br>
167,853<br>
Note: From 2008 onwards, there was a requirement that cholesterol should be in previous 15 months. In 2004 to 2007,<br>
older results could be included if there was no recent result. Excludes patients under 18 years of age and patients whose<br>
date of birth has not been recorded (n = 3133).<br>
49<br>
Scottish Diabetes Survey Monitoring Group<br>
<hr>
<A name=50></a>Scottish Diabetes Survey 2012<br>
Table 43. Type 2 diabetes: mean total cholesterol recorded in previous 15 months in people<br>
aged 50-60 years, by NHS Board, 2012, ranked by mean cholesterol.<br>
NHS Board<br>
Mean total cholesterol<br>
(mmol/l)<br>
Grampian<br>
4.2<br>
Fife<br>
4.2<br>
Tayside<br>
4.2<br>
Forth Valley<br>
4.2<br>
Orkney<br>
4.3<br>
Greater Glasgow &amp; Clyde<br>
4.3<br>
Ayrshire &amp; Arran<br>
4.3<br>
Borders<br>
4.3<br>
Lanarkshire<br>
4.3<br>
Western Isles<br>
4.4<br>
Lothian<br>
4.5<br>
Highland<br>
4.6<br>
Shetland<br>
4.6<br>
Dumfries &amp; Galloway<br>
4.7<br>
Smoking status<br>
Smoking status was recorded for 95.3% of the diabetic population. Almost 1 in 5 people with<br>
diabetes were recorded as being current smokers.<br>
Figure 27. Type 1 diabetes: smoking status as a percentage of all those with type 1 diabetes,<br>
by NHS Board.<br>
100%<br>
Not recorded<br>
90%<br>
Never smoked<br>
80%<br>
70%<br>
Ex-smoker<br>
60%<br>
Current smoker<br>
50%<br>
40%<br>
30%<br>
20%<br>
10%<br>
0%<br>
&amp;<br>
&amp;<br>
Fife<br>
alley<br>
Isles<br>
Orkney<br>
Arran<br>
V<br>
Clyde<br>
Lothian<br>
Shetland<br>
Borders<br>
&amp;<br>
Tayside<br>
Grampian<br>
Galloway<br>
Highland<br>
Scotland<br>
Dumfries<br>
Ayrshire<br>
Glasgow<br>
Lanarkshire<br>
Forth<br>
esternW<br>
Greater<br>
50<br>
Scottish Diabetes Survey Monitoring Group<br>
<hr>
<A name=51></a>Scottish Diabetes Survey 2012<br>
Figure 28. Type 2 diabetes: smoking status as a percentage of all those with type 2 diabetes,<br>
by NHS Board.<br>
100.0%<br>
90.0%<br>
Not recorded<br>
80.0%<br>
Never smoked<br>
70.0%<br>
60.0%<br>
Ex-smoker<br>
50.0%<br>
40.0%<br>
Current smoker<br>
30.0%<br>
20.0%<br>
10.0%<br>
0.0%<br>
Fife<br>
&amp;<br>
Isles<br>
alley<br>
Clyde<br>
Orkney<br>
V<br>
Arran<br>
Lothian<br>
Highland<br>
Shetland<br>
Borders<br>
Tayside<br>
&amp;<br>
Grampian<br>
Galloway<br>
Scotland<br>
&amp;<br>
estern<br>
Forth<br>
Lanarkshire<br>
W<br>
Glasgow<br>
Ayrshire<br>
Dumfries<br>
Greater<br>
Table 44. Type 1 diabetes: Percentage of people who were recorded as current, ex- or never-<br>
smokers, by NHS Board (denominator those with recording of smoking status);<br>
ranked by proportion who are current smokers.<br>
NHS Board<br>
No with<br>
Current<br>
Ex-smoker<br>
Never<br>
% recorded<br>
known<br>
smoker<br>
smoked<br>
status<br>
Shetland<br>
123<br>
17.9%<br>
24.4%<br>
57.7%<br>
96.1%<br>
Orkney<br>
111<br>
18.0%<br>
17.1%<br>
64.9%<br>
93.3%<br>
Borders<br>
553<br>
21.0%<br>
19.5%<br>
59.5%<br>
88.3%<br>
Grampian<br>
2,751<br>
21.2%<br>
20.1%<br>
58.7%<br>
87.9%<br>
Dumfries &amp; Galloway<br>
847<br>
21.7%<br>
26.7%<br>
51.6%<br>
95.3%<br>
Forth Valley<br>
1,570<br>
22.7%<br>
18.0%<br>
59.2%<br>
95.3%<br>
Highland<br>
1,689<br>
23.4%<br>
22.6%<br>
54.0%<br>
94.2%<br>
Ayrshire &amp; Arran<br>
1,984<br>
23.6%<br>
21.3%<br>
55.1%<br>
89.7%<br>
Western Isles<br>
176<br>
23.9%<br>
22.7%<br>
53.4%<br>
95.1%<br>
Lothian<br>
4,188<br>
24.0%<br>
42.0%<br>
34.0%<br>
97.8%<br>
Greater Glasgow &amp; Clyde<br>
5,587<br>
24.7%<br>
16.3%<br>
59.0%<br>
87.8%<br>
Lanarkshire<br>
2,965<br>
25.1%<br>
20.0%<br>
54.8%<br>
82.7%<br>
Fife<br>
1,826<br>
25.1%<br>
20.3%<br>
54.6%<br>
91.9%<br>
Tayside<br>
1,777<br>
25.3%<br>
16.7%<br>
58.0%<br>
93.5%<br>
Scotland<br>
26,147<br>
23.8%<br>
22.9%<br>
53.3%<br>
90.6%<br>
51<br>
Scottish Diabetes Survey Monitoring Group<br>
<hr>
<A name=52></a>Scottish Diabetes Survey 2012<br>
Table 45. Type 2 diabetes: Percentage of people who were recorded as current, ex- or never-<br>
smokers, by NHS Board (denominator those with recording of smoking status);<br>
ranked by proportion who are current smokers.<br>
NHS Board<br>
No with<br>
Current<br>
Ex-smoker<br>
Never<br>
% recorded<br>
known<br>
smoker<br>
smoked<br>
status<br>
Orkney<br>
860<br>
12.6%<br>
38.3%<br>
49.2%<br>
98.1%<br>
Highland<br>
13,159<br>
15.0%<br>
41.1%<br>
43.9%<br>
99.8%<br>
Shetland<br>
877<br>
15.5%<br>
45.2%<br>
39.3%<br>
99.5%<br>
Grampian<br>
20,809<br>
15.6%<br>
38.9%<br>
45.5%<br>
94.4%<br>
Borders<br>
4,661<br>
15.7%<br>
38.7%<br>
45.6%<br>
90.3%<br>
Dumfries &amp; Galloway<br>
7,488<br>
16.5%<br>
41.0%<br>
42.4%<br>
99.5%<br>
Western Isles<br>
1,054<br>
16.8%<br>
44.5%<br>
38.7%<br>
98.5%<br>
Tayside<br>
18,581<br>
16.8%<br>
38.1%<br>
45.1%<br>
98.8%<br>
Fife<br>
16,378<br>
17.8%<br>
37.7%<br>
44.6%<br>
96.2%<br>
Forth Valley<br>
12,376<br>
18.6%<br>
37.7%<br>
43.7%<br>
94.5%<br>
Ayrshire &amp; Arran<br>
18,105<br>
19.0%<br>
37.7%<br>
43.3%<br>
96.3%<br>
Lanarkshire<br>
24,028<br>
19.5%<br>
33.3%<br>
47.1%<br>
90.6%<br>
Lothian<br>
30,668<br>
20.7%<br>
40.7%<br>
38.6%<br>
99.5%<br>
Greater Glasgow &amp; Clyde<br>
49,489<br>
21.3%<br>
31.2%<br>
47.5%<br>
94.7%<br>
Scotland<br>
218,533<br>
18.8%<br>
36.7%<br>
44.5%<br>
95.9%<br>
Table 46. Percentage of people with diabetes (type 1 and type 2 combined) who were<br>
recorded as current, ex- or never-smokers (denominator those with record of<br>
smoking status), Scotland, 2005-2012.<br>
Year<br>
Current smoker<br>
Ex-smoker<br>
Never smoked<br>
Not recorded<br>
2012<br>
19.3%<br>
35.2%<br>
45.5%<br>
4.7%<br>
2011<br>
19.3%<br>
34.4%<br>
46.4%<br>
0.8%<br>
2010<br>
19.3%<br>
35.1%<br>
45.7%<br>
1.0%<br>
2009<br>
19.5%<br>
35.5%<br>
45.0%<br>
1.1%<br>
2008<br>
19.6%<br>
35.6%<br>
44.8%<br>
1.8%<br>
2007<br>
20.0%<br>
35.2%<br>
44.9%<br>
3.3%<br>
2006<br>
20.3%<br>
35.2%<br>
44.6%<br>
6.3%<br>
2005<br>
21.4%<br>
32.9%<br>
45.7%<br>
8.9%<br>
Note: Data for years 2001 to 2012 are calculated as a percentage of all registered patients with recorded smoking status.<br>
52<br>
Scottish Diabetes Survey Monitoring Group<br>
<hr>
<A name=53></a>Scottish Diabetes Survey 2012<br>
Complications of diabetes<br>
The main complications of diabetes include those due to large vessel (arterial) disease;<br>
 </span><span class="ft2">myocardial infarction (MI) ­ the commonest cause of death in people with diabetes<br>
 </span><span class="ft2">stroke ­ the risk is increased compared to people without diabetes<br>
 </span><span class="ft2">peripheral vascular disease, which can lead to amputations<br>
and those due to small vessel disease (microangiopathy);<br>
 </span><span class="ft2">renal disease, which can lead to end-stage renal failure requiring dialysis<br>
 </span><span class="ft2">retinopathy ­ diabetes has been the commonest cause of blindness in the people of working<br>
age<br>
Diabetes also leads to poorer outcomes in pregnancy, but this survey does not include<br>
pregnancy outcomes.<br>
In this section, the data presented include both screening performance and recording of<br>
prevalent complications. The purpose of screening is to detect changes early and intervene to<br>
prevent further deterioration.<br>
Myocardial infarction<br>
24,073 (9.4%) of registered patients have a record of a previous MI. Others will have had an<br>
MI but not survived. Validation of these data is needed. There have been improvements in<br>
recording, increased use of procedures and better survival following an MI in recent years.<br>
53<br>
Scottish Diabetes Survey Monitoring Group<br>
<hr>
<A name=54></a>Scottish Diabetes Survey 2012<br>
Table 47. Percentage of people with diabetes recorded as having had a previous myocardial<br>
infarction (MI), by diabetes type and NHS board, ranked by percentages for type 2.<br>
NHS Board<br>
Recorded as having had an MI<br>
Type 1<br>
Type 2<br>
Number<br>
Percentage<br>
Number<br>
Percentage<br>
Shetland<br>
7<br>
5.5%<br>
63<br>
7.2%<br>
Dumfries &amp;<br>
Galloway<br>
29<br>
3.3%<br>
634<br>
8.4%<br>
Orkney<br>
5<br>
4.2%<br>
79<br>
9.0%<br>
Western Isles<br>
6<br>
3.2%<br>
100<br>
9.3%<br>
Grampian<br>
102<br>
3.3%<br>
2,119<br>
9.6%<br>
Borders<br>
29<br>
4.6%<br>
511<br>
9.9%<br>
Forth Valley<br>
53<br>
3.2%<br>
1,308<br>
10.0%<br>
Lothian<br>
131<br>
3.1%<br>
3,072<br>
10.0%<br>
Ayrshire &amp; Arran<br>
92<br>
4.2%<br>
1,882<br>
10.0%<br>
Fife<br>
71<br>
3.6%<br>
1,709<br>
10.0%<br>
Highland<br>
66<br>
3.7%<br>
1,356<br>
10.3%<br>
Greater Glasgow<br>
&amp; Clyde<br>
233<br>
3.7%<br>
5,403<br>
10.3%<br>
Lanarkshire<br>
161<br>
4.5%<br>
2,771<br>
10.4%<br>
Tayside<br>
64<br>
3.4%<br>
2,017<br>
10.7%<br>
Scotland<br>
1,049<br>
3.6%<br>
23,024<br>
10.1%<br>
Note: These data are as reported and have not been validated.<br>
Table 48. Percentage of people with diabetes (type 1 and type 2 combined) who are recorded<br>
as having had a previous myocardial infarction (MI), Scotland, 2001-2012.<br>
Year of Survey<br>
Myocardial<br>
infarction<br>
2012<br>
9.4%<br>
2011<br>
9.5%<br>
2010<br>
9.1%<br>
2009<br>
9.5%<br>
2008<br>
9.5%<br>
2007<br>
9.5%<br>
2006<br>
9.4%<br>
2005<br>
8.6%<br>
2004<br>
7.3%<br>
2003<br>
7.7%<br>
2002<br>
8.1%<br>
2001<br>
6.7%<br>
Note: This Table shows the percentage of people with diabetes who have ever had a heart attack and survived.<br>
54<br>
Scottish Diabetes Survey Monitoring Group<br>
<hr>
<A name=55></a>Scottish Diabetes Survey 2012<br>
Cardiac revascularisation<br>
17,216 (6.7%) people included in the survey have a record of having undergone cardiac<br>
revascularisation, including coronary artery bypass graft (CABG) and percutaneous transluminal<br>
coronary angioplasty (PTCA).<br>
Table 49. Percentage of people with diabetes who have a record of cardiac revascularisation<br>
by NHS Board and diabetes type, ranked by percentages for type 2.<br>
NHS Board<br>
Recorded as having undergone cardiac revascularisation<br>
Type 1<br>
Type 2<br>
Number<br>
Percentage<br>
Number<br>
Percentage<br>
Shetland<br>
5<br>
3.9%<br>
39<br>
4.4%<br>
Dumfries &amp; Galloway<br>
27<br>
3.0%<br>
444<br>
5.9%<br>
Fife<br>
36<br>
1.8%<br>
1,059<br>
6.2%<br>
Orkney<br>
2<br>
1.7%<br>
58<br>
6.6%<br>
Ayrshire &amp; Arran<br>
51<br>
2.3%<br>
1,255<br>
6.7%<br>
Forth Valley<br>
41<br>
2.5%<br>
882<br>
6.7%<br>
Tayside<br>
49<br>
2.6%<br>
1,317<br>
7.0%<br>
Highland<br>
51<br>
2.8%<br>
958<br>
7.3%<br>
Borders<br>
16<br>
2.6%<br>
384<br>
7.4%<br>
Lanarkshire<br>
117<br>
3.3%<br>
1,993<br>
7.5%<br>
Western Isles<br>
2<br>
1.1%<br>
81<br>
7.6%<br>
Lothian<br>
103<br>
2.4%<br>
2,332<br>
7.6%<br>
Greater Glasgow &amp;<br>
Clyde<br>
147<br>
2.3%<br>
3,976<br>
7.6%<br>
Grampian<br>
78<br>
2.5%<br>
1,713<br>
7.8%<br>
Scotland<br>
725<br>
2.5%<br>
16,491<br>
7.2%<br>
Table 50. Percentage of people with diabetes recorded as having ever had cardiac<br>
revascularisation, Scotland, 2001-2012.<br>
Year of Survey<br>
Cardiac<br>
Revascularisation<br>
2012<br>
6.7%<br>
2011<br>
6.6%<br>
2010<br>
6.4%<br>
2009<br>
6.3%<br>
2008<br>
6.1%<br>
2007<br>
5.9%<br>
2006<br>
5.5%<br>
2005<br>
4.9%<br>
2004<br>
3.9%<br>
2003<br>
2.8%<br>
2002<br>
3.7%<br>
2001<br>
2.1%<br>
55<br>
Scottish Diabetes Survey Monitoring Group<br>
<hr>
<A name=56></a>Scottish Diabetes Survey 2012<br>
Stroke<br>
12,593 (4.9%) people with diabetes were recorded as having ever had a cerebrovascular<br>
accident (stroke), an increase in numbers but a similar percentage to that in previous surveys<br>
(4.9% in 2011, 5.0% in 2010 and 5.1% in each year between 2006 and 2009).<br>
Table 51. Percentage of people with diabetes who were recorded as ever having had a<br>
stroke, by NHS Board and diabetes type, ranked by figures for type 2 diabetes.<br>
NHS Board<br>
Recorded as having had a stroke<br>
Type 1 diabetes<br>
Type 2 diabetes<br>
Number<br>
Percentage<br>
Number<br>
Percentage<br>
Orkney<br>
1<br>
0.8%<br>
30<br>
3.4%<br>
Shetland<br>
2<br>
1.6%<br>
33<br>
3.7%<br>
Dumfries &amp; Galloway<br>
20<br>
2.2%<br>
315<br>
4.2%<br>
Grampian<br>
52<br>
1.7%<br>
1,000<br>
4.5%<br>
Western Isles<br>
2<br>
1.1%<br>
49<br>
4.6%<br>
Lanarkshire<br>
81<br>
2.3%<br>
1,304<br>
4.9%<br>
Highland<br>
39<br>
2.2%<br>
661<br>
5.0%<br>
Fife<br>
47<br>
2.4%<br>
878<br>
5.2%<br>
Forth Valley<br>
27<br>
1.6%<br>
688<br>
5.3%<br>
Greater Glasgow &amp;<br>
Clyde<br>
117<br>
1.8%<br>
2,837<br>
5.4%<br>
Ayrshire &amp; Arran<br>
58<br>
2.6%<br>
1,039<br>
5.5%<br>
Tayside<br>
39<br>
2.1%<br>
1,057<br>
5.6%<br>
Lothian<br>
94<br>
2.2%<br>
1,784<br>
5.8%<br>
Borders<br>
17<br>
2.7%<br>
322<br>
6.2%<br>
Scotland<br>
596<br>
2.1%<br>
11,997<br>
5.3%<br>
56<br>
Scottish Diabetes Survey Monitoring Group<br>
<hr>
<A name=57></a>Scottish Diabetes Survey 2012<br>
Kidney Disease<br>
Serum creatinine<br>
Serum creatinine was recorded for 92.6% of patients overall.<br>
Table 52. Percentage of people with diabetes who have a record of serum creatinine within<br>
the previous 15 months, by NHS board and diabetes type, ranked by percentage<br>
for type 2.<br>
NHS Board<br>
Recorded within previous 15 months<br>
Total<br>
Type 1 diabetes<br>
Type 2 diabetes<br>
Number<br>
Percentage<br>
Number<br>
Percentage<br>
Tayside<br>
1,612<br>
88.3%<br>
18,275<br>
97.2%<br>
19,887<br>
Western Isles<br>
171<br>
95.5%<br>
1,038<br>
97.0%<br>
1,209<br>
Ayrshire &amp; Arran<br>
1,848<br>
86.9%<br>
18,181<br>
96.7%<br>
20,029<br>
Grampian<br>
2,550<br>
84.6%<br>
21,271<br>
96.5%<br>
23,821<br>
Shetland<br>
112<br>
93.3%<br>
848<br>
96.3%<br>
960<br>
Fife<br>
1,641<br>
85.7%<br>
16,378<br>
96.2%<br>
18,019<br>
Forth Valley<br>
1,415<br>
89.1%<br>
12,533<br>
95.8%<br>
13,948<br>
Orkney<br>
107<br>
93.9%<br>
829<br>
94.5%<br>
936<br>
Lothian<br>
3,565<br>
85.8%<br>
28,800<br>
93.7%<br>
32,365<br>
Dumfries &amp; Galloway<br>
700<br>
81.2%<br>
6,947<br>
92.3%<br>
7,647<br>
Greater Glasgow &amp;<br>
Clyde<br>
4,944<br>
80.6%<br>
48,177<br>
92.3%<br>
53,121<br>
Lanarkshire<br>
2,639<br>
77.2%<br>
24,304<br>
91.9%<br>
26,943<br>
Borders<br>
523<br>
87.3%<br>
4,565<br>
88.5%<br>
5,088<br>
Highland<br>
1,333<br>
77.4%<br>
11,457<br>
86.9%<br>
12,790<br>
Scotland<br>
23,160<br>
83.4%<br>
213,603<br>
93.7%<br>
236,763<br>
Note: Excludes children under 12 years of age or patients who have no date of birth recorded (n=1176).<br>
57<br>
Scottish Diabetes Survey Monitoring Group<br>
<hr>
<A name=58></a>Scottish Diabetes Survey 2012<br>
Table 53. Percentage of people with diabetes (type 1 and type 2 combined) who had a record<br>
of serum creatinine within the previous 15 months, 2003-2012.<br>
Year<br>
Recorded within<br>
Total eligible<br>
previous 15 months<br>
population<br>
2012<br>
92.6%<br>
255,640<br>
2011<br>
91.2%<br>
244,800<br>
2010<br>
90.8%<br>
235,198<br>
2009<br>
90.0%<br>
225,635<br>
2008<br>
90.3%<br>
218,903<br>
2007<br>
88.6%<br>
208,652<br>
2006<br>
86.1%<br>
195,717<br>
2005<br>
82.3%<br>
171,899<br>
2004<br>
69.2%<br>
149,353<br>
2003<br>
42.5%<br>
133,889<br>
Note: Excludes children under 12 years of age or patients who have no date of birth recorded (n=1176). Figures prior to<br>
2009 reported on those with all types of diabetes mellitus. The figures for 2009 and onwards report only on those with<br>
type 1 and type 2 diabetes.<br>
Due to existing data flow issues it is still not possible to present adequate figures on direct<br>
eGFR testing. It is however, possible to derive approximate eGFR values by applying the<br>
abbreviated Modification of Diet in Renal Disease (MDRD) formula to creatinine values that are<br>
available to SCI-DC. A breakdown of these by eGFR range as a percentage of the type 1 and<br>
type 2 diabetes populations is shown below.<br>
Table 54. Type 1 diabetes: percentage of people in each eGFR category, using values<br>
derived from creatinine records on SCI-DC, by NHS Board.<br>
NHS Board<br>
eGFR derived<br>
Total<br>
Not<br>
%<br>
derived derived derived<br>
&lt;15<br>
15-29<br>
30-44<br>
45-59<br>
60<br>
Shetland<br>
0.0%<br>
0.0%<br>
3.6%<br>
2.7%<br>
93.7%<br>
111<br>
3<br>
97.4%<br>
Grampian<br>
0.7%<br>
1.0%<br>
2.1%<br>
3.2%<br>
92.9%<br>
2,448<br>
346<br>
87.6%<br>
Tayside<br>
0.5%<br>
1.7%<br>
2.2%<br>
3.0%<br>
92.6%<br>
1,502<br>
197<br>
88.4%<br>
Lothian<br>
0.6%<br>
0.8%<br>
2.2%<br>
4.4%<br>
92.0%<br>
3,446<br>
483<br>
87.7%<br>
Western Isles<br>
0.6%<br>
1.2%<br>
1.9%<br>
6.2%<br>
90.1%<br>
161<br>
4<br>
97.6%<br>
Greater Glasgow &amp;<br>
Clyde<br>
0.6%<br>
1.5%<br>
2.8%<br>
5.2%<br>
90.0%<br>
4,754<br>
983<br>
82.9%<br>
Fife<br>
0.2%<br>
1.7%<br>
3.2%<br>
7.1%<br>
87.8%<br>
1,537<br>
246<br>
86.2%<br>
Orkney<br>
0.0%<br>
3.1%<br>
3.1%<br>
6.2%<br>
87.6%<br>
97<br>
7<br>
93.3%<br>
Highland<br>
0.3%<br>
2.0%<br>
3.9%<br>
6.4%<br>
87.4%<br>
1,306<br>
289<br>
81.9%<br>
Lanarkshire<br>
0.6%<br>
1.6%<br>
3.9%<br>
7.0%<br>
87.0%<br>
2,570<br>
587<br>
81.4%<br>
Ayrshire &amp; Arran<br>
1.1%<br>
2.1%<br>
3.9%<br>
7.4%<br>
85.6%<br>
1,754<br>
202<br>
89.7%<br>
Forth Valley<br>
0.4%<br>
1.6%<br>
3.8%<br>
9.6%<br>
84.7%<br>
1,326<br>
129<br>
91.1%<br>
Dumfries &amp; Galloway<br>
0.3%<br>
1.3%<br>
4.5%<br>
9.7%<br>
84.2%<br>
691<br>
117<br>
85.5%<br>
Borders<br>
0.2%<br>
3.1%<br>
3.1%<br>
9.6%<br>
84.0%<br>
489<br>
63<br>
88.6%<br>
Scotland<br>
0.6%<br>
1.5%<br>
3.0%<br>
5.8%<br>
89.2% 22,192<br>
3,656<br>
85.9%<br>
58<br>
Scottish Diabetes Survey Monitoring Group<br>
<hr>
<A name=59></a>Scottish Diabetes Survey 2012<br>
Table 55. Type 2 diabetes: percentage of people in each eGFR category, using values<br>
derived from creatinine records on SCI-DC, by NHS Board.<br>
NHS Board<br>
eGFR derived<br>
Total<br>
Not<br>
%<br>
derived derived derived<br>
&lt;15<br>
15-29<br>
30-44<br>
45-59<br>
60<br>
Tayside<br>
0.3%<br>
1.2%<br>
4.4%<br>
9.5%<br>
84.6% 18,270<br>
531<br>
97.2%<br>
Grampian<br>
0.3%<br>
1.2%<br>
4.6%<br>
9.6%<br>
84.3% 21,270<br>
764<br>
96.5%<br>
Orkney<br>
0.2%<br>
1.6%<br>
5.3%<br>
9.5%<br>
83.4%<br>
829<br>
48<br>
94.5%<br>
Shetland<br>
0.2%<br>
1.8%<br>
5.4%<br>
9.3%<br>
83.3%<br>
848<br>
33<br>
96.3%<br>
Greater Glasgow &amp;<br>
Clyde<br>
0.3%<br>
1.6%<br>
5.2%<br>
9.8%<br>
83.0% 48,174<br>
4,040<br>
92.3%<br>
Lothian<br>
0.3%<br>
1.6%<br>
5.6%<br>
11.2%<br>
81.3% 28,797<br>
1,935<br>
93.7%<br>
Lanarkshire<br>
0.3%<br>
1.6%<br>
6.0%<br>
12.2%<br>
80.0% 24,301<br>
2,151<br>
91.9%<br>
Ayrshire &amp; Arran<br>
0.3%<br>
1.8%<br>
6.0%<br>
13.3%<br>
78.5% 18,179<br>
617<br>
96.7%<br>
Highland<br>
0.3%<br>
1.9%<br>
7.1%<br>
14.5%<br>
76.1%<br>
11,456<br>
1,733<br>
86.9%<br>
Western Isles<br>
0.2%<br>
2.3%<br>
6.5%<br>
15.0%<br>
76.0%<br>
1,038<br>
32<br>
97.0%<br>
Dumfries &amp; Galloway<br>
0.3%<br>
1.9%<br>
7.3%<br>
15.5%<br>
75.0%<br>
6,947<br>
579<br>
92.3%<br>
Fife<br>
0.2%<br>
1.7%<br>
7.1%<br>
17.4%<br>
73.6% 16,377<br>
643<br>
96.2%<br>
Borders<br>
0.1%<br>
2.3%<br>
8.3%<br>
16.9%<br>
72.4%<br>
4,743<br>
413<br>
92.0%<br>
Forth Valley<br>
0.2%<br>
2.1%<br>
8.9%<br>
22.3%<br>
66.5% 12,532<br>
555<br>
95.8%<br>
Scotland<br>
0.3%<br>
1.6%<br>
5.9%<br>
12.5%<br>
79.7% 213,761 14,074<br>
93.8%<br>
Urinary microalbuminuria<br>
Table 55 below shows information on the recording of microalbuminuria. Note that there are<br>
data quality issues for some boards and that not all boards have decide to collect data on<br>
microalbuminuria for those with type 2 diabetes.<br>
59<br>
Scottish Diabetes Survey Monitoring Group<br>
<hr>
<A name=60></a>Scottish Diabetes Survey 2012<br>
Table 56. Number and percentage of people with diabetes who have a record of estimated<br>
urinary microalbumin value available on SCI-DC within the previous 15 months, by<br>
NHS board and diabetes type, ranked by figures for type 2.<br>
NHS Board<br>
Recorded within previous 15 months<br>
Total<br>
Type 1 diabetes<br>
Type 2 diabetes<br>
Number<br>
Percentage<br>
Number<br>
Percentage<br>
Orkney<br>
85<br>
74.6%<br>
742<br>
84.6%<br>
827<br>
Tayside<br>
1210<br>
66.3%<br>
15,657<br>
83.3%<br>
16,867<br>
Grampian<br>
2,000<br>
66.4%<br>
18,297<br>
83.0%<br>
20,297<br>
Fife<br>
1,353<br>
70.7%<br>
13,893<br>
81.6%<br>
15,246<br>
Western Isles<br>
133<br>
74.3%<br>
868<br>
81.1%<br>
1,001<br>
Shetland<br>
97<br>
80.8%<br>
666<br>
75.6%<br>
763<br>
Highland<br>
994<br>
57.7%<br>
9,353<br>
70.9%<br>
10,347<br>
Lothian<br>
3110<br>
74.9%<br>
21,447<br>
69.8%<br>
24,557<br>
Forth Valley<br>
898<br>
56.5%<br>
9113<br>
69.6%<br>
10,011<br>
Greater Glasgow &amp;<br>
Clyde<br>
3618<br>
59.0%<br>
35337<br>
67.7%<br>
38,955<br>
Ayrshire &amp; Arran<br>
1,097<br>
51.6%<br>
12,299<br>
65.4%<br>
13,396<br>
Lanarkshire<br>
1,706<br>
49.9%<br>
17,265<br>
65.3%<br>
18,971<br>
Dumfries &amp; Galloway<br>
209<br>
24.2%<br>
2,514<br>
33.4%<br>
2,723<br>
Borders<br>
341<br>
56.9%<br>
113<br>
2.2%<br>
454<br>
Scotland<br>
16,851<br>
60.7%<br>
157,564<br>
69.1%<br>
174,415<br>
Note: Excludes children under 12 years of age or patients who have no date of birth recorded (n=1176). In some cases,<br>
urinary microalbumin was estimated from albumin/creatinine ratio (ACR).<br>
60<br>
Scottish Diabetes Survey Monitoring Group<br>
<hr>
<A name=61></a>Scottish Diabetes Survey 2012<br>
Table 57. Number and percentage of people with diabetes who have a record of eGFR<br>
available on SCI-DC within the previous 15 months, by NHS board and diabetes<br>
type, ranked by figures for type 2.<br>
NHS Board<br>
Recorded within previous 15 months<br>
Total<br>
Type 1 diabetes<br>
Type 2 diabetes<br>
Number<br>
Percentage<br>
Number<br>
Percentage<br>
Tayside<br>
1450<br>
85.3%<br>
18213<br>
96.9%<br>
19,663<br>
Shetland<br>
110<br>
96.5%<br>
843<br>
95.7%<br>
953<br>
Grampian<br>
2,390<br>
85.5%<br>
21,053<br>
95.6%<br>
23,443<br>
Orkney<br>
90<br>
86.5%<br>
820<br>
93.5%<br>
910<br>
Borders<br>
489<br>
88.6%<br>
4,743<br>
92.0%<br>
5,232<br>
Forth Valley<br>
1148<br>
78.9%<br>
11,822<br>
90.3%<br>
12,970<br>
Highland<br>
1,328<br>
83.3%<br>
11,884<br>
90.1%<br>
13,212<br>
Western Isles<br>
114<br>
69.1%<br>
937<br>
87.6%<br>
1,051<br>
Greater Glasgow &amp;<br>
Clyde<br>
3900<br>
68.0%<br>
45276<br>
86.7%<br>
49,176<br>
Fife<br>
1022<br>
57.3%<br>
12972<br>
76.2%<br>
13,994<br>
Lothian<br>
1,399<br>
35.6%<br>
15,720<br>
51.2%<br>
17,119<br>
Dumfries &amp; Galloway<br>
192<br>
23.8%<br>
2,632<br>
35.0%<br>
2,824<br>
Ayrshire &amp; Arran<br>
414<br>
21.2%<br>
6,010<br>
32.0%<br>
6,424<br>
Lanarkshire<br>
613<br>
19.4%<br>
7702<br>
29.1%<br>
8,315<br>
Scotland<br>
14,659<br>
56.7%<br>
160,627<br>
70.5%<br>
175,286<br>
Note: The figures in Table 52 relate to eGFR results found on SCI-DC while the larger number of results presented in<br>
tables 53 and 56 are based on derived results calculated from information held in SCI-DC.<br>
End stage renal failure<br>
End stage renal failure implies a need for renal dialysis or transplantation.<br>
61<br>
Scottish Diabetes Survey Monitoring Group<br>
<hr>
<A name=62></a>Scottish Diabetes Survey 2012<br>
Table 58. Percentage of people with diabetes recorded as having end stage renal failure, by<br>
NHS board and diabetes type, ranked by percentage for type 2.<br>
NHS Board<br>
Recorded as having end stage renal failure<br>
Type 1 diabetes<br>
Type 2 diabetes<br>
Number<br>
Percentage<br>
Number<br>
Percentage<br>
Orkney<br>
2<br>
1.7%<br>
2<br>
0.2%<br>
Western Isles<br>
1<br>
0.5%<br>
3<br>
0.3%<br>
Dumfries &amp; Galloway<br>
5<br>
0.6%<br>
27<br>
0.4%<br>
Lanarkshire<br>
43<br>
1.2%<br>
105<br>
0.4%<br>
Ayrshire &amp; Arran<br>
40<br>
1.8%<br>
80<br>
0.4%<br>
Borders<br>
10<br>
1.6%<br>
22<br>
0.4%<br>
Fife<br>
17<br>
0.9%<br>
86<br>
0.5%<br>
Forth Valley<br>
15<br>
0.9%<br>
67<br>
0.5%<br>
Greater Glasgow &amp; Clyde<br>
59<br>
0.9%<br>
272<br>
0.5%<br>
Highland<br>
19<br>
1.1%<br>
70<br>
0.5%<br>
Grampian<br>
46<br>
1.5%<br>
121<br>
0.5%<br>
Lothian<br>
41<br>
1.0%<br>
184<br>
0.6%<br>
Tayside<br>
38<br>
2.0%<br>
122<br>
0.6%<br>
Shetland<br>
1<br>
0.8%<br>
6<br>
0.7%<br>
Scotland<br>
337<br>
1.2%<br>
1,167<br>
0.5%<br>
Diabetic Eye Disease<br>
Diabetic retinal screening<br>
86.1% of patients had a record of eye screening through the retinal screening service recorded<br>
on SCI-DC in the previous 15 months, including those attending ophthalmology services. More<br>
exploratory work on data accuracy needs to be carried out.<br>
Note that figures for retinopathy and blindness are not provided in this year's report. Quantifying<br>
blindness and retinopathy (using last known retinal status) requires interrogation of historical<br>
data that may be some years old. As the move from SCI-DC to SCI-Diabetes limited historical<br>
data migration to 2 years it was not possible to provide accurate figures for these items. At the<br>
time of data extraction this affected 10 of the 14 Health Board Regions and thus it was decided<br>
to exclude these questions from this year's report. All historical data should be back-populated<br>
into SCI-Diabetes in time for next year's survey and questions relating to blindness and<br>
retinopathy will be re-instated.<br>
62<br>
Scottish Diabetes Survey Monitoring Group<br>
<hr>
<A name=63></a>Scottish Diabetes Survey 2012<br>
Figure 29. Percentage of people with diabetes with a record of diabetic retinopathy screening<br>
within the previous 15 months through retinal screening service, including<br>
those attending ophthalmology clinics and those suspended, by NHS Board and<br>
diabetes type, ranked by percentage for type 2.<br>
100%<br>
Type 1<br>
90%<br>
Type 2<br>
80%<br>
Scotland -<br>
70%<br>
Type 1<br>
60%<br>
Scotland -<br>
Type 2<br>
50%<br>
40%<br>
30%<br>
20%<br>
10%<br>
0%<br>
&amp;<br>
&amp;<br>
Fife<br>
Isles<br>
alley<br>
Arran<br>
Orkney<br>
V<br>
Clyde<br>
Tayside<br>
Lothian<br>
Galloway<br>
Shetland<br>
Glasgow &amp;<br>
Highland<br>
Borders<br>
Dumfries<br>
Grampian<br>
estern<br>
Forth<br>
Ayrshire<br>
Lanarkshire<br>
W<br>
Greater<br>
Note: Excludes patients under 18 years of age and patients whose date of birth has not been recorded (n = 3,133).<br>
Table 58 shows the number of patients of appropriate age (12 years) who were either<br>
screened, were getting eye-care via specialist services or were deliberately (for clinical or social<br>
reasons) suspended from screening as a proportion of the total number of patients who had a<br>
record of date of birth and were over 12 years of age.<br>
63<br>
Scottish Diabetes Survey Monitoring Group<br>
<hr>
<A name=64></a>Scottish Diabetes Survey 2012<br>
Table 59. Percentage of people with diabetes who were either recorded as having had<br>
diabetic retinopathy screening within the previous 15 months, were attending<br>
specialist ophthalmology clinics or were appropriately suspended from screening;<br>
by NHS Board and diabetes type, ranked (descending) by percentage Figure for<br>
Type 2.<br>
NHS Board<br>
Type 1 diabetes<br>
Type 2 diabetes<br>
All (type 1<br>
Not<br>
and type 2)<br>
recorded<br>
Number Percentage Number Percentage Number Percentage<br>
Dumfries &amp;<br>
Galloway<br>
795<br>
92.2%<br>
7,064<br>
93.9%<br>
7,859<br>
93.7%<br>
529<br>
Orkney<br>
103<br>
90.4%<br>
822<br>
93.7%<br>
925<br>
93.3%<br>
66<br>
Shetland<br>
110<br>
91.7%<br>
790<br>
89.7%<br>
900<br>
89.9%<br>
101<br>
Grampian<br>
2,569<br>
85.3%<br>
19,692<br>
89.4%<br>
22,261<br>
88.9%<br>
2,789<br>
Western Isles<br>
158<br>
88.3%<br>
949<br>
88.7%<br>
1,107<br>
88.6%<br>
142<br>
Forth Valley<br>
1,344<br>
84.6%<br>
11,599<br>
88.6%<br>
12,943<br>
88.2%<br>
1,732<br>
Ayrshire &amp;<br>
Arran<br>
1,756<br>
82.6%<br>
16,545<br>
88.0%<br>
18,301<br>
87.5%<br>
2,623<br>
Fife<br>
1,544<br>
80.6%<br>
14,970<br>
87.9%<br>
16,514<br>
87.2%<br>
2,424<br>
Greater<br>
Glasgow &amp;<br>
5,005<br>
81.6%<br>
45,168<br>
86.5%<br>
50,173<br>
86.0%<br>
8,183<br>
Clyde<br>
Tayside<br>
1,527<br>
83.6%<br>
16,195<br>
86.1%<br>
17,722<br>
85.9%<br>
2,909<br>
Lothian<br>
3,428<br>
82.5%<br>
26,261<br>
85.4%<br>
29,689<br>
85.1%<br>
5,200<br>
Highland<br>
1,336<br>
77.5%<br>
11,069<br>
83.9%<br>
12,405<br>
83.2%<br>
2,508<br>
Lanarkshire<br>
2,647<br>
77.4%<br>
22,117<br>
83.6%<br>
24,764<br>
82.9%<br>
5,113<br>
Borders<br>
467<br>
78.0%<br>
4,032<br>
78.2%<br>
4,499<br>
78.1%<br>
1,258<br>
Scotland<br>
22,789<br>
82.0% 197,273<br>
86.6% 220,062<br>
86.1%<br>
35,577<br>
Note: Excludes children under 12 years of age or patients who have no date of birth recorded (n = 1176).<br>
64<br>
Scottish Diabetes Survey Monitoring Group<br>
<hr>
<A name=65></a>Scottish Diabetes Survey 2012<br>
Table 60. Numbers of patients eligible for screening and percentages of those who were<br>
actually screened (type 1 and type 2 combined), 2012, ranked by percentage of<br>
screened patients.<br>
NHS Board<br>
Eligible for<br>
Screened<br>
Percentage<br>
screening<br>
screened<br>
Dumfries &amp; Galloway<br>
7,645<br>
7,116<br>
93.1%<br>
Orkney<br>
873<br>
807<br>
92.4%<br>
Shetland<br>
936<br>
835<br>
89.2%<br>
Grampian<br>
23,311<br>
20,522<br>
88.0%<br>
Western Isles<br>
1,148<br>
1,006<br>
87.6%<br>
Forth Valley<br>
13,919<br>
12,187<br>
87.6%<br>
Ayrshire &amp; Arran<br>
19,519<br>
16,896<br>
86.6%<br>
Fife<br>
17,170<br>
14,746<br>
85.9%<br>
Greater Glasgow &amp; Clyde<br>
53,559<br>
45,376<br>
84.7%<br>
Tayside<br>
17,684<br>
14,775<br>
83.6%<br>
Lothian<br>
31,495<br>
26,295<br>
83.5%<br>
Lanarkshire<br>
27,506<br>
22,393<br>
81.4%<br>
Highland<br>
13,344<br>
10,836<br>
81.2%<br>
Borders<br>
4,908<br>
3,650<br>
74.4%<br>
Scotland<br>
233,017<br>
197,440<br>
84.7%<br>
Table 61. Percentage of people with diabetes (type 1 and type 2 combined) who were<br>
recorded as having had eye-screening, ophthalmology care or an appropriate<br>
suspension from screening (depending on methodology at the time of each<br>
report): 2001-2012.<br>
Year<br>
Recorded within previous<br>
15 months<br>
2012<br>
86.1%<br>
2011<br>
85.6%<br>
2010<br>
85.1%<br>
2009<br>
80.6%<br>
2008<br>
71.9%<br>
2007<br>
83.6%<br>
2006<br>
70.8%<br>
2005<br>
67.7%<br>
2004<br>
60.4%<br>
2003<br>
40.4%<br>
2002<br>
60.3%<br>
2001<br>
42.2%<br>
Note: Excludes children under 12 years or patients who have no date of birth recorded (n=1.176). 2008 data is taken<br>
only from digital imaging via Diabetes Retinopathy Screening. For 2002 to 2007, data from any form of screening was<br>
acceptable.<br>
65<br>
Scottish Diabetes Survey Monitoring Group<br>
<hr>
<A name=66></a>Scottish Diabetes Survey 2012<br>
Foot Complications<br>
Peripheral pulses<br>
70% of people with type 1 or type 2 diabetes have had their feet checked (peripheral pulses recorded)<br>
in the previous 15 months. This is a decrease from 2011 where 75.0% had their feet checked.<br>
Figure 30. Type 1 diabetes: percentage of people who had peripheral pulses recorded within<br>
the previous 15 months.<br>
100%<br>
Type 1<br>
90%<br>
Scotland<br>
80%<br>
70%<br>
60%<br>
50%<br>
40%<br>
30%<br>
20%<br>
10%<br>
0%<br>
&amp;<br>
&amp;<br>
Isles<br>
Fife<br>
Arran<br>
Orkney<br>
Valley<br>
Clyde<br>
Shetland<br>
Lothian<br>
Galloway<br>
Borders<br>
Grampian<br>
Highland<br>
Tayside<br>
Glasgow &amp;<br>
Forth<br>
Dumfries<br>
Lanarkshire<br>
Ayrshire<br>
Western<br>
Greater<br>
Figure 31. Type 2 diabetes: percentage of people who had peripheral pulses recorded within<br>
the previous 15 months.<br>
100%<br>
90%<br>
Type 2<br>
Scotland<br>
80%<br>
70%<br>
60%<br>
50%<br>
40%<br>
30%<br>
20%<br>
10%<br>
0%<br>
&amp;<br>
Fife<br>
Isles<br>
alleyV<br>
Clyde<br>
Arran<br>
Lothian<br>
Shetland<br>
Tayside<br>
&amp;<br>
&amp;<br>
Grampian<br>
Glasgow<br>
Galloway<br>
Highland<br>
Borders<br>
Orkney<br>
estern<br>
Forth<br>
Dumfries<br>
Lanarkshire<br>
W<br>
Greater<br>
Ayrshire<br>
66<br>
Scottish Diabetes Survey Monitoring Group<br>
<hr>
<A name=67></a>Scottish Diabetes Survey 2012<br>
Table 62. Percentage of people with diabetes who had peripheral pulses recorded within<br>
previous 15 months, by NHS board and diabetes type, ranked by figures for type 2.<br>
NHS Board<br>
Recorded within previous 15 months<br>
Type 1 diabetes<br>
Type 2 diabetes<br>
Number<br>
Percentage<br>
Number<br>
Percentage<br>
Shetland<br>
106<br>
82.8%<br>
749<br>
85.0%<br>
Western Isles<br>
143<br>
77.3%<br>
897<br>
83.8%<br>
Forth Valley<br>
1,118<br>
67.8%<br>
10,520<br>
80.4%<br>
Grampian<br>
1,980<br>
63.3%<br>
17,674<br>
80.2%<br>
Tayside<br>
1,130<br>
59.4%<br>
14,649<br>
77.9%<br>
Greater Glasgow &amp; Clyde<br>
3,390<br>
53.3%<br>
39,854<br>
76.3%<br>
Dumfries &amp; Galloway<br>
564<br>
63.4%<br>
5,718<br>
76.0%<br>
Fife<br>
1,131<br>
56.9%<br>
12,815<br>
75.2%<br>
Highland<br>
1,082<br>
60.3%<br>
9,725<br>
73.7%<br>
Borders<br>
318<br>
50.8%<br>
3,715<br>
72.0%<br>
Orkney<br>
84<br>
70.6%<br>
576<br>
65.7%<br>
Lanarkshire<br>
1801<br>
50.2%<br>
17365<br>
65.5%<br>
Ayrshire &amp; Arran<br>
964<br>
43.6%<br>
11,924<br>
63.4%<br>
Lothian<br>
2321<br>
54.2%<br>
17,409<br>
56.6%<br>
Scotland<br>
16,132<br>
55.9%<br>
163,590<br>
71.8%<br>
Table 63. Percentage of people with diabetes (type 1 and type 2 combined) who had<br>
peripheral pulses recorded within previous 15 months, Scotland, 2004-2012.<br>
Year<br>
Recorded within previous<br>
15 months<br>
2012<br>
70.0%<br>
2011<br>
75.0%<br>
2010<br>
75.9%<br>
2009<br>
76.5%<br>
2008<br>
76.1%<br>
2007<br>
74.5%<br>
2006<br>
73.9%<br>
2005<br>
66.9%<br>
2004<br>
55.2%<br>
Foot ulceration<br>
13,091 (5.1%) people with type 1 or type 2 diabetes were reported to have had a foot ulcer.<br>
The increasing percentages for foot ulcer shown in table 64 below are likely to be due to better<br>
recording rather than a real increase in the risk of foot ulcer.<br>
67<br>
Scottish Diabetes Survey Monitoring Group<br>
<hr>
<A name=68></a>Scottish Diabetes Survey 2012<br>
Table 64. Percentage of people with diabetes with a record of ever having had a foot ulcer,<br>
by NHS board and diabetes type, ranked by figures for type 2.<br>
NHS Board<br>
Recorded as ever having had a foot ulcer<br>
Type 1 diabetes<br>
Type 2 diabetes<br>
Number<br>
Percentage<br>
Number<br>
Percentage<br>
Shetland<br>
2<br>
1.6%<br>
6<br>
0.7%<br>
Dumfries &amp; Galloway<br>
34<br>
3.8%<br>
145<br>
1.9%<br>
Ayrshire &amp; Arran<br>
111<br>
5.0%<br>
365<br>
1.9%<br>
Grampian<br>
125<br>
4.0%<br>
441<br>
2.0%<br>
Highland<br>
69<br>
3.8%<br>
327<br>
2.5%<br>
Borders<br>
47<br>
7.5%<br>
145<br>
2.8%<br>
Tayside<br>
139<br>
7.3%<br>
678<br>
3.6%<br>
Orkney<br>
7<br>
5.9%<br>
32<br>
3.6%<br>
Forth Valley<br>
161<br>
9.8%<br>
563<br>
4.3%<br>
Greater Glasgow &amp; Clyde<br>
555<br>
8.7%<br>
2,294<br>
4.4%<br>
Fife<br>
118<br>
5.9%<br>
758<br>
4.5%<br>
Western Isles<br>
13<br>
7.0%<br>
58<br>
5.4%<br>
Lothian<br>
336<br>
7.8%<br>
1,933<br>
6.3%<br>
Lanarkshire<br>
724<br>
20.2%<br>
2,905<br>
11.0%<br>
Scotland<br>
2,441<br>
8.5%<br>
10,650<br>
4.7%<br>
Note: These data are provisional.<br>
Table 65. Percentage of people with diabetes (type 1 and type 2 combined) who had a record<br>
of ever having had a foot ulcer, Scotland, 2001-2012.<br>
Year of Survey<br>
Recorded as ever having<br>
had a foot ulcer<br>
2012<br>
5.1%<br>
2011<br>
4.3%<br>
2010<br>
4.4%<br>
2009<br>
4.3%<br>
2008<br>
4.6%<br>
2007<br>
4.7%<br>
2006<br>
5.0%<br>
2005 (a)<br>
3.9%<br>
2004<br>
2.2%<br>
2003<br>
1.5%<br>
2002<br>
1.4%<br>
2001<br>
1.0%<br>
(a) Excludes NHS Borders and NHS Lanarkshire.<br>
68<br>
Scottish Diabetes Survey Monitoring Group<br>
<hr>
<A name=69></a>Scottish Diabetes Survey 2012<br>
Lower limb amputation<br>
1854 (0.7%) patients have ever had a lower limb amputation.<br>
Table 66. Percentage of people with diabetes with a record of ever having had a major lower<br>
limb amputation, by NHS board and diabetes type, ranked by figures for type 2.<br>
NHS Board<br>
Recorded as ever having had a lower limb amputation<br>
Type 1 diabetes<br>
Type 2 diabetes<br>
Number<br>
Percentage<br>
Number<br>
Percentage<br>
Shetland<br>
1<br>
0.8%<br>
2<br>
0.2%<br>
Lothian<br>
24<br>
0.6%<br>
141<br>
0.5%<br>
Western Isles<br>
1<br>
0.5%<br>
5<br>
0.5%<br>
Lanarkshire<br>
39<br>
1.1%<br>
163<br>
0.6%<br>
Ayrshire &amp; Arran<br>
26<br>
1.2%<br>
118<br>
0.6%<br>
Dumfries &amp; Galloway<br>
14<br>
1.6%<br>
49<br>
0.7%<br>
Highland<br>
20<br>
1.1%<br>
89<br>
0.7%<br>
Borders<br>
8<br>
1.3%<br>
35<br>
0.7%<br>
Tayside<br>
22<br>
1.2%<br>
129<br>
0.7%<br>
Greater Glasgow &amp; Clyde<br>
68<br>
1.1%<br>
364<br>
0.7%<br>
Grampian<br>
38<br>
1.2%<br>
178<br>
0.8%<br>
Fife<br>
27<br>
1.4%<br>
145<br>
0.9%<br>
Forth Valley<br>
23<br>
1.4%<br>
113<br>
0.9%<br>
Orkney<br>
2<br>
1.7%<br>
10<br>
1.1%<br>
Scotland<br>
313<br>
1.1%<br>
1,541<br>
0.7%<br>
Table 67. Percentage of people with diabetes (type 1 and type 2 combined) who had a record<br>
of ever having had a lower limb amputation, Scotland, 2002-2012.<br>
Year of Survey<br>
Lower limb amputation<br>
Number<br>
Percentage<br>
2012<br>
1854<br>
0.7%<br>
2011<br>
1359<br>
0.6%<br>
2010<br>
1250<br>
0.5%<br>
2009<br>
1132<br>
0.5%<br>
2008<br>
1051<br>
0.5%<br>
2007<br>
950<br>
0.5%<br>
2006<br>
868<br>
0.4%<br>
2005 (a)<br>
774<br>
0.5%<br>
2004<br>
845<br>
0.6%<br>
2003<br>
1014<br>
0.8%<br>
2002<br>
996<br>
1.0%<br>
Note: These figures are for those who have ever had an amputation in any year, and are still alive.<br>
(a) excludes NHS Borders and NHS Lanarkshire.<br>
69<br>
Scottish Diabetes Survey Monitoring Group<br>
<hr>
<A name=70></a>Scottish Diabetes Survey 2012<br>
Foot risk calculation<br>
Table 68. Type 1 diabetes: percentage of people with high, moderate or low foot risk score<br>
recorded in the previous 15 months, by NHS board, ranked by Figure for high foot risk.<br>
NHS Board<br>
Recorded as<br>
Recorded as<br>
Recorded as<br>
Recorded as<br>
having high foot having moderate having low foot<br>
having foot risk<br>
risk score<br>
foot risk score<br>
risk score<br>
score<br>
Number Percent- Number Percent- Number Percent- Number Percent-<br>
age<br>
age<br>
age<br>
age<br>
Shetland<br>
3<br>
2.8%<br>
8<br>
7.5%<br>
96<br>
89.7%<br>
107<br>
83.6%<br>
Grampian<br>
90<br>
4.3%<br>
195<br>
9.3%<br>
1,791<br>
85.6%<br>
2,076<br>
66.4%<br>
Ayrshire &amp; Arran<br>
55<br>
4.4%<br>
125<br>
10.0%<br>
1,050<br>
84.1%<br>
1,230<br>
55.6%<br>
Forth Valley<br>
53<br>
4.6%<br>
171<br>
14.9%<br>
916<br>
79.7%<br>
1,140<br>
69.2%<br>
Lothian<br>
147<br>
5.3%<br>
306<br>
10.9%<br>
2,303<br>
82.3%<br>
2,756<br>
64.4%<br>
Fife<br>
69<br>
6.0%<br>
156<br>
13.7%<br>
895<br>
78.4%<br>
1,120<br>
56.4%<br>
Greater Glasgow<br>
&amp; Clyde<br>
209<br>
6.1%<br>
443<br>
12.9%<br>
2,699<br>
78.5%<br>
3,351<br>
52.6%<br>
Orkney<br>
6<br>
6.5%<br>
11<br>
11.8%<br>
75<br>
80.6%<br>
92<br>
77.3%<br>
Lanarkshire<br>
147<br>
7.3%<br>
290<br>
14.4%<br>
1,521<br>
75.3%<br>
1,958<br>
54.6%<br>
Dumfries &amp;<br>
Galloway<br>
46<br>
7.5%<br>
65<br>
10.6%<br>
489<br>
79.5%<br>
600<br>
67.5%<br>
Tayside<br>
92<br>
7.6%<br>
102<br>
8.5%<br>
978<br>
81.2%<br>
1,172<br>
61.7%<br>
Highland<br>
94<br>
7.8%<br>
139<br>
11.5%<br>
951<br>
78.6%<br>
1,184<br>
66.0%<br>
Western Isles<br>
15<br>
10.5%<br>
30<br>
21.0%<br>
95<br>
66.4%<br>
140<br>
75.7%<br>
Borders<br>
45<br>
10.7%<br>
49<br>
11.6%<br>
320<br>
75.8%<br>
414<br>
66.1%<br>
Scotland<br>
1,071<br>
6.1%<br>
2,090<br>
11.8%<br>
14,179<br>
80.2%<br>
17,340<br>
60.1%<br>
Note: The denominator is the number of patients with a foot risk score plus the number of patients recorded as having<br>
`Active foot disease'. In the last column, the denominator is the number of patients with foot risk or active foot disease<br>
plus the number of patients with no record of foot risk score.<br>
70<br>
Scottish Diabetes Survey Monitoring Group<br>
<hr>
<A name=71></a>Scottish Diabetes Survey 2012<br>
Table 69. Type 2 diabetes: percentage of people with high, moderate or low foot risk score<br>
recorded in the previous 15 months, by NHS board, ranked by Figure for high foot<br>
risk.<br>
NHS Board<br>
Recorded as<br>
Recorded as<br>
Recorded as<br>
Recorded as<br>
having high foot having moderate having low foot<br>
having foot risk<br>
risk score<br>
foot risk score<br>
risk score<br>
score<br>
Number Percent- Number Percent- Number Percent- Number Percent-<br>
age<br>
age<br>
age<br>
age<br>
Ayrshire &amp; Arran<br>
434<br>
2.8%<br>
1,804<br>
11.6%<br>
13,223<br>
85.0%<br>
15,461<br>
82.2%<br>
Forth Valley<br>
435<br>
4.0%<br>
1,958<br>
17.9%<br>
8,504<br>
77.8%<br>
10,897<br>
83.2%<br>
Grampian<br>
769<br>
4.1%<br>
3,063<br>
16.4%<br>
14,805<br>
79.1%<br>
18,637<br>
84.6%<br>
Shetland<br>
31<br>
4.1%<br>
141<br>
18.8%<br>
567<br>
75.7%<br>
739<br>
83.9%<br>
Dumfries &amp;<br>
Galloway<br>
280<br>
4.5%<br>
1,193<br>
19.2%<br>
4,657<br>
75.0%<br>
6,130<br>
81.4%<br>
Lothian<br>
1,300<br>
5.0%<br>
4,711<br>
18.2%<br>
19,527<br>
75.6%<br>
25,538<br>
83.1%<br>
Greater Glasgow<br>
&amp; Clyde<br>
2,061<br>
5.1%<br>
9,149<br>
22.6%<br>
28,917<br>
71.3%<br>
40,127<br>
76.8%<br>
Borders<br>
239<br>
5.5%<br>
560<br>
12.8%<br>
3,544<br>
81.3%<br>
4,343<br>
84.2%<br>
Orkney<br>
42<br>
5.7%<br>
189<br>
25.5%<br>
498<br>
67.1%<br>
729<br>
83.1%<br>
Lanarkshire<br>
1,158<br>
5.8%<br>
3,279<br>
16.4%<br>
15,284<br>
76.4%<br>
19,721<br>
74.3%<br>
Tayside<br>
1,086<br>
6.7%<br>
3,051<br>
18.9%<br>
11,823<br>
73.3%<br>
15,960<br>
84.9%<br>
Highland<br>
822<br>
7.4%<br>
2,089<br>
18.8%<br>
8,079<br>
72.6%<br>
10,990<br>
83.3%<br>
Fife<br>
1,161<br>
8.9%<br>
3,701<br>
28.4%<br>
8,083<br>
62.0%<br>
12,945<br>
76.0%<br>
Western Isles<br>
146<br>
16.5%<br>
296<br>
33.5%<br>
430<br>
48.6%<br>
872<br>
81.5%<br>
Scotland<br>
9,964<br>
5.4%<br>
35,184<br>
19.0% 137,941<br>
74.6% 183,089<br>
80.3%<br>
Note: The denominator is the number of patients with a foot risk score plus the number of patients recorded as having<br>
`Active foot disease'. In the last column, the denominator is the number of patients with foot risk or active foot disease<br>
plus the number of patients with no record of foot risk score.<br>
Other statistics<br>
My Diabetes My Way<br>
"My Diabetes My Way" is the NHS Scotland interactive diabetes website that helps to support<br>
people who have diabetes and their carers. The Table below shows the number of people who<br>
had registered to access their own clinical information using the website by the end of 2012.<br>
Records access is a key objective of the Scottish Diabetes Action Plan.<br>
71<br>
Scottish Diabetes Survey Monitoring Group<br>
<hr>
<A name=72></a>Scottish Diabetes Survey 2012<br>
Table 70. Numbers of people with diabetes registered to access their clinical information<br>
using the "My Diabetes My Way" website by NHS Board, 2012, Scotland.<br>
NHS Board<br>
Type 1<br>
Type 2<br>
Total<br>
Ayrshire &amp; Arran<br>
24<br>
110<br>
134<br>
Borders<br>
14<br>
26<br>
40<br>
Dumfries &amp; Galloway<br>
30<br>
56<br>
86<br>
Fife<br>
79<br>
228<br>
307<br>
Forth Valley<br>
52<br>
107<br>
159<br>
Grampian<br>
70<br>
180<br>
250<br>
Greater Glasgow &amp; Clyde<br>
144<br>
281<br>
425<br>
Highland<br>
43<br>
135<br>
178<br>
Lanarkshire<br>
140<br>
151<br>
291<br>
Lothian<br>
297<br>
577<br>
874<br>
Orkney<br>
140<br>
6<br>
146<br>
Shetland<br>
16<br>
22<br>
38<br>
Tayside<br>
73<br>
233<br>
306<br>
Western Isles<br>
2<br>
4<br>
6<br>
Scotland<br>
985<br>
2,116<br>
3,101<br>
Scottish Diabetes Research Network (SDRN) Research Register<br>
The SDRN research register allows people with diabetes to indicate their interest in taking<br>
part in research on diabetes in Scotland, including clinical trials. The Table below shows the<br>
numbers who had joined the register by the end of 2012. It should be noted that many other<br>
people with diabetes who are not necessarily on this registry also take part in research.<br>
Table 71. Numbers of people with diabetes who had joined the SDRN diabetes research<br>
register by the end of 2012, by NHS Board, Scotland.<br>
NHS Board<br>
Type 1<br>
Type 2<br>
Total<br>
Ayrshire &amp; Arran<br>
2<br>
4<br>
6<br>
Borders<br>
-<br>
1<br>
1<br>
Dumfries &amp; Galloway<br>
145<br>
725<br>
870<br>
Fife<br>
62<br>
218<br>
280<br>
Forth Valley<br>
5<br>
39<br>
44<br>
Grampian<br>
131<br>
487<br>
618<br>
Greater Glasgow &amp; Clyde<br>
426<br>
865<br>
1,291<br>
Highland<br>
447<br>
841<br>
1,288<br>
Lanarkshire<br>
60<br>
216<br>
276<br>
Lothian<br>
892<br>
1,795<br>
2,687<br>
Orkney<br>
60<br>
-<br>
60<br>
Shetland<br>
-<br>
-<br>
-<br>
Tayside<br>
307<br>
1,473<br>
1,780<br>
Western Isles<br>
-<br>
-<br>
-<br>
Scotland<br>
2,477<br>
6,664<br>
9,141<br>
72<br>
Scottish Diabetes Survey Monitoring Group<br>
<hr>
<A name=73></a>Scottish Diabetes Survey 2012<br>
Acknowledgements<br>
The data for this survey were provided by the Diabetes Managed Clinical Networks in each<br>
health board, and collated by the SCI-DC Team, Erwin Oosterhoorn and Leena Pandit. Eleni<br>
Kotzampasaki produced the tables and graphs and edited the report. The spine charts were<br>
produced by Andrew Gasiorowski. The draft report was considered and approved by the<br>
Scottish Diabetes Survey Monitoring Group, the members of which are:<br>
Prof John McKnight (Chair)<br>
Dr Karen Adamson<br>
Dr Louise Bath<br>
Mr Mike Black<br>
Prof Helen Colhoun<br>
Mr Scott Cunningham<br>
Dr Colin Fischbacher<br>
Dr Mark Houliston<br>
Ms Morag Low<br>
Mr Ritchie McAlpine<br>
Dr William Simpson<br>
Prof Sarah Wild<br>
73<br>
Scottish Diabetes Survey Monitoring Group<br>
<hr>
<A name=74></a>Scottish Diabetes Survey 2012<br>
List of tables<br>
Table 1.<br>
Crude and age-adjusted prevalence of diabetes (all types), 2012, Scotland, by NHS<br>
Board, ranked by age adjusted prevalence.<br>
Table 2.<br>
Crude prevalence of diabetes for patients aged 65 and over (all types), 2012,<br>
Scotland, by NHS Board, ranked by prevalence.<br>
Table 3.<br>
Number of people with diabetes (all types) included in Scottish Diabetes Surveys<br>
2007 ­ 2012<br>
Table 4.<br>
Type 1 diabetes: number of new cases and incidence (per 100,000 population per<br>
year) by age, Scotland 2009-2012.<br>
Table 5.<br>
Type 2 diabetes: number of new cases and incidence (per 100,000 population per<br>
year) of by age, Scotland 2009-2012.<br>
Table 6.<br>
Type 1 diabetes: number of new cases and crude incidence rate for all ages (cases<br>
per 100,000 population per year) by NHS Board, 2009-2012, ranked by rate in 2012.<br>
Table 7.<br>
Type 2 diabetes: number of new cases of type 2 diabetes and crude incidence rate<br>
for all ages (cases per 100,000 population per year) by NHS Board, 2009-2012,<br>
ranked by rate in 2012.<br>
Table 8.<br>
Duration of diabetes (years since diagnosis) by type of diabetes, Scotland, 2012.<br>
Table 9.<br>
Age group of people recorded with type 1 or type 2 diabetes, percentage in each age<br>
group and cumulative percentage in each age group, by diabetes type.<br>
Table 10. The percentage of the diabetes population (all diabetes types) who have died within<br>
the last year, by NHS Board, Scotland 2012, ranked by mortality.<br>
Table 11. Numbers of people with diabetes and percentage in each diabetes type, by NHS<br>
board, Scotland 2012, ranked by the percentage with type 2 diabetes.<br>
Table 12. Type 1 diabetes: completeness of recording of ethnic group by NHS board, Scotland,<br>
2012, ranked by completeness.<br>
Table 13. Type 2 diabetes: completeness of recording of ethnic group by NHS board, Scotland,<br>
2012, ranked by completeness.<br>
Table 14. Completeness of recording of ethnic group, 2002-2012 (type 1 and type 2 combined).<br>
Table 15. Proportion of people with diabetes who had a record of BMI within the previous 15<br>
months, by NHS Board and diabetes type, 2012, ranked by completeness for type 2.<br>
Table 16. Proportion of people with diabetes (types 1 and 2 combined) with a record of BMI in<br>
the previous 15 months, Scotland 2001 ­ 2012.<br>
Table 17. Type 1 diabetes: percentage of people with a record of BMI in the last 15 months)<br>
who are in each BMI category (by NHS board), 2012.<br>
Table 18. Type 2 diabetes: proportion of people who are in each BMI category (by NHS board),<br>
2011.<br>
Table 19. Percentage of people with diabetes who had a record of HbA within the previous 15<br>
1c<br>
months, by diabetes type and NHS board, 2012, ranked by figures for type 2.<br>
Table 20. Percentage of people with diabetes (type 1 and type 2 combined) with a record of<br>
HbA in previous 15 months, Scotland, 2004-2012.<br>
1c<br>
74<br>
Scottish Diabetes Survey Monitoring Group<br>
<hr>
<A name=75></a>Scottish Diabetes Survey 2012<br>
Table 21. Type 1 diabetes: HbA category as a percentage of patients with HbA recorded in<br>
1c<br>
1c<br>
previous 15 months, by NHS Board, ranked by proportion with HbA over 75mmol/<br>
1c<br>
mol (9%).<br>
Table 22. Type 2 diabetes: HbA category as percentage of patients with HbA recorded in<br>
1c<br>
1c<br>
previous 15 months, by NHS Board, ranked by proportion with HbA over 75mmol/<br>
1c<br>
mol (9%).<br>
Table23. Type 1 diabetes: number and percentage of people with a record of HbA in each<br>
1c<br>
HbA category, Scotland, 2009-2012.<br>
1c<br>
Table24. Type 2 diabetes: number and percentage of people with a record of HbA in each<br>
1c<br>
HbA category, Scotland, 2009-2012.<br>
1c<br>
Table 25. Type 1 diabetes: HbA category as percent of all those with HbA recorded in the<br>
1c<br>
1c<br>
previous 15 months (HbA in mmol/mol), by NHS Board, 2012, ranked by proportion<br>
1c<br>
with HbA over 75mmol/mol.<br>
1c<br>
Table 26. Type 2 diabetes: HbA category as percent of all those with HbA recorded in the<br>
1c<br>
1c<br>
previous 15 months (HbA in mmol/mol), by NHS Board, 2012, ranked by proportion<br>
1c<br>
with HbA over 75 mmol/mol (9%).<br>
1c<br>
Table 27. Mean HbA (mmol/mol) recorded in the previous 15 months, by NHS Board, for<br>
1c<br>
people with type 1 diabetes by age and for type 2 diabetes (all ages combined),<br>
ranked by mean HbA for those with type 2 diabetes.<br>
1c<br>
Table 28. Numbers (and percentages) of people aged under 18 with type 1 diabetes on insulin<br>
pumps by age and NHS Board.<br>
Table 29. Numbers (and percentages) of people aged 18 and over with type 1 diabetes on<br>
insulin pumps by age and NHS Board.<br>
Table 30. Percentage of people with diabetes with a recording of BP in previous 15 months, by<br>
NHS Board and diabetes type, ranked by figures for type 2 diabetes.<br>
Table 31. Percentage of people with diabetes (type 1 and type 2 combined) with a record of BP<br>
within the previous 15 months, Scotland, 2009-2012.<br>
Table 32. Type 1 diabetes: percentage of people with systolic blood pressure (SBP) &lt; 140<br>
mmHg by NHS Board, ranked by percentage &gt; 140.<br>
Table 33. Type 1 diabetes: percentage of people with systolic blood pressure (SBP) &lt;130<br>
mmHg AND diastolic blood pressure (DBP) &lt;80mmHg, by NHS Board (denominator<br>
those with recording of SBP and DBP within the previous 15 months), ranked by<br>
percentage &gt; 130/80.<br>
Table 34. Type 2 diabetes: percentage of people with systolic blood pressure (SBP) &lt; 140<br>
mmHg by NHS Board (denominator those with recording of SBP within the previous<br>
15 months), ranked by percentage &gt; 140.<br>
Table 35. Type 2 diabetes: percentage of people with systolic blood pressure (SBP) &lt;130<br>
mmHg AND diastolic blood pressure (DBP) &lt;80mmHg, by NHS Board (denominator<br>
those with recording of SBP and DBP within the previous 15 months), ranked by<br>
percentage &gt; 130/80.<br>
Table 36. Percentage of people with diabetes (type 1 and type 2 combined) with systolic blood<br>
pressure (SBP) &lt; 140 mmHg (denominator those with recording of SBP within the<br>
previous 15 months), Scotland, 2005-2012.<br>
Table 37. Mean BP recorded in previous 15 months in people with type 1 diabetes aged &lt;40<br>
years, by NHS Board, 2012, ranked by mean systolic BP.<br>
75<br>
Scottish Diabetes Survey Monitoring Group<br>
<hr>
<A name=76></a>Scottish Diabetes Survey 2012<br>
Table 38. Mean BP recorded in previous 15 months in people with type 2 diabetes aged 50-60<br>
years, by NHS Board, 2012, ranked by mean systolic BP.<br>
Table 39. Percentage of people with diabetes (type 1 and type 2 combined) with a record of<br>
cholesterol within the previous 15 months, Scotland, 2002-2012.<br>
Table 40. Type 1 diabetes: percentage of people with cholesterol 5mmol/l, by NHS Board<br>
(denominator those with recording of cholesterol within the previous 15 months),<br>
ranked by percentage.<br>
Table 41. Type 2 diabetes: percentage of people with cholesterol 5mmol/l, by NHS Board<br>
(denominator those with recording of cholesterol within the previous 15 months),<br>
ranked by percentage.<br>
Table 42. Percentage of people with diabetes (type 1 and type 2 combined) with cholesterol<br>
5mmol/l, by NHS Board (denominator those with recording of cholesterol within the<br>
previous 15 months).<br>
Table 43. Type 2 diabetes: mean total cholesterol recorded in previous 15 months in people<br>
aged 50-60 years, by NHS Board, 2012, ranked by mean cholesterol.<br>
Table 44. Type 1 diabetes: percentage of people with who were recorded as current, ex- or<br>
never-smokers, by NHS Board (denominator those with recording of smoking status);<br>
ranked by proportion who are current smokers.<br>
Table 45. Type 2 diabetes: percentage of people who were recorded as current, ex- or never-<br>
smokers, by NHS Board (denominator those with recording of smoking status);<br>
ranked by proportion who are current smokers.<br>
Table 46. Percentage of people with diabetes (type 1 and type 2 combined) who were recorded<br>
as current, ex- or never-smokers (denominator those with record of smoking status),<br>
Scotland, 2005-2012.<br>
Table 47. Percentage of people with diabetes recorded as having had a previous myocardial<br>
infarction (MI), by diabetes type and NHS board, ranked by percentages for type 2.<br>
Table 48. Percentage of people with diabetes (type 1 and type 2 combined) who are recorded<br>
as having had a previous myocardial infarction (MI), Scotland, 2001-2012.<br>
Table 49. Percentage of people with diabetes who have a record of cardiac revascularisation<br>
by NHS Board and diabetes type, ranked by percentages for type 2.<br>
Table 50. Percentage of people with diabetes recorded as having ever had cardiac<br>
revascularisation, Scotland, 2001-2012.<br>
Table 51. Percentage of people with diabetes who were recorded has having had a stroke, by<br>
NHS Board and diabetes type, ranked by figures for type 2 diabetes.<br>
Table 52. Percentage of people with diabetes who have a record of serum creatinine within the<br>
previous 15 months, by NHS board and diabetes type, ranked by percentage for type 2.<br>
Table 53. Percentage of people with diabetes (type 1 and type 2 combined) who have a record<br>
of serum creatinine within the previous 15 months, 2003-2012.<br>
Table 54. Type 1 diabetes: percentage of people in each eGFR category, using values derived<br>
from creatinine records on SCI-DC, by NHS Board.<br>
Table 55. Type 2 diabetes: percentage of people in each eGFR category, using values derived<br>
from creatinine records on SCI-DC, by NHS Board.<br>
Table 56. Number and percentage of people with diabetes who have a record of a urinary<br>
microalbumin value available on SCI-DC within the previous 15 months, by NHS<br>
board and diabetes type, ranked by figures for type 2.<br>
76<br>
Scottish Diabetes Survey Monitoring Group<br>
<hr>
<A name=77></a>Scottish Diabetes Survey 2012<br>
Table 57. Number and percentage of people with diabetes who have a record of eGFR<br>
available on SCI-DC within the previous 15 months, by NHS board and diabetes<br>
type, ranked by figures for type 2.<br>
Table 58. Percentage of people with diabetes recorded as having end stage renal failure, by<br>
NHS board and diabetes type, ranked by percentage for type 2.<br>
Table 59. Percentage of people with diabetes who were either recorded as having had diabetic<br>
retinopathy screening within the previous 15 months, were attending specialist<br>
ophthalmology clinics or were appropriately suspended from screening; by NHS<br>
Board and diabetes type, ranked (descending) by percentage Figure for Type 2.<br>
Table 60. Numbers of patients eligible for screening and percentages of those who were<br>
actually screened (type 1 and type 2 combined), 2012, ranked by percentage of<br>
screened patients.<br>
Table 61. Percentage of people with diabetes (type 1 and type 2 combined) who were recorded<br>
as having had eye-screening, ophthalmology care or an appropriate suspension from<br>
screening (depending on methodology at the time of each report): 2001-2012.<br>
Table 62. Percentage of people with diabetes who had peripheral pulses recorded within<br>
previous 15 months, by NHS board and diabetes type, ranked by figures for type 2.<br>
Table 63. Percentage of people with diabetes (type 1 and type 2 combined) who had peripheral<br>
pulses recorded within previous 15 months, Scotland, 2004-2012.<br>
Table 64. Percentage of people with diabetes with a record of ever having had a foot ulcer, by<br>
NHS board and diabetes type, ranked by figures for type 2.<br>
Table 65. Percentage of people with diabetes (type 1 and type 2 combined) who had a record<br>
of ever having had a foot ulcer, Scotland, 2001-2012.<br>
Table 66. Percentage of people with diabetes with a record of ever having had a major lower<br>
limb amputation, by NHS board and diabetes type, ranked by figures for type 2.<br>
Table 67. Percentage of people with diabetes (type 1 and type 2 combined) who had a record<br>
of ever having had a lower limb amputation, Scotland, 2002-2012.<br>
Table 68. Type 1 diabetes: percentage of people who had a foot risk score recorded in the<br>
previous 15 months, by NHS board.<br>
Table 69. Type 1 diabetes: percentage of people who had a foot risk score recorded in the<br>
previous 15 months, by NHS board.<br>
Table 70. Numbers of people with diabetes registered to access their clinical information using<br>
the "My Diabetes My Way" website by NHS Board, 2012, Scotland.<br>
Table 71. Numbers of people with diabetes who had joined the SDRN diabetes research<br>
register by the end of 2012, by NHS Board, Scotland.<br>
Table 72. Progress towards links from SCI Store to SCI-DC.<br>
Table 73. Progress towards back-population of GP systems from SCI-DC.<br>
77<br>
Scottish Diabetes Survey Monitoring Group<br>
<hr>
<A name=78></a>Scottish Diabetes Survey 2012<br>
List of figures<br>
Figure 1. Crude diabetes prevalence (all types) by NHS Health Board, Scotland, 2012. Vertical<br>
capped lines show 95% confidence intervals.<br>
Figure 2. Age-adjusted diabetes prevalence (all types) by NHS Health Board, Scotland, 2012,<br>
ranked by prevalence. Vertical capped lines show 95% confidence intervals.<br>
Figure 3. Number of people with all types of diabetes in each NHS Health Board in 2012.<br>
Figure 4. Number of people recorded with diabetes (all types), Scotland 2001 ­ 2012.<br>
Figure 5. Type 1 diabetes: age distribution of people recorded(right side) compared with age<br>
distribution of general population (left side), Scotland, 2012.<br>
Figure 6. Type 2 diabetes: age distribution of people recorded with (right side) compared with<br>
age distribution of general population (left side), Scotland, 2012.<br>
Figure 7. Proportions of diabetes population by type.<br>
Figure 8. Completeness of recording of ethnic group from 2011 to 2012: Arrows showing the<br>
direction of change have been added for all boards with more than 4% change<br>
between 2011 and 2012.<br>
Figure 9. Proportion of people who had a record of BMI from 2011 to 2012: Arrows showing<br>
the direction of change have been added for all boards with more than 1.5% change<br>
between 2011 and 2012.<br>
Figure 10. Percentage of patients with diabetes with a recording of HbA1c within the previous<br>
15 months by NHS Board and diabetes type, Scotland, 2012 (horizontal lines show<br>
figures for Scotland as a whole and bars are ranked by figures for type 2 diabetes.<br>
Figure 11. Proportion of people with type 1 diabetes who had a record of HbA1c from 2011 to<br>
2012: Arrows showing the direction of change have been added for all boards with<br>
more than 3.5% change between 2011 and 2012.<br>
Figure 12. Proportion of people with type 2 diabetes who had a record of HbA1c from 2011 to<br>
2012: Arrows showing the direction of change have been added for all boards with<br>
more than 1.5% change between 2011 and 2012.<br>
Figure 13. Type 1 diabetes: percentage of people in each HbA1c category for HbA1c recorded<br>
in the previous 15 months, by NHS Board, 2012, ranked by proportion with HbA1c<br>
over 75 mmol/mol.<br>
Figure 14. Type 2 diabetes:percentage of people in each HbA1c category for HbA1c recorded in<br>
the previous 15 months, ranked by percentage with HbA1c over 75mmol/mol (9%).<br>
Figure 15. Percentage of people with diabetes (by diabetes type) with a recording of BP in<br>
previous 15 months, by NHS Board (horizontal lines show levels for Scotland as a<br>
whole); ranked by figures for type 2 (Note that Y axis is interrupted at 50%).<br>
Figure 16. Type 1 diabetes: percentage of people with most recent systolic blood pressure<br>
(SBP) &lt; 140 mmHg in the last 15 months by NHS Board. Horizontal line indicates<br>
level for Scotland as a whole.<br>
Figure 17. Type 1 diabetes: Percentage of people with most recent blood pressure in the last 15<br>
months &lt; 130 mmHg (systolic) and &lt;80mmHg (diastolic), by NHS Board. Horizontal<br>
line indicates level for Scotland as a whole.<br>
78<br>
Scottish Diabetes Survey Monitoring Group<br>
<hr>
<A name=79></a>Scottish Diabetes Survey 2012<br>
Figure 18. Type 2 diabetes: percentage of people with most recent systolic blood pressure<br>
(SBP) &lt; 140 mmHg in the last 15 months by NHS Board. Horizontal line indicates<br>
level for Scotland as a whole.<br>
Figure 19. Type 2 diabetes: percentage of people with most recent blood pressure in the last 15<br>
months &lt; 130 mmHg (systolic) and &lt;80mmHg (diastolic), by NHS Board. Horizontal<br>
line indicates level for Scotland as a whole.<br>
Figure 20. Type 1 diabetes: percentage of people with SBP  140mmHg from 2011 to<br>
2012:Arrows showing the direction of change have been added for all boards with<br>
more than 2.5% change between 2011 and 2012.<br>
Figure 21. Type 2 diabetes: percentage of people with SBP  140mmHg from 2011 to 2012:<br>
Arrows showing the direction of change have been added for all boards with more<br>
than 1.5% change between 2011 and 2012.<br>
Figure 22. Percentage of people with diabetes with a record of cholesterol within the previous<br>
15 months by diabetes type and NHS Board, 2012. Horizontal lines indicate figures<br>
for Scotland as a whole and capped lines show 95% confidence intervals.<br>
Figure 23. Percentage of people with diabetes with a record of cholesterol within the previous<br>
15 months from 2011 to 2012.<br>
Figure 24. Type 1 diabetes: percentage of people with cholesterol 5mmol/l, by NHS Board<br>
(denominator those with recording of cholesterol within the previous 15 months).<br>
Horizontal line indicates level for Scotland as a whole.<br>
Figure 25. Type 2 diabetes: Percentage of people with with cholesterol 5mmol/l, by NHS Board<br>
(denominator those with recording of cholesterol within the previous 15 months).<br>
Horizontal line indicates level for Scotland as a whole.<br>
Figure 26. Percentage of people with diabetes with cholesterol  5 mmol/l within the previous<br>
15 months from 2011 to 2012.<br>
Figure 27. Type 1 diabetes: smoking status as a percentage of all those with type 1 diabetes, by<br>
NHS Board.<br>
Figure 28. Type 2 diabetes: smoking status as a percentage of all those with type 2 diabetes, by<br>
NHS Board.<br>
Figure 29. Percentage of people with diabetes with a record of diabetic retinopathy screening<br>
within the previous 15 months through retinal screening service, including those<br>
attending ophthalmology clinics and those suspended, by NHS Board and diabetes<br>
type, ranked by percentage for type 2.<br>
Figure 30. Type 1 diabetes: percentage of people who had peripheral pulses recorded within the<br>
previous 15 months.<br>
Figure 31. Type 2 diabetes: percentage of people who had peripheral pulses recorded within the<br>
previous 15 months.<br>
79<br>
Scottish Diabetes Survey Monitoring Group<br>
<hr>
<A name=80></a>Scottish Diabetes Survey 2012<br>
Appendix 1: SCI-DC Data Sources<br>
SCI-DC Network receives data from a variety of data sources in order to maintain its shared<br>
electronic record for diabetes. A breakdown of the main sources at January 2012 is as follows:<br>
 </span><span class="ft2">All 997 general practices across Scotland (EMIS, Vision)<br>
 </span><span class="ft2">39 hospital diabetes clinics (SCI-DC Clinical and SCI-Diabetes)<br>
 </span><span class="ft2">7 regions linking to local laboratory data (SCI Store ­ see below)<br>
 </span><span class="ft2">National Diabetic Retinopathy Screening (DRS) System<br>
 </span><span class="ft2">Community Health Index (master patient identifier)<br>
 </span><span class="ft2">Direct web entry on both SCI-Diabetes and SCI-DC Network<br>
Registration onto the system can be initiated via the primary and secondary care feeds,<br>
registration onto the DRS system or the web patient administration forms. As part of the DRS<br>
registration process, primary care users are expected to review their SCI-DC lists periodically to<br>
ensure that all patients eligible for screening are included.<br>
At present, SCI-DC are, via its National Implementation Group, encouraging those boards<br>
that have not yet activated their SCI Store link to do so to ensure the completeness of their<br>
laboratory data. Although transcribed versions of these data are received from practice and<br>
clinic systems, data accuracy and completeness cannot be guaranteed and so a SCI Store link<br>
is essential. The current SCI Store Implementation matrix is shown below.<br>
Table 72. Progress towards links from SCI Store to SCI-DC.<br>
Region<br>
Implementation<br>
Status<br>
Comments<br>
Requested<br>
Ayrshire and Arran<br>
Yes<br>
Live<br>
Borders<br>
Yes<br>
Region contacted Have confirmed that they will<br>
with documentation proceed.<br>
Dumfries and<br>
Galloway<br>
No<br>
n/a<br>
Reviewing documentation. Further<br>
discussion required<br>
Fife<br>
Yes<br>
Live<br>
Fife/Tayside<br>
Yes<br>
Live<br>
Tayside store feeding to Fife for<br>
north Fife patients<br>
Forth Valley<br>
Yes<br>
Live<br>
Grampian<br>
Yes<br>
Live<br>
Greater Glasgow<br>
and Clyde<br>
Yes<br>
n/a<br>
GGC noted intention to implement.<br>
Highland<br>
Highland do not want SCI-Store<br>
Yes<br>
n/a<br>
data feeding to primary care. This<br>
link would initiate this transfer<br>
Lanarkshire<br>
Yes<br>
n/a<br>
Lothian<br>
Temporarily suspended due to<br>
Yes<br>
n/a<br>
performance issues. Link will be re-<br>
initiated by mid-late 2013<br>
Orkney<br>
No<br>
n/a<br>
SCI-Store not yet fully implemented<br>
in Orkney. This is progressing.<br>
continued<br>
80<br>
Scottish Diabetes Survey Monitoring Group<br>
<hr>
<A name=81></a>Scottish Diabetes Survey 2012<br>
Region<br>
Implementation<br>
Status<br>
Comments<br>
Requested<br>
Shetland<br>
Yes<br>
Live<br>
Tayside<br>
Yes<br>
Live<br>
Western Isles<br>
Yes<br>
Live<br>
In addition to incoming feeds, SCI-DC data is also transferred to external systems<br>
 </span><span class="ft2">National Diabetic Retinopathy Screening: to maintain the call-recall system<br>
 </span><span class="ft2">My Diabetes My Way: patients accessing their own information<br>
 </span><span class="ft2">SCI-DC Audit Server: for regional and national reporting<br>
 </span><span class="ft2">Back-Population of 828 GP systems (in support of a single-point of data entry). The<br>
implementation matrix for back-population is shown below:<br>
Table 73. Progress towards back-population of GP systems from SCI-DC.<br>
Region<br>
01/01/2013<br>
Total<br>
Percentage<br>
Comments<br>
Practices<br>
Ayrshire &amp; Arran<br>
38<br>
55<br>
69%<br>
Borders<br>
19<br>
23<br>
83%<br>
Dumfries &amp;<br>
24<br>
34<br>
71%<br>
Galloway<br>
Fife<br>
56<br>
58<br>
97%<br>
Forth Valley<br>
57<br>
57<br>
100%<br>
Glasgow<br>
257<br>
263<br>
98%<br>
Grampian<br>
76<br>
82<br>
93%<br>
Highland<br>
12<br>
100<br>
12% 7 Highland Practices represented<br>
in a pilot. Wider rollout is awaiting<br>
assessment of this pilot.<br>
Lanarkshire<br>
96<br>
99<br>
97%<br>
Lothian<br>
104<br>
126<br>
83%<br>
Orkney<br>
6<br>
12<br>
50%<br>
Tayside<br>
63<br>
68<br>
93%<br>
Western Isles<br>
10<br>
10<br>
100%<br>
Shetland<br>
10<br>
10<br>
100%<br>
Total<br>
828<br>
997<br>
83%<br>
More information about SCI-DC is available at:<br>
<A href="http://www.sci-diabetes.scot.nhs.uk">http://www.sci-diabetes.scot.nhs.uk</a>/<br>
The full details of the questions and definitions used in data collection for the 2012 Scottish<br>
Diabetes Survey are available at:<br>
<A href="http://www.sci-diabetes.scot.nhs.uk/wp-content/uploads/2013/05/ScottishDiabetesSurvey2012GuidelinesFINAL.pdf">http://www.sci-diabetes.scot.nhs.uk/wp-content/uploads/2013/05/</a><br>
<A href="http://www.sci-diabetes.scot.nhs.uk/wp-content/uploads/2013/05/ScottishDiabetesSurvey2012GuidelinesFINAL.pdf">ScottishDiabetesSurvey2012GuidelinesFINAL.pdf</a><br>
81<br>
Scottish Diabetes Survey Monitoring Group<br>
<hr>
<A name=82></a>Scottish Diabetes Survey 2012<br>
Appendix 2: Comparison with England<br>
This section provides a comparison of the results of this survey with the 2011-12 National<br>
Diabetes Audit (NDA) in England. Please note that because the definitions and cutoff values are<br>
not exactly the same the comparisons should be treated with caution.<br>
Diabetes prevalence. The 2012 Scottish Diabetes survey reports that 4.9% of the population<br>
had diabetes, compared to 4.6% among 83% of general practices in England that participated in<br>
the National diabetes Audit for 2010-11 (NDA)</span><span class="ft3">1</span><span class="ft2">.<br>
 </span><span class="ft2">HbA . The 2012 Scottish Diabetes Survey reports that 87.1% (type 1) and 92.8% (type 2)<br>
1c<br>
had an HbA recorded in the previous 15 months. Of these, 21.5% and 59.7% had a result &lt;<br>
1c<br>
58mmol/mol (7.5%), the target reported in previous surveys (tables 20, 22 and 23). The NDA<br>
reported that for all types of diabetes the proportion with HbA  58 mmol/mol (7.5%) was<br>
1c<br>
63.3%</span><span class="ft3">1</span><span class="ft2">;<br>
 </span><span class="ft2">Blood pressure. The 2012 Scottish Diabetes Survey reports that 85.2% of those with type 1<br>
and 94.6% of those with type 2 diabetes had their blood pressure recorded in the previous 15<br>
months. Of these, 47.6% and 32.6% respectively had a systolic BP measurement of  130/80<br>
mmHg (tables 29, 32 and 34). The NDA reported that 36.4% of patients of all ages with all<br>
types of diabetes</span><span class="ft3">1 </span><span class="ft2">had blood pressure &lt;140/80 for patients without recorded eye, kidney<br>
or vascular disease and blood pressure &lt;130/40 for patients with recorded eye, kidney or<br>
vascular disease;<br>
 </span><span class="ft2">Cholesterol. The 2012 Scottish Diabetes Survey reports that cholesterol was recorded in<br>
90.6% of patients within the previous 15 months, and the target of 5 mmol/l was achieved<br>
in 69.7% of those with type 1 and 80.5% of those with type 2 diabetes (tables 38, 39 and 40)<br>
compared to 77.6% with cholesterol &lt;5mmol/l in English NDA data</span><span class="ft3">1</span><span class="ft2">.<br>
1 National Diabetes Audit 2011-2012 for England. Available at <A href="https://catalogue.ic.nhs.uk/publications/clinical/diabetes/nati-diab-audi-10-11/nati-diab-audi-10-11-care-proc-rep-V4.pdf">https://catalogue.ic.nhs.uk/publications/clinical/diabetes/</a><br>
<A href="https://catalogue.ic.nhs.uk/publications/clinical/diabetes/nati-diab-audi-10-11/nati-diab-audi-10-11-care-proc-rep-V4.pdf">nati-diab-audi-10-11/nati-diab-audi-10-11-care-proc-rep-V4.pdf</a><br>
82<br>
Scottish Diabetes Survey Monitoring Group<br>
<hr>
<A name=83></a>Scottish Diabetes Survey 2012<br>
Appendix 3: Variability of HbA1c<br>
In Scotland laboratory service are provided by 14 separately funded Health Boards from<br>
multiple sites. A range of technologies are used in those various sites. Recent information from<br>
Birmingham UK National External Quality Assurance Schemes indicated returns from Scotland<br>
for 20 sites using ion exchange methods (17 Akray HA systems and 3 Tosoh G8 systems), 2<br>
affinity chromatograph systems (Menarini 9210) and 6 immunoassay systems (Siemens DCA).<br>
Some services use different technologies for high volume workloads (e.g. Arkray HA) and point<br>
of care testing (Siemens DCA immunoassay). Although systems are similarly calibrated against<br>
IFCC standards, differences are seen in methods-specific bias (deviation) from all-method mean<br>
values in EQA schemes and from target values set by secondary IFCC assay methods. Recently<br>
the Tosoh G8 methods, used by two health boards in Scotland, for instance have shown UK-<br>
wide a median bias against method means of circa +5%, with the Arkray method demonstrating<br>
a median bias of -1.6%.<br>
83<br>
Scottish Diabetes Survey Monitoring Group<br>
<hr>
<A name=84></a>Scottish Diabetes Survey 2012<br>
Ayrshire &amp; Arran Health Board Spine Chart 201<br>
Domain<br>
Indicator<br>
Period<br>
Number<br>
Measure<br>
Type &quot;National<br>
Average&quot;<br>
1<br>
Age/sex standardised prevalence of T1 diabetes<br>
2012<br>
2212<br>
0.6<br>
sr2<br>
0.5<br>
2<br>
Age/sex standardised prevalence of T2 diabetes<br>
2012<br>
18799<br>
4.6<br>
sr2<br>
4.3<br>
Prevalence<br>
Incidence<br>
3<br>
Crude prevalence of T1 diabetes<br>
2012<br>
2212<br>
0.6<br>
%<br>
0.5<br>
&amp;<br>
4<br>
Crude prevalence T2 diabetes<br>
2012<br>
18799<br>
5.1<br>
%<br>
4.3<br>
Mortality<br>
5<br>
Estimated % pop with undiagnosed diabetes<br>
2012<br>
3234<br>
0.9<br>
%<br>
0.9<br>
6<br>
Crude mortality rate for all people with diabetes<br>
2012<br>
795<br>
3.6<br>
%<br>
3.6<br>
7<br>
% of diabetes pop with recorded BMI<br>
2012<br>
18810<br>
90.6<br>
%<br>
89.2<br>
8<br>
% of diabetes pop (T1) with recorded HbA1c<br>
2012<br>
1990<br>
90.0<br>
%<br>
87.1<br>
9<br>
% of diabetes pop (T2) with recorded HbA1c<br>
2012<br>
17937<br>
95.4<br>
%<br>
92.8<br>
10 % of diabetes pop (T1) with recorded BP<br>
2012<br>
1808<br>
81.7<br>
%<br>
85.2<br>
11 % of diabetes pop (T2) with recorded BP<br>
2012<br>
18106<br>
96.3<br>
%<br>
94.6<br>
12 % of diabetes pop (T1) with recorded cholesterol<br>
2012<br>
1626<br>
83.1<br>
%<br>
81.2<br>
13 % of diabetes pop (T2) with recorded cholesterol<br>
2012<br>
17713<br>
94.2<br>
%<br>
91.6<br>
14 % of diabetes pop (T1) with a recorded smoking status<br>
2012<br>
1984<br>
89.7<br>
%<br>
90.6<br>
15 % of diabetes pop (T2) with a recorded smoking status<br>
2012<br>
18105<br>
96.3<br>
%<br>
95.9<br>
Quality<br>
16 % of diabetes pop (T1) with recorded creatinine<br>
2012<br>
1848<br>
86.9<br>
%<br>
83.4<br>
of<br>
17 % of diabetes pop (T2) with recorded creatinine<br>
2012<br>
18181<br>
96.7<br>
%<br>
93.7<br>
Recording<br>
18 % of diabetes pop (T1) with recorded microalbumin<br>
2012<br>
1097<br>
51.6<br>
%<br>
60.7<br>
19 % of diabetes pop (T2) with recorded microalbumin<br>
2012<br>
12299<br>
65.4<br>
%<br>
69.1<br>
20 % of diabetes pop (T1) with recorded eGFR<br>
2012<br>
414<br>
21.2<br>
%<br>
56.7<br>
21 % of diabetes pop (T2) with recorded eGFR<br>
2012<br>
6010<br>
32.0<br>
%<br>
70.5<br>
22 % of diabetes pop (T1) with recorded eye screen<br>
2012<br>
1756<br>
82.6<br>
%<br>
82.0<br>
23 % of diabetes pop (T2) with recorded eye screen<br>
2012<br>
16545<br>
88.0<br>
%<br>
86.6<br>
24 % of diabetes pop (T1) with recorded pulses<br>
2012<br>
964<br>
43.6<br>
%<br>
55.9<br>
25 % of diabetes pop (T2) with recorded pulses<br>
2012<br>
11924<br>
63.4<br>
%<br>
71.8<br>
26 % of diabetes pop (T1) with recorded foot risk<br>
2012<br>
1248<br>
56.4<br>
%<br>
61.3<br>
27 % of diabetes pop (T2) with recorded foot risk<br>
2012<br>
15565<br>
82.8<br>
%<br>
81.1<br>
28 % of diabetes pop (T1) current smokers<br>
2012<br>
468<br>
21.2<br>
%<br>
21.6<br>
Smoking<br>
29 % of diabetes pop (T2) current smokers<br>
2012<br>
3446<br>
18.3<br>
%<br>
18.0<br>
30 % of diabetes pop (T1) obese (BMI&gt;=30)<br>
2012<br>
457<br>
27.2<br>
%<br>
25.5<br>
Obesity<br>
31 % of diabetes pop (T2) obese (BMI&gt;=30)<br>
2012<br>
9403<br>
54.9<br>
%<br>
55.4<br>
&amp;<br>
hypertension<br>
32 % of diabetes pop (T1) with SBP &lt;= 140mmHg<br>
2012<br>
1527<br>
84.5<br>
%<br>
80.7<br>
33 % of diabetes pop (T2) with SBP &lt;=140mmHg<br>
2012<br>
14031<br>
77.5<br>
%<br>
77.2<br>
34 % of diabetes pop (T1) with HbA1c &gt; 75mmol/mol<br>
2012<br>
773<br>
38.8<br>
%<br>
39.3<br>
Metabolic<br>
35 % of diabetes pop (T2) with HbA1c &gt; 75mmol/mol<br>
2012<br>
2507<br>
14.0<br>
%<br>
15.5<br>
complications<br>
36 % of diabetes pop (T1) with cholesterol &gt;5mmol<br>
2012<br>
483<br>
29.7<br>
%<br>
30.3<br>
37 % of diabetes pop (T2) with cholesterol &gt;5mmol<br>
2012<br>
3539<br>
20.0<br>
%<br>
19.5<br>
38 % of diabetes pop (T1) with eGFR &lt;15<br>
2012<br>
20<br>
1.1<br>
%<br>
0.6<br>
39 % of diabetes pop (T2) with eGFR &lt;15<br>
2012<br>
57<br>
0.3<br>
%<br>
0.3<br>
Microvascular<br>
40 % of diabetes pop (T1) with end-stage renal failure<br>
2012<br>
40<br>
1.8<br>
%<br>
1.2<br>
complications<br>
41 % of diabetes pop (T2) with end-stage renal failure<br>
2012<br>
80<br>
0.4<br>
%<br>
0.5<br>
42 % of diabetes pop (T1) with diabetic retinopathy<br>
2011<br>
1302<br>
69.4<br>
%<br>
57.5<br>
43 % of diabetes pop (T2) with diabetic retinopathy<br>
2011<br>
6228<br>
37.2<br>
%<br>
27.2<br>
44 % of diabetes pop (T1) with previous MI<br>
2012<br>
92<br>
4.2<br>
%<br>
3.6<br>
45 % of diabetes pop (T2) with previous MI<br>
2012<br>
1882<br>
10.0<br>
%<br>
10.1<br>
46 % of diabetes pop (T1) with previous cardiac revascularisation<br>
2012<br>
51<br>
2.3<br>
%<br>
2.5<br>
47 % of diabetes pop (T2) with previous cardiac revascularisation<br>
2012<br>
1255<br>
6.7<br>
%<br>
7.2<br>
Macrovascular<br>
48 % of diabetes pop (T1) with previous stroke<br>
2012<br>
58<br>
2.6<br>
%<br>
2.1<br>
complications<br>
49 % of diabetes pop (T2) with previous stroke<br>
2012<br>
1039<br>
5.5<br>
%<br>
5.3<br>
50 % of diabetes pop (T1) with previous foot ulcer<br>
2012<br>
111<br>
5.0<br>
%<br>
8.5<br>
51 % of diabetes pop (T2) with previous foot ulcer<br>
2012<br>
365<br>
1.9<br>
%<br>
4.7<br>
52 % of diabetes pop (T1) with previous lower limb amputation<br>
2012<br>
26<br>
1.2<br>
%<br>
1.1<br>
53 % of diabetes pop (T2) with previous lower limb amputation<br>
2012<br>
118<br>
0.6<br>
%<br>
0.7<br>
`Worse' Area<br>
Scotland Average<br>
`Better' Area<br>
5</span><span class="ft4">th </span><span class="ft3">Percentile<br>
25</span><span class="ft4">th </span><span class="ft3">Percentile<br>
75</span><span class="ft4">th </span><span class="ft3">Percentile<br>
95</span><span class="ft4">th </span><span class="ft3">Percentile<br>
Note: T1 = Type 1 diabetes; T2 = Type 2 diabetes; n/a = data not available, or cannot be calculated; sr2 = directly<br>
Spine Chart Key:<br>
standardised rate per 100 population; % = percent. Only measures one and two are age adjusted. Differences in age<br>
Statistically significantly `worse' than National average<br>
composition of health board populations may partly explain differences in measures between boards. High level of<br>
recorded smoking in some boards may reflect the fact that smoking status has not been updated for those who have<br>
Statistically not significantly different from National average<br>
stopped smoking. All measures exclude those of `unknown' status in the denominator. Further details of diabetes<br>
Statistically significantly `better' than National average<br>
measure definitions are given in the main report for the 2012 Scottish Diabetes Survey.<br>
No significance can be calculated<br>
84<br>
Scottish Diabetes Survey Monitoring Group<br>
<hr>
<A name=85></a>Scottish Diabetes Survey 2012<br>
Borders Health Board Spine Chart 2012<br>
Domain<br>
Indicator<br>
Period<br>
Number<br>
Measure<br>
Type &quot;National<br>
Average&quot;<br>
1<br>
Age/sex standardised prevalence of T1 diabetes<br>
2012<br>
626<br>
0.6<br>
sr2<br>
0.5<br>
2<br>
Age/sex standardised prevalence of T2 diabetes<br>
2012<br>
5160<br>
3.9<br>
sr2<br>
4.3<br>
Prevalence<br>
Incidence<br>
3<br>
Crude prevalence of T1 diabetes<br>
2012<br>
626<br>
0.6<br>
%<br>
0.5<br>
&amp;<br>
4<br>
Crude prevalence T2 diabetes<br>
2012<br>
5160<br>
4.6<br>
%<br>
4.3<br>
Mortality<br>
5<br>
Estimated % pop with undiagnosed diabetes<br>
2012<br>
1168<br>
1.0<br>
%<br>
0.9<br>
6<br>
Crude mortality rate for all people with diabetes<br>
2012<br>
211<br>
3.5<br>
%<br>
3.6<br>
7<br>
% of diabetes pop with recorded BMI<br>
2012<br>
5136<br>
90.0<br>
%<br>
89.2<br>
8<br>
% of diabetes pop (T1) with recorded HbA1c<br>
2012<br>
543<br>
86.7<br>
%<br>
87.1<br>
9<br>
% of diabetes pop (T2) with recorded HbA1c<br>
2012<br>
4574<br>
88.6<br>
%<br>
92.8<br>
10 % of diabetes pop (T1) with recorded BP<br>
2012<br>
556<br>
88.8<br>
%<br>
85.2<br>
11 % of diabetes pop (T2) with recorded BP<br>
2012<br>
4982<br>
96.6<br>
%<br>
94.6<br>
12 % of diabetes pop (T1) with recorded cholesterol<br>
2012<br>
487<br>
88.2<br>
%<br>
81.2<br>
13 % of diabetes pop (T2) with recorded cholesterol<br>
2012<br>
4742<br>
92.0<br>
%<br>
91.6<br>
14 % of diabetes pop (T1) with a recorded smoking status<br>
2012<br>
553<br>
88.3<br>
%<br>
90.6<br>
15 % of diabetes pop (T2) with a recorded smoking status<br>
2012<br>
4661<br>
90.3<br>
%<br>
95.9<br>
Quality<br>
16 % of diabetes pop (T1) with recorded creatinine<br>
2012<br>
523<br>
87.3<br>
%<br>
83.4<br>
of<br>
17 % of diabetes pop (T2) with recorded creatinine<br>
2012<br>
4565<br>
88.5<br>
%<br>
93.7<br>
Recording<br>
18 % of diabetes pop (T1) with recorded microalbumin<br>
2012<br>
341<br>
56.9<br>
%<br>
60.7<br>
19 % of diabetes pop (T2) with recorded microalbumin<br>
2012<br>
113<br>
2.2<br>
%<br>
69.1<br>
20 % of diabetes pop (T1) with recorded eGFR<br>
2012<br>
489<br>
88.6<br>
%<br>
56.7<br>
21 % of diabetes pop (T2) with recorded eGFR<br>
2012<br>
4743<br>
92.0<br>
%<br>
70.5<br>
22 % of diabetes pop (T1) with recorded eye screen<br>
2012<br>
467<br>
78.0<br>
%<br>
82.0<br>
23 % of diabetes pop (T2) with recorded eye screen<br>
2012<br>
4032<br>
78.2<br>
%<br>
86.6<br>
24 % of diabetes pop (T1) with recorded pulses<br>
2012<br>
318<br>
50.8<br>
%<br>
55.9<br>
25 % of diabetes pop (T2) with recorded pulses<br>
2012<br>
3715<br>
72.0<br>
%<br>
71.8<br>
26 % of diabetes pop (T1) with recorded foot risk<br>
2012<br>
422<br>
67.4<br>
%<br>
61.3<br>
27 % of diabetes pop (T2) with recorded foot risk<br>
2012<br>
4361<br>
84.5<br>
%<br>
81.1<br>
28 % of diabetes pop (T1) current smokers<br>
2012<br>
116<br>
18.5<br>
%<br>
21.6<br>
Smoking<br>
29 % of diabetes pop (T2) current smokers<br>
2012<br>
731<br>
14.2<br>
%<br>
18.0<br>
30 % of diabetes pop (T1) obese (BMI&gt;=30)<br>
2012<br>
157<br>
31.6<br>
%<br>
25.5<br>
Obesity<br>
31 % of diabetes pop (T2) obese (BMI&gt;=30)<br>
2012<br>
2586<br>
55.7<br>
%<br>
55.4<br>
&amp;<br>
hypertension<br>
32 % of diabetes pop (T1) with SBP &lt;= 140mmHg<br>
2012<br>
367<br>
66.0<br>
%<br>
80.7<br>
33 % of diabetes pop (T2) with SBP &lt;=140mmHg<br>
2012<br>
3739<br>
75.1<br>
%<br>
77.2<br>
34 % of diabetes pop (T1) with HbA1c &gt; 75mmol/mol<br>
2012<br>
197<br>
36.3<br>
%<br>
39.3<br>
Metabolic<br>
35 % of diabetes pop (T2) with HbA1c &gt; 75mmol/mol<br>
2012<br>
573<br>
12.5<br>
%<br>
15.5<br>
complications<br>
36 % of diabetes pop (T1) with cholesterol &gt;5mmol<br>
2012<br>
139<br>
28.5<br>
%<br>
30.3<br>
37 % of diabetes pop (T2) with cholesterol &gt;5mmol<br>
2012<br>
927<br>
19.5<br>
%<br>
19.5<br>
38 % of diabetes pop (T1) with eGFR &lt;15<br>
2012<br>
1<br>
0.2<br>
%<br>
0.6<br>
39 % of diabetes pop (T2) with eGFR &lt;15<br>
2012<br>
7<br>
0.1<br>
%<br>
0.3<br>
Microvascular<br>
40 % of diabetes pop (T1) with end-stage renal failure<br>
2012<br>
10<br>
1.6<br>
%<br>
1.2<br>
complications<br>
41 % of diabetes pop (T2) with end-stage renal failure<br>
2012<br>
22<br>
0.4<br>
%<br>
0.5<br>
42 % of diabetes pop (T1) with diabetic retinopathy<br>
2011<br>
285<br>
56.7<br>
%<br>
57.5<br>
43 % of diabetes pop (T2) with diabetic retinopathy<br>
2011<br>
963<br>
22.3<br>
%<br>
27.2<br>
44 % of diabetes pop (T1) with previous MI<br>
2012<br>
29<br>
4.6<br>
%<br>
3.6<br>
45 % of diabetes pop (T2) with previous MI<br>
2012<br>
511<br>
9.9<br>
%<br>
10.1<br>
46 % of diabetes pop (T1) with previous cardiac revascularisation<br>
2012<br>
16<br>
2.6<br>
%<br>
2.5<br>
47 % of diabetes pop (T2) with previous cardiac revascularisation<br>
2012<br>
384<br>
7.4<br>
%<br>
7.2<br>
Macrovascular<br>
48 % of diabetes pop (T1) with previous stroke<br>
2012<br>
17<br>
2.7<br>
%<br>
2.1<br>
complications<br>
49 % of diabetes pop (T2) with previous stroke<br>
2012<br>
322<br>
6.2<br>
%<br>
5.3<br>
50 % of diabetes pop (T1) with previous foot ulcer<br>
2012<br>
47<br>
7.5<br>
%<br>
8.5<br>
51 % of diabetes pop (T2) with previous foot ulcer<br>
2012<br>
145<br>
2.8<br>
%<br>
4.7<br>
52 % of diabetes pop (T1) with previous lower limb amputation<br>
2012<br>
8<br>
1.3<br>
%<br>
1.1<br>
53 % of diabetes pop (T2) with previous lower limb amputation<br>
2012<br>
35<br>
0.7<br>
%<br>
0.7<br>
`Worse' Area<br>
Scotland Average<br>
`Better' Area<br>
5</span><span class="ft4">th </span><span class="ft3">Percentile<br>
25</span><span class="ft4">th </span><span class="ft3">Percentile<br>
75</span><span class="ft4">th </span><span class="ft3">Percentile<br>
95</span><span class="ft4">th </span><span class="ft3">Percentile<br>
Note: T1 = Type 1 diabetes; T2 = Type 2 diabetes; n/a = data not available, or cannot be calculated; sr2 = directly<br>
Spine Chart Key:<br>
standardised rate per 100 population; % = percent. Only measures one and two are age adjusted. Differences in age<br>
Statistically significantly `worse' than National average<br>
composition of health board populations may partly explain differences in measures between boards. High level of<br>
recorded smoking in some boards may reflect the fact that smoking status has not been updated for those who have<br>
Statistically not significantly different from National average<br>
stopped smoking. All measures exclude those of `unknown' status in the denominator. Further details of diabetes<br>
Statistically significantly `better' than National average<br>
measure definitions are given in the main report for the 2012 Scottish Diabetes Survey.<br>
No significance can be calculated<br>
85<br>
Scottish Diabetes Survey Monitoring Group<br>
<hr>
<A name=86></a>Scottish Diabetes Survey 2012<br>
Dumfries &amp; Galloway Health Board Spine Chart 2012<br>
Domain<br>
Indicator<br>
Period<br>
Number<br>
Measure<br>
Type &quot;National<br>
Average&quot;<br>
1<br>
Age/sex standardised prevalence of T1 diabetes<br>
2012<br>
889<br>
0.6<br>
sr2<br>
0.5<br>
2<br>
Age/sex standardised prevalence of T2 diabetes<br>
2012<br>
7528<br>
4.1<br>
sr2<br>
4.3<br>
Prevalence<br>
Incidence<br>
3<br>
Crude prevalence of T1 diabetes<br>
2012<br>
889<br>
0.6<br>
%<br>
0.5<br>
&amp;<br>
4<br>
Crude prevalence T2 diabetes<br>
2012<br>
7528<br>
5.1<br>
%<br>
4.3<br>
Mortality<br>
5<br>
Estimated % pop with undiagnosed diabetes<br>
2012<br>
2316<br>
1.6<br>
%<br>
0.9<br>
6<br>
Crude mortality rate for all people with diabetes<br>
2012<br>
342<br>
3.9<br>
%<br>
3.6<br>
7<br>
% of diabetes pop with recorded BMI<br>
2012<br>
7447<br>
89.4<br>
%<br>
89.2<br>
8<br>
% of diabetes pop (T1) with recorded HbA1c<br>
2012<br>
742<br>
83.5<br>
%<br>
87.1<br>
9<br>
% of diabetes pop (T2) with recorded HbA1c<br>
2012<br>
7001<br>
93.0<br>
%<br>
92.8<br>
10 % of diabetes pop (T1) with recorded BP<br>
2012<br>
764<br>
85.9<br>
%<br>
85.2<br>
11 % of diabetes pop (T2) with recorded BP<br>
2012<br>
7070<br>
93.9<br>
%<br>
94.6<br>
12 % of diabetes pop (T1) with recorded cholesterol<br>
2012<br>
672<br>
83.2<br>
%<br>
81.2<br>
13 % of diabetes pop (T2) with recorded cholesterol<br>
2012<br>
6885<br>
91.5<br>
%<br>
91.6<br>
14 % of diabetes pop (T1) with a recorded smoking status<br>
2012<br>
847<br>
95.3<br>
%<br>
90.6<br>
15 % of diabetes pop (T2) with a recorded smoking status<br>
2012<br>
7488<br>
99.5<br>
%<br>
95.9<br>
Quality<br>
16 % of diabetes pop (T1) with recorded creatinine<br>
2012<br>
700<br>
81.2<br>
%<br>
83.4<br>
of<br>
17 % of diabetes pop (T2) with recorded creatinine<br>
2012<br>
6947<br>
92.3<br>
%<br>
93.7<br>
Recording<br>
18 % of diabetes pop (T1) with recorded microalbumin<br>
2012<br>
209<br>
24.2<br>
%<br>
60.7<br>
19 % of diabetes pop (T2) with recorded microalbumin<br>
2012<br>
2514<br>
33.4<br>
%<br>
69.1<br>
20 % of diabetes pop (T1) with recorded eGFR<br>
2012<br>
192<br>
23.8<br>
%<br>
56.7<br>
21 % of diabetes pop (T2) with recorded eGFR<br>
2012<br>
2632<br>
35.0<br>
%<br>
70.5<br>
22 % of diabetes pop (T1) with recorded eye screen<br>
2012<br>
795<br>
92.2<br>
%<br>
82.0<br>
23 % of diabetes pop (T2) with recorded eye screen<br>
2012<br>
7064<br>
93.9<br>
%<br>
86.6<br>
24 % of diabetes pop (T1) with recorded pulses<br>
2012<br>
564<br>
63.4<br>
%<br>
55.9<br>
25 % of diabetes pop (T2) with recorded pulses<br>
2012<br>
5718<br>
76.0<br>
%<br>
71.8<br>
26 % of diabetes pop (T1) with recorded foot risk<br>
2012<br>
615<br>
69.2<br>
%<br>
61.3<br>
27 % of diabetes pop (T2) with recorded foot risk<br>
2012<br>
6207<br>
82.5<br>
%<br>
81.1<br>
28 % of diabetes pop (T1) current smokers<br>
2012<br>
184<br>
20.7<br>
%<br>
21.6<br>
Smoking<br>
29 % of diabetes pop (T2) current smokers<br>
2012<br>
1239<br>
16.5<br>
%<br>
18.0<br>
30 % of diabetes pop (T1) obese (BMI&gt;=30)<br>
2012<br>
200<br>
28.1<br>
%<br>
25.5<br>
Obesity<br>
31 % of diabetes pop (T2) obese (BMI&gt;=30)<br>
2012<br>
3744<br>
55.6<br>
%<br>
55.4<br>
&amp;<br>
hypertension<br>
32 % of diabetes pop (T1) with SBP &lt;= 140mmHg<br>
2012<br>
603<br>
78.9<br>
%<br>
80.7<br>
33 % of diabetes pop (T2) with SBP &lt;=140mmHg<br>
2012<br>
5411<br>
76.5<br>
%<br>
77.2<br>
34 % of diabetes pop (T1) with HbA1c &gt; 75mmol/mol<br>
2012<br>
276<br>
37.2<br>
%<br>
39.3<br>
Metabolic<br>
35 % of diabetes pop (T2) with HbA1c &gt; 75mmol/mol<br>
2012<br>
956<br>
13.7<br>
%<br>
15.5<br>
complications<br>
36 % of diabetes pop (T1) with cholesterol &gt;5mmol<br>
2012<br>
231<br>
34.4<br>
%<br>
30.3<br>
37 % of diabetes pop (T2) with cholesterol &gt;5mmol<br>
2012<br>
1569<br>
22.8<br>
%<br>
19.5<br>
38 % of diabetes pop (T1) with eGFR &lt;15<br>
2012<br>
2<br>
0.3<br>
%<br>
0.6<br>
39 % of diabetes pop (T2) with eGFR &lt;15<br>
2012<br>
23<br>
0.3<br>
%<br>
0.3<br>
Microvascular<br>
40 % of diabetes pop (T1) with end-stage renal failure<br>
2012<br>
5<br>
0.6<br>
%<br>
1.2<br>
complications<br>
41 % of diabetes pop (T2) with end-stage renal failure<br>
2012<br>
27<br>
0.4<br>
%<br>
0.5<br>
42 % of diabetes pop (T1) with diabetic retinopathy<br>
2011<br>
576<br>
73.2<br>
%<br>
57.5<br>
43 % of diabetes pop (T2) with diabetic retinopathy<br>
2011<br>
3211<br>
46.7<br>
%<br>
27.2<br>
44 % of diabetes pop (T1) with previous MI<br>
2012<br>
29<br>
3.3<br>
%<br>
3.6<br>
45 % of diabetes pop (T2) with previous MI<br>
2012<br>
634<br>
8.4<br>
%<br>
10.1<br>
46 % of diabetes pop (T1) with previous cardiac revascularisation<br>
2012<br>
27<br>
3.0<br>
%<br>
2.5<br>
47 % of diabetes pop (T2) with previous cardiac revascularisation<br>
2012<br>
444<br>
5.9<br>
%<br>
7.2<br>
Macrovascular<br>
48 % of diabetes pop (T1) with previous stroke<br>
2012<br>
20<br>
2.2<br>
%<br>
2.1<br>
complications<br>
49 % of diabetes pop (T2) with previous stroke<br>
2012<br>
315<br>
4.2<br>
%<br>
5.3<br>
50 % of diabetes pop (T1) with previous foot ulcer<br>
2012<br>
34<br>
3.8<br>
%<br>
8.5<br>
51 % of diabetes pop (T2) with previous foot ulcer<br>
2012<br>
145<br>
1.9<br>
%<br>
4.7<br>
52 % of diabetes pop (T1) with previous lower limb amputation<br>
2012<br>
14<br>
1.6<br>
%<br>
1.1<br>
53 % of diabetes pop (T2) with previous lower limb amputation<br>
2012<br>
49<br>
0.7<br>
%<br>
0.7<br>
`Worse' Area<br>
Scotland Average<br>
`Better' Area<br>
5</span><span class="ft4">th </span><span class="ft3">Percentile<br>
25</span><span class="ft4">th </span><span class="ft3">Percentile<br>
75</span><span class="ft4">th </span><span class="ft3">Percentile<br>
95</span><span class="ft4">th </span><span class="ft3">Percentile<br>
Note: T1 = Type 1 diabetes; T2 = Type 2 diabetes; n/a = data not available, or cannot be calculated; sr2 = directly<br>
Spine Chart Key:<br>
standardised rate per 100 population; % = percent. Only measures one and two are age adjusted. Differences in age<br>
Statistically significantly `worse' than National average<br>
composition of health board populations may partly explain differences in measures between boards. High level of<br>
recorded smoking in some boards may reflect the fact that smoking status has not been updated for those who have<br>
Statistically not significantly different from National average<br>
stopped smoking. All measures exclude those of `unknown' status in the denominator. Further details of diabetes<br>
Statistically significantly `better' than National average<br>
measure definitions are given in the main report for the 2012 Scottish Diabetes Survey.<br>
No significance can be calculated<br>
86<br>
Scottish Diabetes Survey Monitoring Group<br>
<hr>
<A name=87></a>Scottish Diabetes Survey 2012<br>
Fife Health Board Spine Chart 2012<br>
Domain<br>
Indicator<br>
Period<br>
Number<br>
Measure<br>
Type &quot;National<br>
Average&quot;<br>
1<br>
Age/sex standardised prevalence of T1 diabetes<br>
2012<br>
1986<br>
0.5<br>
sr2<br>
0.5<br>
2<br>
Age/sex standardised prevalence of T2 diabetes<br>
2012<br>
17030<br>
4.5<br>
sr2<br>
4.3<br>
Prevalence<br>
Incidence<br>
3<br>
Crude prevalence of T1 diabetes<br>
2012<br>
1986<br>
0.5<br>
%<br>
0.5<br>
&amp;<br>
4<br>
Crude prevalence T2 diabetes<br>
2012<br>
17030<br>
4.6<br>
%<br>
4.3<br>
Mortality<br>
5<br>
Estimated % pop with undiagnosed diabetes<br>
2012<br>
2556<br>
0.7<br>
%<br>
0.9<br>
6<br>
Crude mortality rate for all people with diabetes<br>
2012<br>
665<br>
3.4<br>
%<br>
3.6<br>
7<br>
% of diabetes pop with recorded BMI<br>
2012<br>
16552<br>
88.0<br>
%<br>
89.2<br>
8<br>
% of diabetes pop (T1) with recorded HbA1c<br>
2012<br>
1767<br>
89.0<br>
%<br>
87.1<br>
9<br>
% of diabetes pop (T2) with recorded HbA1c<br>
2012<br>
16097<br>
94.5<br>
%<br>
92.8<br>
10 % of diabetes pop (T1) with recorded BP<br>
2012<br>
1671<br>
84.1<br>
%<br>
85.2<br>
11 % of diabetes pop (T2) with recorded BP<br>
2012<br>
16072<br>
94.4<br>
%<br>
94.6<br>
12 % of diabetes pop (T1) with recorded cholesterol<br>
2012<br>
1450<br>
81.3<br>
%<br>
81.2<br>
13 % of diabetes pop (T2) with recorded cholesterol<br>
2012<br>
15964<br>
93.8<br>
%<br>
91.6<br>
14 % of diabetes pop (T1) with a recorded smoking status<br>
2012<br>
1826<br>
91.9<br>
%<br>
90.6<br>
15 % of diabetes pop (T2) with a recorded smoking status<br>
2012<br>
16378<br>
96.2<br>
%<br>
95.9<br>
Quality<br>
16 % of diabetes pop (T1) with recorded creatinine<br>
2012<br>
1641<br>
85.7<br>
%<br>
83.4<br>
of<br>
17 % of diabetes pop (T2) with recorded creatinine<br>
2012<br>
16378<br>
96.2<br>
%<br>
93.7<br>
Recording<br>
18 % of diabetes pop (T1) with recorded microalbumin<br>
2012<br>
1353<br>
70.7<br>
%<br>
60.7<br>
19 % of diabetes pop (T2) with recorded microalbumin<br>
2012<br>
13893<br>
81.6<br>
%<br>
69.1<br>
20 % of diabetes pop (T1) with recorded eGFR<br>
2012<br>
1022<br>
57.3<br>
%<br>
56.7<br>
21 % of diabetes pop (T2) with recorded eGFR<br>
2012<br>
12972<br>
76.2<br>
%<br>
70.5<br>
22 % of diabetes pop (T1) with recorded eye screen<br>
2012<br>
1544<br>
80.6<br>
%<br>
82.0<br>
23 % of diabetes pop (T2) with recorded eye screen<br>
2012<br>
14970<br>
87.9<br>
%<br>
86.6<br>
24 % of diabetes pop (T1) with recorded pulses<br>
2012<br>
1131<br>
56.9<br>
%<br>
55.9<br>
25 % of diabetes pop (T2) with recorded pulses<br>
2012<br>
12815<br>
75.2<br>
%<br>
71.8<br>
26 % of diabetes pop (T1) with recorded foot risk<br>
2012<br>
1141<br>
57.5<br>
%<br>
61.3<br>
27 % of diabetes pop (T2) with recorded foot risk<br>
2012<br>
13043<br>
76.6<br>
%<br>
81.1<br>
28 % of diabetes pop (T1) current smokers<br>
2012<br>
459<br>
23.1<br>
%<br>
21.6<br>
Smoking<br>
29 % of diabetes pop (T2) current smokers<br>
2012<br>
2909<br>
17.1<br>
%<br>
18.0<br>
30 % of diabetes pop (T1) obese (BMI&gt;=30)<br>
2012<br>
426<br>
27.4<br>
%<br>
25.5<br>
Obesity<br>
31 % of diabetes pop (T2) obese (BMI&gt;=30)<br>
2012<br>
8668<br>
57.8<br>
%<br>
55.4<br>
&amp;<br>
hypertension<br>
32 % of diabetes pop (T1) with SBP &lt;= 140mmHg<br>
2012<br>
1264<br>
75.6<br>
%<br>
80.7<br>
33 % of diabetes pop (T2) with SBP &lt;=140mmHg<br>
2012<br>
12069<br>
75.1<br>
%<br>
77.2<br>
34 % of diabetes pop (T1) with HbA1c &gt; 75mmol/mol<br>
2012<br>
752<br>
42.6<br>
%<br>
39.3<br>
Metabolic<br>
35 % of diabetes pop (T2) with HbA1c &gt; 75mmol/mol<br>
2012<br>
2280<br>
14.2<br>
%<br>
15.5<br>
complications<br>
36 % of diabetes pop (T1) with cholesterol &gt;5mmol<br>
2012<br>
435<br>
30.0<br>
%<br>
30.3<br>
37 % of diabetes pop (T2) with cholesterol &gt;5mmol<br>
2012<br>
2930<br>
18.4<br>
%<br>
19.5<br>
38 % of diabetes pop (T1) with eGFR &lt;15<br>
2012<br>
3<br>
0.2<br>
%<br>
0.6<br>
39 % of diabetes pop (T2) with eGFR &lt;15<br>
2012<br>
33<br>
0.2<br>
%<br>
0.3<br>
Microvascular<br>
40 % of diabetes pop (T1) with end-stage renal failure<br>
2012<br>
17<br>
0.9<br>
%<br>
1.2<br>
complications<br>
41 % of diabetes pop (T2) with end-stage renal failure<br>
2012<br>
86<br>
0.5<br>
%<br>
0.5<br>
42 % of diabetes pop (T1) with diabetic retinopathy<br>
2011<br>
1000<br>
59.5<br>
%<br>
57.5<br>
43 % of diabetes pop (T2) with diabetic retinopathy<br>
2011<br>
3977<br>
26.1<br>
%<br>
27.2<br>
44 % of diabetes pop (T1) with previous MI<br>
2012<br>
71<br>
3.6<br>
%<br>
3.6<br>
45 % of diabetes pop (T2) with previous MI<br>
2012<br>
1709<br>
10.0<br>
%<br>
10.1<br>
46 % of diabetes pop (T1) with previous cardiac revascularisation<br>
2012<br>
36<br>
1.8<br>
%<br>
2.5<br>
47 % of diabetes pop (T2) with previous cardiac revascularisation<br>
2012<br>
1059<br>
6.2<br>
%<br>
7.2<br>
Macrovascular<br>
48 % of diabetes pop (T1) with previous stroke<br>
2012<br>
47<br>
2.4<br>
%<br>
2.1<br>
complications<br>
49 % of diabetes pop (T2) with previous stroke<br>
2012<br>
878<br>
5.2<br>
%<br>
5.3<br>
50 % of diabetes pop (T1) with previous foot ulcer<br>
2012<br>
118<br>
5.9<br>
%<br>
8.5<br>
51 % of diabetes pop (T2) with previous foot ulcer<br>
2012<br>
758<br>
4.5<br>
%<br>
4.7<br>
52 % of diabetes pop (T1) with previous lower limb amputation<br>
2012<br>
27<br>
1.4<br>
%<br>
1.1<br>
53 % of diabetes pop (T2) with previous lower limb amputation<br>
2012<br>
145<br>
0.9<br>
%<br>
0.7<br>
`Worse' Area<br>
Scotland Average<br>
`Better' Area<br>
5</span><span class="ft4">th </span><span class="ft3">Percentile<br>
25</span><span class="ft4">th </span><span class="ft3">Percentile<br>
75</span><span class="ft4">th </span><span class="ft3">Percentile<br>
95</span><span class="ft4">th </span><span class="ft3">Percentile<br>
Note: T1 = Type 1 diabetes; T2 = Type 2 diabetes; n/a = data not available, or cannot be calculated; sr2 = directly<br>
Spine Chart Key:<br>
standardised rate per 100 population; % = percent. Only measures one and two are age adjusted. Differences in age<br>
Statistically significantly `worse' than National average<br>
composition of health board populations may partly explain differences in measures between boards. High level of<br>
recorded smoking in some boards may reflect the fact that smoking status has not been updated for those who have<br>
Statistically not significantly different from National average<br>
stopped smoking. All measures exclude those of `unknown' status in the denominator. Further details of diabetes<br>
Statistically significantly `better' than National average<br>
measure definitions are given in the main report for the 2012 Scottish Diabetes Survey.<br>
No significance can be calculated<br>
87<br>
Scottish Diabetes Survey Monitoring Group<br>
<hr>
<A name=88></a>Scottish Diabetes Survey 2012<br>
Forth Valley Health Board Spine Chart 2012<br>
Domain<br>
Indicator<br>
Period<br>
Number<br>
Measure<br>
Type &quot;National<br>
Average&quot;<br>
1<br>
Age/sex standardised prevalence of T1 diabetes<br>
2012<br>
1648<br>
0.6<br>
sr2<br>
0.5<br>
2<br>
Age/sex standardised prevalence of T2 diabetes<br>
2012<br>
13091<br>
4.5<br>
sr2<br>
4.3<br>
Prevalence<br>
Incidence<br>
3<br>
Crude prevalence of T1 diabetes<br>
2012<br>
1648<br>
0.6<br>
%<br>
0.5<br>
&amp;<br>
4<br>
Crude prevalence T2 diabetes<br>
2012<br>
13091<br>
4.4<br>
%<br>
4.3<br>
Mortality<br>
5<br>
Estimated % pop with undiagnosed diabetes<br>
2012<br>
1933<br>
0.7<br>
%<br>
0.9<br>
6<br>
Crude mortality rate for all people with diabetes<br>
2012<br>
581<br>
3.8<br>
%<br>
3.6<br>
7<br>
% of diabetes pop with recorded BMI<br>
2012<br>
12953<br>
89.1<br>
%<br>
89.2<br>
8<br>
% of diabetes pop (T1) with recorded HbA1c<br>
2012<br>
1464<br>
88.8<br>
%<br>
87.1<br>
9<br>
% of diabetes pop (T2) with recorded HbA1c<br>
2012<br>
12110<br>
92.5<br>
%<br>
92.8<br>
10 % of diabetes pop (T1) with recorded BP<br>
2012<br>
1396<br>
84.7<br>
%<br>
85.2<br>
11 % of diabetes pop (T2) with recorded BP<br>
2012<br>
12417<br>
94.9<br>
%<br>
94.6<br>
12 % of diabetes pop (T1) with recorded cholesterol<br>
2012<br>
1247<br>
85.7<br>
%<br>
81.2<br>
13 % of diabetes pop (T2) with recorded cholesterol<br>
2012<br>
11583<br>
88.5<br>
%<br>
91.6<br>
14 % of diabetes pop (T1) with a recorded smoking status<br>
2012<br>
1570<br>
95.3<br>
%<br>
90.6<br>
15 % of diabetes pop (T2) with a recorded smoking status<br>
2012<br>
12376<br>
94.5<br>
%<br>
95.9<br>
Quality<br>
16 % of diabetes pop (T1) with recorded creatinine<br>
2012<br>
1415<br>
89.1<br>
%<br>
83.4<br>
of<br>
17 % of diabetes pop (T2) with recorded creatinine<br>
2012<br>
12533<br>
95.8<br>
%<br>
93.7<br>
Recording<br>
18 % of diabetes pop (T1) with recorded microalbumin<br>
2012<br>
898<br>
56.5<br>
%<br>
60.7<br>
19 % of diabetes pop (T2) with recorded microalbumin<br>
2012<br>
9113<br>
69.6<br>
%<br>
69.1<br>
20 % of diabetes pop (T1) with recorded eGFR<br>
2012<br>
1148<br>
78.9<br>
%<br>
56.7<br>
21 % of diabetes pop (T2) with recorded eGFR<br>
2012<br>
11822<br>
90.3<br>
%<br>
70.5<br>
22 % of diabetes pop (T1) with recorded eye screen<br>
2012<br>
1344<br>
84.6<br>
%<br>
82.0<br>
23 % of diabetes pop (T2) with recorded eye screen<br>
2012<br>
11599<br>
88.6<br>
%<br>
86.6<br>
24 % of diabetes pop (T1) with recorded pulses<br>
2012<br>
1118<br>
67.8<br>
%<br>
55.9<br>
25 % of diabetes pop (T2) with recorded pulses<br>
2012<br>
10520<br>
80.4<br>
%<br>
71.8<br>
26 % of diabetes pop (T1) with recorded foot risk<br>
2012<br>
1150<br>
69.8<br>
%<br>
61.3<br>
27 % of diabetes pop (T2) with recorded foot risk<br>
2012<br>
10931<br>
83.5<br>
%<br>
81.1<br>
28 % of diabetes pop (T1) current smokers<br>
2012<br>
357<br>
21.7<br>
%<br>
21.6<br>
Smoking<br>
29 % of diabetes pop (T2) current smokers<br>
2012<br>
2308<br>
17.6<br>
%<br>
18.0<br>
30 % of diabetes pop (T1) obese (BMI&gt;=30)<br>
2012<br>
323<br>
25.1<br>
%<br>
25.5<br>
Obesity<br>
31 % of diabetes pop (T2) obese (BMI&gt;=30)<br>
2012<br>
6725<br>
57.6<br>
%<br>
55.4<br>
&amp;<br>
hypertension<br>
32 % of diabetes pop (T1) with SBP &lt;= 140mmHg<br>
2012<br>
1101<br>
78.9<br>
%<br>
80.7<br>
33 % of diabetes pop (T2) with SBP &lt;=140mmHg<br>
2012<br>
9593<br>
77.3<br>
%<br>
77.2<br>
34 % of diabetes pop (T1) with HbA1c &gt; 75mmol/mol<br>
2012<br>
654<br>
44.7<br>
%<br>
39.3<br>
Metabolic<br>
35 % of diabetes pop (T2) with HbA1c &gt; 75mmol/mol<br>
2012<br>
1862<br>
15.4<br>
%<br>
15.5<br>
complications<br>
36 % of diabetes pop (T1) with cholesterol &gt;5mmol<br>
2012<br>
383<br>
30.7<br>
%<br>
30.3<br>
37 % of diabetes pop (T2) with cholesterol &gt;5mmol<br>
2012<br>
2318<br>
20.0<br>
%<br>
19.5<br>
38 % of diabetes pop (T1) with eGFR &lt;15<br>
2012<br>
5<br>
0.4<br>
%<br>
0.6<br>
39 % of diabetes pop (T2) with eGFR &lt;15<br>
2012<br>
19<br>
0.2<br>
%<br>
0.3<br>
Microvascular<br>
40 % of diabetes pop (T1) with end-stage renal failure<br>
2012<br>
15<br>
0.9<br>
%<br>
1.2<br>
complications<br>
41 % of diabetes pop (T2) with end-stage renal failure<br>
2012<br>
67<br>
0.5<br>
%<br>
0.5<br>
42 % of diabetes pop (T1) with diabetic retinopathy<br>
2011<br>
895<br>
62.5<br>
%<br>
57.5<br>
43 % of diabetes pop (T2) with diabetic retinopathy<br>
2011<br>
3793<br>
32.1<br>
%<br>
27.2<br>
44 % of diabetes pop (T1) with previous MI<br>
2012<br>
53<br>
3.2<br>
%<br>
3.6<br>
45 % of diabetes pop (T2) with previous MI<br>
2012<br>
1308<br>
10.0<br>
%<br>
10.1<br>
46 % of diabetes pop (T1) with previous cardiac revascularisation<br>
2012<br>
41<br>
2.5<br>
%<br>
2.5<br>
47 % of diabetes pop (T2) with previous cardiac revascularisation<br>
2012<br>
882<br>
6.7<br>
%<br>
7.2<br>
Macrovascular<br>
48 % of diabetes pop (T1) with previous stroke<br>
2012<br>
27<br>
1.6<br>
%<br>
2.1<br>
complications<br>
49 % of diabetes pop (T2) with previous stroke<br>
2012<br>
688<br>
5.3<br>
%<br>
5.3<br>
50 % of diabetes pop (T1) with previous foot ulcer<br>
2012<br>
161<br>
9.8<br>
%<br>
8.5<br>
51 % of diabetes pop (T2) with previous foot ulcer<br>
2012<br>
563<br>
4.3<br>
%<br>
4.7<br>
52 % of diabetes pop (T1) with previous lower limb amputation<br>
2012<br>
23<br>
1.4<br>
%<br>
1.1<br>
53 % of diabetes pop (T2) with previous lower limb amputation<br>
2012<br>
113<br>
0.9<br>
%<br>
0.7<br>
`Worse' Area<br>
Scotland Average<br>
`Better' Area<br>
5</span><span class="ft4">th </span><span class="ft3">Percentile<br>
25</span><span class="ft4">th </span><span class="ft3">Percentile<br>
75</span><span class="ft4">th </span><span class="ft3">Percentile<br>
95</span><span class="ft4">th </span><span class="ft3">Percentile<br>
Note: T1 = Type 1 diabetes; T2 = Type 2 diabetes; n/a = data not available, or cannot be calculated; sr2 = directly<br>
Spine Chart Key:<br>
standardised rate per 100 population; % = percent. Only measures one and two are age adjusted. Differences in age<br>
Statistically significantly `worse' than National average<br>
composition of health board populations may partly explain differences in measures between boards. High level of<br>
recorded smoking in some boards may reflect the fact that smoking status has not been updated for those who have<br>
Statistically not significantly different from National average<br>
stopped smoking. All measures exclude those of `unknown' status in the denominator. Further details of diabetes<br>
Statistically significantly `better' than National average<br>
measure definitions are given in the main report for the 2012 Scottish Diabetes Survey.<br>
No significance can be calculated<br>
88<br>
Scottish Diabetes Survey Monitoring Group<br>
<hr>
<A name=89></a>Scottish Diabetes Survey 2012<br>
Grampian Health Board Spine Chart 2012<br>
Domain<br>
Indicator<br>
Period<br>
Number<br>
Measure<br>
Type &quot;National<br>
Average&quot;<br>
1<br>
Age/sex standardised prevalence of T1 diabetes<br>
2012<br>
3129<br>
0.6<br>
sr2<br>
0.5<br>
2<br>
Age/sex standardised prevalence of T2 diabetes<br>
2012<br>
22037<br>
4.0<br>
sr2<br>
4.3<br>
Prevalence<br>
Incidence<br>
3<br>
Crude prevalence of T1 diabetes<br>
2012<br>
3129<br>
0.6<br>
%<br>
0.5<br>
&amp;<br>
4<br>
Crude prevalence T2 diabetes<br>
2012<br>
22037<br>
4.0<br>
%<br>
4.3<br>
Mortality<br>
5<br>
Estimated % pop with undiagnosed diabetes<br>
2012<br>
4507<br>
0.8<br>
%<br>
0.9<br>
6<br>
Crude mortality rate for all people with diabetes<br>
2012<br>
940<br>
3.6<br>
%<br>
3.6<br>
7<br>
% of diabetes pop with recorded BMI<br>
2012<br>
22863<br>
92.1<br>
%<br>
89.2<br>
8<br>
% of diabetes pop (T1) with recorded HbA1c<br>
2012<br>
2734<br>
87.4<br>
%<br>
87.1<br>
9<br>
% of diabetes pop (T2) with recorded HbA1c<br>
2012<br>
20623<br>
93.6<br>
%<br>
92.8<br>
10 % of diabetes pop (T1) with recorded BP<br>
2012<br>
2674<br>
85.5<br>
%<br>
85.2<br>
11 % of diabetes pop (T2) with recorded BP<br>
2012<br>
21266<br>
96.5<br>
%<br>
94.6<br>
12 % of diabetes pop (T1) with recorded cholesterol<br>
2012<br>
2277<br>
81.5<br>
%<br>
81.2<br>
13 % of diabetes pop (T2) with recorded cholesterol<br>
2012<br>
20777<br>
94.3<br>
%<br>
91.6<br>
14 % of diabetes pop (T1) with a recorded smoking status<br>
2012<br>
2751<br>
87.9<br>
%<br>
90.6<br>
15 % of diabetes pop (T2) with a recorded smoking status<br>
2012<br>
20809<br>
94.4<br>
%<br>
95.9<br>
Quality<br>
16 % of diabetes pop (T1) with recorded creatinine<br>
2012<br>
2550<br>
84.6<br>
%<br>
83.4<br>
of<br>
17 % of diabetes pop (T2) with recorded creatinine<br>
2012<br>
21271<br>
96.5<br>
%<br>
93.7<br>
Recording<br>
18 % of diabetes pop (T1) with recorded microalbumin<br>
2012<br>
2000<br>
66.4<br>
%<br>
60.7<br>
19 % of diabetes pop (T2) with recorded microalbumin<br>
2012<br>
18297<br>
83.0<br>
%<br>
69.1<br>
20 % of diabetes pop (T1) with recorded eGFR<br>
2012<br>
2390<br>
85.5<br>
%<br>
56.7<br>
21 % of diabetes pop (T2) with recorded eGFR<br>
2012<br>
21053<br>
95.5<br>
%<br>
70.5<br>
22 % of diabetes pop (T1) with recorded eye screen<br>
2012<br>
2569<br>
85.3<br>
%<br>
82.0<br>
23 % of diabetes pop (T2) with recorded eye screen<br>
2012<br>
19692<br>
89.4<br>
%<br>
86.6<br>
24 % of diabetes pop (T1) with recorded pulses<br>
2012<br>
1980<br>
63.3<br>
%<br>
55.9<br>
25 % of diabetes pop (T2) with recorded pulses<br>
2012<br>
17674<br>
80.2<br>
%<br>
71.8<br>
26 % of diabetes pop (T1) with recorded foot risk<br>
2012<br>
2092<br>
66.9<br>
%<br>
61.3<br>
27 % of diabetes pop (T2) with recorded foot risk<br>
2012<br>
18720<br>
84.9<br>
%<br>
81.1<br>
28 % of diabetes pop (T1) current smokers<br>
2012<br>
584<br>
18.7<br>
%<br>
21.6<br>
Smoking<br>
29 % of diabetes pop (T2) current smokers<br>
2012<br>
3244<br>
14.7<br>
%<br>
18.0<br>
30 % of diabetes pop (T1) obese (BMI&gt;=30)<br>
2012<br>
598<br>
23.6<br>
%<br>
25.5<br>
Obesity<br>
31 % of diabetes pop (T2) obese (BMI&gt;=30)<br>
2012<br>
11103<br>
54.6<br>
%<br>
55.4<br>
&amp;<br>
hypertension<br>
32 % of diabetes pop (T1) with SBP &lt;= 140mmHg<br>
2012<br>
2246<br>
84.0<br>
%<br>
80.7<br>
33 % of diabetes pop (T2) with SBP &lt;=140mmHg<br>
2012<br>
15998<br>
75.2<br>
%<br>
77.2<br>
34 % of diabetes pop (T1) with HbA1c &gt; 75mmol/mol<br>
2012<br>
1338<br>
48.9<br>
%<br>
39.3<br>
Metabolic<br>
35 % of diabetes pop (T2) with HbA1c &gt; 75mmol/mol<br>
2012<br>
3774<br>
18.3<br>
%<br>
15.5<br>
complications<br>
36 % of diabetes pop (T1) with cholesterol &gt;5mmol<br>
2012<br>
595<br>
26.1<br>
%<br>
30.3<br>
37 % of diabetes pop (T2) with cholesterol &gt;5mmol<br>
2012<br>
3642<br>
17.5<br>
%<br>
19.5<br>
38 % of diabetes pop (T1) with eGFR &lt;15<br>
2012<br>
18<br>
0.7<br>
%<br>
0.6<br>
39 % of diabetes pop (T2) with eGFR &lt;15<br>
2012<br>
55<br>
0.3<br>
%<br>
0.3<br>
Microvascular<br>
40 % of diabetes pop (T1) with end-stage renal failure<br>
2012<br>
46<br>
1.5<br>
%<br>
1.2<br>
complications<br>
41 % of diabetes pop (T2) with end-stage renal failure<br>
2012<br>
121<br>
0.5<br>
%<br>
0.5<br>
42 % of diabetes pop (T1) with diabetic retinopathy<br>
2011<br>
1307<br>
48.4<br>
%<br>
57.5<br>
43 % of diabetes pop (T2) with diabetic retinopathy<br>
2011<br>
4243<br>
21.4<br>
%<br>
27.2<br>
44 % of diabetes pop (T1) with previous MI<br>
2012<br>
102<br>
3.3<br>
%<br>
3.6<br>
45 % of diabetes pop (T2) with previous MI<br>
2012<br>
2119<br>
9.6<br>
%<br>
10.1<br>
46 % of diabetes pop (T1) with previous cardiac revascularisation<br>
2012<br>
78<br>
2.5<br>
%<br>
2.5<br>
47 % of diabetes pop (T2) with previous cardiac revascularisation<br>
2012<br>
1713<br>
7.8<br>
%<br>
7.2<br>
Macrovascular<br>
48 % of diabetes pop (T1) with previous stroke<br>
2012<br>
52<br>
1.7<br>
%<br>
2.1<br>
complications<br>
49 % of diabetes pop (T2) with previous stroke<br>
2012<br>
1000<br>
4.5<br>
%<br>
5.3<br>
50 % of diabetes pop (T1) with previous foot ulcer<br>
2012<br>
125<br>
4.0<br>
%<br>
8.5<br>
51 % of diabetes pop (T2) with previous foot ulcer<br>
2012<br>
441<br>
2.0<br>
%<br>
4.7<br>
52 % of diabetes pop (T1) with previous lower limb amputation<br>
2012<br>
38<br>
1.2<br>
%<br>
1.1<br>
53 % of diabetes pop (T2) with previous lower limb amputation<br>
2012<br>
178<br>
0.8<br>
%<br>
0.7<br>
`Worse' Area<br>
Scotland Average<br>
`Better' Area<br>
5</span><span class="ft4">th </span><span class="ft3">Percentile<br>
25</span><span class="ft4">th </span><span class="ft3">Percentile<br>
75</span><span class="ft4">th </span><span class="ft3">Percentile<br>
95</span><span class="ft4">th </span><span class="ft3">Percentile<br>
Note: T1 = Type 1 diabetes; T2 = Type 2 diabetes; n/a = data not available, or cannot be calculated; sr2 = directly<br>
Spine Chart Key:<br>
standardised rate per 100 population; % = percent. Only measures one and two are age adjusted. Differences in age<br>
Statistically significantly `worse' than National average<br>
composition of health board populations may partly explain differences in measures between boards. High level of<br>
recorded smoking in some boards may reflect the fact that smoking status has not been updated for those who have<br>
Statistically not significantly different from National average<br>
stopped smoking. All measures exclude those of `unknown' status in the denominator. Further details of diabetes<br>
Statistically significantly `better' than National average<br>
measure definitions are given in the main report for the 2012 Scottish Diabetes Survey.<br>
No significance can be calculated<br>
89<br>
Scottish Diabetes Survey Monitoring Group<br>
<hr>
<A name=90></a>Scottish Diabetes Survey 2012<br>
Greater Glasgow &amp; Clyde Health Board Spine Chart 2012<br>
Domain<br>
Indicator<br>
Period<br>
Number<br>
Measure<br>
Type &quot;National<br>
Average&quot;<br>
1<br>
Age/sex standardised prevalence of T1 diabetes<br>
2012<br>
6366<br>
0.5<br>
sr2<br>
0.5<br>
2<br>
Age/sex standardised prevalence of T2 diabetes<br>
2012<br>
52236<br>
4.6<br>
sr2<br>
4.3<br>
Prevalence<br>
Incidence<br>
3<br>
Crude prevalence of T1 diabetes<br>
2012<br>
6366<br>
0.5<br>
%<br>
0.5<br>
&amp;<br>
4<br>
Crude prevalence T2 diabetes<br>
2012<br>
52236<br>
4.3<br>
%<br>
4.3<br>
Mortality<br>
5<br>
Estimated % pop with undiagnosed diabetes<br>
2012<br>
11007<br>
0.9<br>
%<br>
0.9<br>
6<br>
Crude mortality rate for all people with diabetes<br>
2012<br>
2249<br>
3.7<br>
%<br>
3.6<br>
7<br>
% of diabetes pop with recorded BMI<br>
2012<br>
50675<br>
87.4<br>
%<br>
89.2<br>
8<br>
% of diabetes pop (T1) with recorded HbA1c<br>
2012<br>
5467<br>
85.9<br>
%<br>
87.1<br>
9<br>
% of diabetes pop (T2) with recorded HbA1c<br>
2012<br>
47629<br>
91.2<br>
%<br>
92.8<br>
10 % of diabetes pop (T1) with recorded BP<br>
2012<br>
5509<br>
86.5<br>
%<br>
85.2<br>
11 % of diabetes pop (T2) with recorded BP<br>
2012<br>
48849<br>
93.5<br>
%<br>
94.6<br>
12 % of diabetes pop (T1) with recorded cholesterol<br>
2012<br>
4474<br>
78.0<br>
%<br>
81.2<br>
13 % of diabetes pop (T2) with recorded cholesterol<br>
2012<br>
46706<br>
89.5<br>
%<br>
91.6<br>
14 % of diabetes pop (T1) with a recorded smoking status<br>
2012<br>
5587<br>
87.8<br>
%<br>
90.6<br>
15 % of diabetes pop (T2) with a recorded smoking status<br>
2012<br>
49489<br>
94.7<br>
%<br>
95.9<br>
Quality<br>
16 % of diabetes pop (T1) with recorded creatinine<br>
2012<br>
4944<br>
80.6<br>
%<br>
83.4<br>
of<br>
17 % of diabetes pop (T2) with recorded creatinine<br>
2012<br>
48177<br>
92.3<br>
%<br>
93.7<br>
Recording<br>
18 % of diabetes pop (T1) with recorded microalbumin<br>
2012<br>
3618<br>
59.0<br>
%<br>
60.7<br>
19 % of diabetes pop (T2) with recorded microalbumin<br>
2012<br>
35337<br>
67.7<br>
%<br>
69.1<br>
20 % of diabetes pop (T1) with recorded eGFR<br>
2012<br>
3900<br>
68.0<br>
%<br>
56.7<br>
21 % of diabetes pop (T2) with recorded eGFR<br>
2012<br>
45276<br>
86.7<br>
%<br>
70.5<br>
22 % of diabetes pop (T1) with recorded eye screen<br>
2012<br>
5005<br>
81.6<br>
%<br>
82.0<br>
23 % of diabetes pop (T2) with recorded eye screen<br>
2012<br>
45168<br>
86.5<br>
%<br>
86.6<br>
24 % of diabetes pop (T1) with recorded pulses<br>
2012<br>
3390<br>
53.3<br>
%<br>
55.9<br>
25 % of diabetes pop (T2) with recorded pulses<br>
2012<br>
39854<br>
76.3<br>
%<br>
71.8<br>
26 % of diabetes pop (T1) with recorded foot risk<br>
2012<br>
3437<br>
54.0<br>
%<br>
61.3<br>
27 % of diabetes pop (T2) with recorded foot risk<br>
2012<br>
40539<br>
77.6<br>
%<br>
81.1<br>
28 % of diabetes pop (T1) current smokers<br>
2012<br>
1378<br>
21.6<br>
%<br>
21.6<br>
Smoking<br>
29 % of diabetes pop (T2) current smokers<br>
2012<br>
10526<br>
20.2<br>
%<br>
18.0<br>
30 % of diabetes pop (T1) obese (BMI&gt;=30)<br>
2012<br>
1190<br>
24.4<br>
%<br>
25.5<br>
Obesity<br>
31 % of diabetes pop (T2) obese (BMI&gt;=30)<br>
2012<br>
24587<br>
53.7<br>
%<br>
55.4<br>
&amp;<br>
hypertension<br>
32 % of diabetes pop (T1) with SBP &lt;= 140mmHg<br>
2012<br>
4405<br>
80.0<br>
%<br>
80.7<br>
33 % of diabetes pop (T2) with SBP &lt;=140mmHg<br>
2012<br>
38454<br>
78.7<br>
%<br>
77.2<br>
34 % of diabetes pop (T1) with HbA1c &gt; 75mmol/mol<br>
2012<br>
1972<br>
36.1<br>
%<br>
39.3<br>
Metabolic<br>
35 % of diabetes pop (T2) with HbA1c &gt; 75mmol/mol<br>
2012<br>
7929<br>
16.6<br>
%<br>
15.5<br>
complications<br>
36 % of diabetes pop (T1) with cholesterol &gt;5mmol<br>
2012<br>
1373<br>
30.7<br>
%<br>
30.3<br>
37 % of diabetes pop (T2) with cholesterol &gt;5mmol<br>
2012<br>
9138<br>
19.6<br>
%<br>
19.5<br>
38 % of diabetes pop (T1) with eGFR &lt;15<br>
2012<br>
29<br>
0.6<br>
%<br>
0.6<br>
39 % of diabetes pop (T2) with eGFR &lt;15<br>
2012<br>
161<br>
0.3<br>
%<br>
0.3<br>
Microvascular<br>
40 % of diabetes pop (T1) with end-stage renal failure<br>
2012<br>
59<br>
0.9<br>
%<br>
1.2<br>
complications<br>
41 % of diabetes pop (T2) with end-stage renal failure<br>
2012<br>
272<br>
0.5<br>
%<br>
0.5<br>
42 % of diabetes pop (T1) with diabetic retinopathy<br>
2011<br>
3055<br>
57.3<br>
%<br>
57.5<br>
43 % of diabetes pop (T2) with diabetic retinopathy<br>
2011<br>
12147<br>
26.0<br>
%<br>
27.2<br>
44 % of diabetes pop (T1) with previous MI<br>
2012<br>
233<br>
3.7<br>
%<br>
3.6<br>
45 % of diabetes pop (T2) with previous MI<br>
2012<br>
5403<br>
10.3<br>
%<br>
10.1<br>
46 % of diabetes pop (T1) with previous cardiac revascularisation<br>
2012<br>
147<br>
2.3<br>
%<br>
2.5<br>
47 % of diabetes pop (T2) with previous cardiac revascularisation<br>
2012<br>
3976<br>
7.6<br>
%<br>
7.2<br>
Macrovascular<br>
48 % of diabetes pop (T1) with previous stroke<br>
2012<br>
117<br>
1.8<br>
%<br>
2.1<br>
complications<br>
49 % of diabetes pop (T2) with previous stroke<br>
2012<br>
2837<br>
5.4<br>
%<br>
5.3<br>
50 % of diabetes pop (T1) with previous foot ulcer<br>
2012<br>
555<br>
8.7<br>
%<br>
8.5<br>
51 % of diabetes pop (T2) with previous foot ulcer<br>
2012<br>
2294<br>
4.4<br>
%<br>
4.7<br>
52 % of diabetes pop (T1) with previous lower limb amputation<br>
2012<br>
68<br>
1.1<br>
%<br>
1.1<br>
53 % of diabetes pop (T2) with previous lower limb amputation<br>
2012<br>
364<br>
0.7<br>
%<br>
0.7<br>
`Worse' Area<br>
Scotland Average<br>
`Better' Area<br>
5</span><span class="ft4">th </span><span class="ft3">Percentile<br>
25</span><span class="ft4">th </span><span class="ft3">Percentile<br>
75</span><span class="ft4">th </span><span class="ft3">Percentile<br>
95</span><span class="ft4">th </span><span class="ft3">Percentile<br>
Note: T1 = Type 1 diabetes; T2 = Type 2 diabetes; n/a = data not available, or cannot be calculated; sr2 = directly<br>
Spine Chart Key:<br>
standardised rate per 100 population; % = percent. Only measures one and two are age adjusted. Differences in age<br>
Statistically significantly `worse' than National average<br>
composition of health board populations may partly explain differences in measures between boards. High level of<br>
recorded smoking in some boards may reflect the fact that smoking status has not been updated for those who have<br>
Statistically not significantly different from National average<br>
stopped smoking. All measures exclude those of `unknown' status in the denominator. Further details of diabetes<br>
Statistically significantly `better' than National average<br>
measure definitions are given in the main report for the 2012 Scottish Diabetes Survey.<br>
No significance can be calculated<br>
90<br>
Scottish Diabetes Survey Monitoring Group<br>
<hr>
<A name=91></a>Scottish Diabetes Survey 2012<br>
Highland Health Board Spine Chart 2012<br>
Domain<br>
Indicator<br>
Period<br>
Number<br>
Measure<br>
Type &quot;National<br>
Average&quot;<br>
1<br>
Age/sex standardised prevalence of T1 diabetes<br>
2012<br>
1793<br>
0.6<br>
sr2<br>
0.5<br>
2<br>
Age/sex standardised prevalence of T2 diabetes<br>
2012<br>
13190<br>
3.7<br>
sr2<br>
4.3<br>
Prevalence<br>
Incidence<br>
3<br>
Crude prevalence of T1 diabetes<br>
2012<br>
1793<br>
0.6<br>
%<br>
0.5<br>
&amp;<br>
4<br>
Crude prevalence T2 diabetes<br>
2012<br>
13190<br>
4.2<br>
%<br>
4.3<br>
Mortality<br>
5<br>
Estimated % pop with undiagnosed diabetes<br>
2012<br>
5929<br>
1.9<br>
%<br>
0.9<br>
6<br>
Crude mortality rate for all people with diabetes<br>
2012<br>
521<br>
3.3<br>
%<br>
3.6<br>
7<br>
% of diabetes pop with recorded BMI<br>
2012<br>
13339<br>
90.2<br>
%<br>
89.2<br>
8<br>
% of diabetes pop (T1) with recorded HbA1c<br>
2012<br>
1514<br>
84.4<br>
%<br>
87.1<br>
9<br>
% of diabetes pop (T2) with recorded HbA1c<br>
2012<br>
12141<br>
92.0<br>
%<br>
92.8<br>
10 % of diabetes pop (T1) with recorded BP<br>
2012<br>
1488<br>
83.0<br>
%<br>
85.2<br>
11 % of diabetes pop (T2) with recorded BP<br>
2012<br>
12462<br>
94.5<br>
%<br>
94.6<br>
12 % of diabetes pop (T1) with recorded cholesterol<br>
2012<br>
1348<br>
84.5<br>
%<br>
81.2<br>
13 % of diabetes pop (T2) with recorded cholesterol<br>
2012<br>
11977<br>
90.8<br>
%<br>
91.6<br>
14 % of diabetes pop (T1) with a recorded smoking status<br>
2012<br>
1689<br>
94.2<br>
%<br>
90.6<br>
15 % of diabetes pop (T2) with a recorded smoking status<br>
2012<br>
13159<br>
99.8<br>
%<br>
95.9<br>
Quality<br>
16 % of diabetes pop (T1) with recorded creatinine<br>
2012<br>
1333<br>
77.4<br>
%<br>
83.4<br>
of<br>
17 % of diabetes pop (T2) with recorded creatinine<br>
2012<br>
11457<br>
86.9<br>
%<br>
93.7<br>
Recording<br>
18 % of diabetes pop (T1) with recorded microalbumin<br>
2012<br>
994<br>
57.7<br>
%<br>
60.7<br>
19 % of diabetes pop (T2) with recorded microalbumin<br>
2012<br>
9353<br>
70.9<br>
%<br>
69.1<br>
20 % of diabetes pop (T1) with recorded eGFR<br>
2012<br>
1328<br>
83.3<br>
%<br>
56.7<br>
21 % of diabetes pop (T2) with recorded eGFR<br>
2012<br>
11884<br>
90.1<br>
%<br>
70.5<br>
22 % of diabetes pop (T1) with recorded eye screen<br>
2012<br>
1336<br>
77.5<br>
%<br>
82.0<br>
23 % of diabetes pop (T2) with recorded eye screen<br>
2012<br>
11069<br>
83.9<br>
%<br>
86.6<br>
24 % of diabetes pop (T1) with recorded pulses<br>
2012<br>
1082<br>
60.3<br>
%<br>
55.9<br>
25 % of diabetes pop (T2) with recorded pulses<br>
2012<br>
9725<br>
73.7<br>
%<br>
71.8<br>
26 % of diabetes pop (T1) with recorded foot risk<br>
2012<br>
1210<br>
67.5<br>
%<br>
61.3<br>
27 % of diabetes pop (T2) with recorded foot risk<br>
2012<br>
11129<br>
84.4<br>
%<br>
81.1<br>
28 % of diabetes pop (T1) current smokers<br>
2012<br>
396<br>
22.1<br>
%<br>
21.6<br>
Smoking<br>
29 % of diabetes pop (T2) current smokers<br>
2012<br>
1979<br>
15.0<br>
%<br>
18.0<br>
30 % of diabetes pop (T1) obese (BMI&gt;=30)<br>
2012<br>
377<br>
26.9<br>
%<br>
25.5<br>
Obesity<br>
31 % of diabetes pop (T2) obese (BMI&gt;=30)<br>
2012<br>
6487<br>
54.3<br>
%<br>
55.4<br>
&amp;<br>
hypertension<br>
32 % of diabetes pop (T1) with SBP &lt;= 140mmHg<br>
2012<br>
1214<br>
81.6<br>
%<br>
80.7<br>
33 % of diabetes pop (T2) with SBP &lt;=140mmHg<br>
2012<br>
9289<br>
74.5<br>
%<br>
77.2<br>
34 % of diabetes pop (T1) with HbA1c &gt; 75mmol/mol<br>
2012<br>
557<br>
36.8<br>
%<br>
39.3<br>
Metabolic<br>
35 % of diabetes pop (T2) with HbA1c &gt; 75mmol/mol<br>
2012<br>
1860<br>
15.3<br>
%<br>
15.5<br>
complications<br>
36 % of diabetes pop (T1) with cholesterol &gt;5mmol<br>
2012<br>
374<br>
27.7<br>
%<br>
30.3<br>
37 % of diabetes pop (T2) with cholesterol &gt;5mmol<br>
2012<br>
2740<br>
22.9<br>
%<br>
19.5<br>
38 % of diabetes pop (T1) with eGFR &lt;15<br>
2012<br>
4<br>
0.3<br>
%<br>
0.6<br>
39 % of diabetes pop (T2) with eGFR &lt;15<br>
2012<br>
40<br>
0.3<br>
%<br>
0.3<br>
Microvascular<br>
40 % of diabetes pop (T1) with end-stage renal failure<br>
2012<br>
19<br>
1.1<br>
%<br>
1.2<br>
complications<br>
41 % of diabetes pop (T2) with end-stage renal failure<br>
2012<br>
70<br>
0.5<br>
%<br>
0.5<br>
42 % of diabetes pop (T1) with diabetic retinopathy<br>
2011<br>
826<br>
52.9<br>
%<br>
57.5<br>
43 % of diabetes pop (T2) with diabetic retinopathy<br>
2011<br>
2750<br>
23.8<br>
%<br>
27.2<br>
44 % of diabetes pop (T1) with previous MI<br>
2012<br>
66<br>
3.7<br>
%<br>
3.6<br>
45 % of diabetes pop (T2) with previous MI<br>
2012<br>
1356<br>
10.3<br>
%<br>
10.1<br>
46 % of diabetes pop (T1) with previous cardiac revascularisation<br>
2012<br>
51<br>
2.8<br>
%<br>
2.5<br>
47 % of diabetes pop (T2) with previous cardiac revascularisation<br>
2012<br>
958<br>
7.3<br>
%<br>
7.2<br>
Macrovascular<br>
48 % of diabetes pop (T1) with previous stroke<br>
2012<br>
39<br>
2.2<br>
%<br>
2.1<br>
complications<br>
49 % of diabetes pop (T2) with previous stroke<br>
2012<br>
661<br>
5.0<br>
%<br>
5.3<br>
50 % of diabetes pop (T1) with previous foot ulcer<br>
2012<br>
69<br>
3.8<br>
%<br>
8.5<br>
51 % of diabetes pop (T2) with previous foot ulcer<br>
2012<br>
327<br>
2.5<br>
%<br>
4.7<br>
52 % of diabetes pop (T1) with previous lower limb amputation<br>
2012<br>
20<br>
1.1<br>
%<br>
1.1<br>
53 % of diabetes pop (T2) with previous lower limb amputation<br>
2012<br>
89<br>
0.7<br>
%<br>
0.7<br>
`Worse' Area<br>
Scotland Average<br>
`Better' Area<br>
5</span><span class="ft4">th </span><span class="ft3">Percentile<br>
25</span><span class="ft4">th </span><span class="ft3">Percentile<br>
75</span><span class="ft4">th </span><span class="ft3">Percentile<br>
95</span><span class="ft4">th </span><span class="ft3">Percentile<br>
Note: T1 = Type 1 diabetes; T2 = Type 2 diabetes; n/a = data not available, or cannot be calculated; sr2 = directly<br>
Spine Chart Key:<br>
standardised rate per 100 population; % = percent. Only measures one and two are age adjusted. Differences in age<br>
Statistically significantly `worse' than National average<br>
composition of health board populations may partly explain differences in measures between boards. High level of<br>
recorded smoking in some boards may reflect the fact that smoking status has not been updated for those who have<br>
Statistically not significantly different from National average<br>
stopped smoking. All measures exclude those of `unknown' status in the denominator. Further details of diabetes<br>
Statistically significantly `better' than National average<br>
measure definitions are given in the main report for the 2012 Scottish Diabetes Survey.<br>
No significance can be calculated<br>
91<br>
Scottish Diabetes Survey Monitoring Group<br>
<hr>
<A name=92></a>Scottish Diabetes Survey 2012<br>
Lanarkshire Health Board Spine Chart 2012<br>
Domain<br>
Indicator<br>
Period<br>
Number<br>
Measure<br>
Type &quot;National<br>
Average&quot;<br>
1<br>
Age/sex standardised prevalence of T1 diabetes<br>
2012<br>
3585<br>
0.6<br>
sr2<br>
0.5<br>
2<br>
Age/sex standardised prevalence of T2 diabetes<br>
2012<br>
26527<br>
4.8<br>
sr2<br>
4.3<br>
Prevalence<br>
Incidence<br>
3<br>
Crude prevalence of T1 diabetes<br>
2012<br>
3585<br>
0.6<br>
%<br>
0.5<br>
&amp;<br>
4<br>
Crude prevalence T2 diabetes<br>
2012<br>
26527<br>
4.7<br>
%<br>
4.3<br>
Mortality<br>
5<br>
Estimated % pop with undiagnosed diabetes<br>
2012<br>
4470<br>
0.8<br>
%<br>
0.9<br>
6<br>
Crude mortality rate for all people with diabetes<br>
2012<br>
1089<br>
3.5<br>
%<br>
3.6<br>
7<br>
% of diabetes pop with recorded BMI<br>
2012<br>
25359<br>
85.6<br>
%<br>
89.2<br>
8<br>
% of diabetes pop (T1) with recorded HbA1c<br>
2012<br>
2765<br>
77.1<br>
%<br>
87.1<br>
9<br>
% of diabetes pop (T2) with recorded HbA1c<br>
2012<br>
23921<br>
90.2<br>
%<br>
92.8<br>
10 % of diabetes pop (T1) with recorded BP<br>
2012<br>
2910<br>
81.2<br>
%<br>
85.2<br>
11 % of diabetes pop (T2) with recorded BP<br>
2012<br>
24441<br>
92.1<br>
%<br>
94.6<br>
12 % of diabetes pop (T1) with recorded cholesterol<br>
2012<br>
2430<br>
77.0<br>
%<br>
81.2<br>
13 % of diabetes pop (T2) with recorded cholesterol<br>
2012<br>
23579<br>
89.1<br>
%<br>
91.6<br>
14 % of diabetes pop (T1) with a recorded smoking status<br>
2012<br>
2965<br>
82.7<br>
%<br>
90.6<br>
15 % of diabetes pop (T2) with a recorded smoking status<br>
2012<br>
24028<br>
90.6<br>
%<br>
95.9<br>
Quality<br>
16 % of diabetes pop (T1) with recorded creatinine<br>
2012<br>
2639<br>
77.2<br>
%<br>
83.4<br>
of<br>
17 % of diabetes pop (T2) with recorded creatinine<br>
2012<br>
24304<br>
91.9<br>
%<br>
93.7<br>
Recording<br>
18 % of diabetes pop (T1) with recorded microalbumin<br>
2012<br>
1706<br>
49.9<br>
%<br>
60.7<br>
19 % of diabetes pop (T2) with recorded microalbumin<br>
2012<br>
17265<br>
65.3<br>
%<br>
69.1<br>
20 % of diabetes pop (T1) with recorded eGFR<br>
2012<br>
613<br>
19.4<br>
%<br>
56.7<br>
21 % of diabetes pop (T2) with recorded eGFR<br>
2012<br>
7702<br>
29.1<br>
%<br>
70.5<br>
22 % of diabetes pop (T1) with recorded eye screen<br>
2012<br>
2647<br>
77.4<br>
%<br>
82.0<br>
23 % of diabetes pop (T2) with recorded eye screen<br>
2012<br>
22117<br>
83.6<br>
%<br>
86.6<br>
24 % of diabetes pop (T1) with recorded pulses<br>
2012<br>
1801<br>
50.2<br>
%<br>
55.9<br>
25 % of diabetes pop (T2) with recorded pulses<br>
2012<br>
17365<br>
65.5<br>
%<br>
71.8<br>
26 % of diabetes pop (T1) with recorded foot risk<br>
2012<br>
2019<br>
56.3<br>
%<br>
61.3<br>
27 % of diabetes pop (T2) with recorded foot risk<br>
2012<br>
20006<br>
75.4<br>
%<br>
81.1<br>
28 % of diabetes pop (T1) current smokers<br>
2012<br>
745<br>
20.8<br>
%<br>
21.6<br>
Smoking<br>
29 % of diabetes pop (T2) current smokers<br>
2012<br>
4696<br>
17.7<br>
%<br>
18.0<br>
30 % of diabetes pop (T1) obese (BMI&gt;=30)<br>
2012<br>
664<br>
27.3<br>
%<br>
25.5<br>
Obesity<br>
31 % of diabetes pop (T2) obese (BMI&gt;=30)<br>
2012<br>
12984<br>
56.6<br>
%<br>
55.4<br>
&amp;<br>
hypertension<br>
32 % of diabetes pop (T1) with SBP &lt;= 140mmHg<br>
2012<br>
2449<br>
84.2<br>
%<br>
80.7<br>
33 % of diabetes pop (T2) with SBP &lt;=140mmHg<br>
2012<br>
19780<br>
80.9<br>
%<br>
77.2<br>
34 % of diabetes pop (T1) with HbA1c &gt; 75mmol/mol<br>
2012<br>
1109<br>
40.1<br>
%<br>
39.3<br>
Metabolic<br>
35 % of diabetes pop (T2) with HbA1c &gt; 75mmol/mol<br>
2012<br>
4005<br>
16.7<br>
%<br>
15.5<br>
complications<br>
36 % of diabetes pop (T1) with cholesterol &gt;5mmol<br>
2012<br>
854<br>
35.1<br>
%<br>
30.3<br>
37 % of diabetes pop (T2) with cholesterol &gt;5mmol<br>
2012<br>
4983<br>
21.1<br>
%<br>
19.5<br>
38 % of diabetes pop (T1) with eGFR &lt;15<br>
2012<br>
16<br>
0.6<br>
%<br>
0.6<br>
39 % of diabetes pop (T2) with eGFR &lt;15<br>
2012<br>
64<br>
0.3<br>
%<br>
0.3<br>
Microvascular<br>
40 % of diabetes pop (T1) with end-stage renal failure<br>
2012<br>
43<br>
1.2<br>
%<br>
1.2<br>
complications<br>
41 % of diabetes pop (T2) with end-stage renal failure<br>
2012<br>
105<br>
0.4<br>
%<br>
0.5<br>
42 % of diabetes pop (T1) with diabetic retinopathy<br>
2011<br>
1863<br>
61.8<br>
%<br>
57.5<br>
43 % of diabetes pop (T2) with diabetic retinopathy<br>
2011<br>
6975<br>
30.5<br>
%<br>
27.2<br>
44 % of diabetes pop (T1) with previous MI<br>
2012<br>
161<br>
4.5<br>
%<br>
3.6<br>
45 % of diabetes pop (T2) with previous MI<br>
2012<br>
2771<br>
10.4<br>
%<br>
10.1<br>
46 % of diabetes pop (T1) with previous cardiac revascularisation<br>
2012<br>
117<br>
3.3<br>
%<br>
2.5<br>
47 % of diabetes pop (T2) with previous cardiac revascularisation<br>
2012<br>
1993<br>
7.5<br>
%<br>
7.2<br>
Macrovascular<br>
48 % of diabetes pop (T1) with previous stroke<br>
2012<br>
81<br>
2.3<br>
%<br>
2.1<br>
complications<br>
49 % of diabetes pop (T2) with previous stroke<br>
2012<br>
1304<br>
4.9<br>
%<br>
5.3<br>
50 % of diabetes pop (T1) with previous foot ulcer<br>
2012<br>
724<br>
20.2<br>
%<br>
8.5<br>
51 % of diabetes pop (T2) with previous foot ulcer<br>
2012<br>
2905<br>
11.0<br>
%<br>
4.7<br>
52 % of diabetes pop (T1) with previous lower limb amputation<br>
2012<br>
39<br>
1.1<br>
%<br>
1.1<br>
53 % of diabetes pop (T2) with previous lower limb amputation<br>
2012<br>
163<br>
0.6<br>
%<br>
0.7<br>
`Worse' Area<br>
Scotland Average<br>
`Better' Area<br>
5</span><span class="ft4">th </span><span class="ft3">Percentile<br>
25</span><span class="ft4">th </span><span class="ft3">Percentile<br>
75</span><span class="ft4">th </span><span class="ft3">Percentile<br>
95</span><span class="ft4">th </span><span class="ft3">Percentile<br>
Note: T1 = Type 1 diabetes; T2 = Type 2 diabetes; n/a = data not available, or cannot be calculated; sr2 = directly<br>
Spine Chart Key:<br>
standardised rate per 100 population; % = percent. Only measures one and two are age adjusted. Differences in age<br>
Statistically significantly `worse' than National average<br>
composition of health board populations may partly explain differences in measures between boards. High level of<br>
recorded smoking in some boards may reflect the fact that smoking status has not been updated for those who have<br>
Statistically not significantly different from National average<br>
stopped smoking. All measures exclude those of `unknown' status in the denominator. Further details of diabetes<br>
Statistically significantly `better' than National average<br>
measure definitions are given in the main report for the 2012 Scottish Diabetes Survey.<br>
No significance can be calculated<br>
92<br>
Scottish Diabetes Survey Monitoring Group<br>
<hr>
<A name=93></a>Scottish Diabetes Survey 2012<br>
Lothian Health Board Spine Chart 2012<br>
Domain<br>
Indicator<br>
Period<br>
Number<br>
Measure<br>
Type &quot;National<br>
Average&quot;<br>
1<br>
Age/sex standardised prevalence of T1 diabetes<br>
2012<br>
4282<br>
0.5<br>
sr2<br>
0.5<br>
2<br>
Age/sex standardised prevalence of T2 diabetes<br>
2012<br>
30735<br>
4.0<br>
sr2<br>
4.3<br>
Prevalence<br>
Incidence<br>
3<br>
Crude prevalence of T1 diabetes<br>
2012<br>
4282<br>
0.5<br>
%<br>
0.5<br>
&amp;<br>
4<br>
Crude prevalence T2 diabetes<br>
2012<br>
30735<br>
3.6<br>
%<br>
4.3<br>
Mortality<br>
5<br>
Estimated % pop with undiagnosed diabetes<br>
2012<br>
7586<br>
0.9<br>
%<br>
0.9<br>
6<br>
Crude mortality rate for all people with diabetes<br>
2012<br>
1229<br>
3.4<br>
%<br>
3.6<br>
7<br>
% of diabetes pop with recorded BMI<br>
2012<br>
31739<br>
91.6<br>
%<br>
89.2<br>
8<br>
% of diabetes pop (T1) with recorded HbA1c<br>
2012<br>
3930<br>
91.8<br>
%<br>
87.1<br>
9<br>
% of diabetes pop (T2) with recorded HbA1c<br>
2012<br>
28675<br>
93.3<br>
%<br>
92.8<br>
10 % of diabetes pop (T1) with recorded BP<br>
2012<br>
3789<br>
88.5<br>
%<br>
85.2<br>
11 % of diabetes pop (T2) with recorded BP<br>
2012<br>
29487<br>
95.9<br>
%<br>
94.6<br>
12 % of diabetes pop (T1) with recorded cholesterol<br>
2012<br>
3295<br>
83.9<br>
%<br>
81.2<br>
13 % of diabetes pop (T2) with recorded cholesterol<br>
2012<br>
28409<br>
92.4<br>
%<br>
91.6<br>
14 % of diabetes pop (T1) with a recorded smoking status<br>
2012<br>
4188<br>
97.8<br>
%<br>
90.6<br>
15 % of diabetes pop (T2) with a recorded smoking status<br>
2012<br>
30668<br>
99.8<br>
%<br>
95.9<br>
Quality<br>
16 % of diabetes pop (T1) with recorded creatinine<br>
2012<br>
3565<br>
85.8<br>
%<br>
83.4<br>
of<br>
17 % of diabetes pop (T2) with recorded creatinine<br>
2012<br>
28800<br>
93.7<br>
%<br>
93.7<br>
Recording<br>
18 % of diabetes pop (T1) with recorded microalbumin<br>
2012<br>
3110<br>
74.9<br>
%<br>
60.7<br>
19 % of diabetes pop (T2) with recorded microalbumin<br>
2012<br>
21447<br>
69.8<br>
%<br>
69.1<br>
20 % of diabetes pop (T1) with recorded eGFR<br>
2012<br>
1399<br>
35.6<br>
%<br>
56.7<br>
21 % of diabetes pop (T2) with recorded eGFR<br>
2012<br>
15720<br>
51.2<br>
%<br>
70.5<br>
22 % of diabetes pop (T1) with recorded eye screen<br>
2012<br>
3428<br>
82.5<br>
%<br>
82.0<br>
23 % of diabetes pop (T2) with recorded eye screen<br>
2012<br>
26261<br>
85.4<br>
%<br>
86.6<br>
24 % of diabetes pop (T1) with recorded pulses<br>
2012<br>
2321<br>
54.2<br>
%<br>
55.9<br>
25 % of diabetes pop (T2) with recorded pulses<br>
2012<br>
17409<br>
56.6<br>
%<br>
71.8<br>
26 % of diabetes pop (T1) with recorded foot risk<br>
2012<br>
2797<br>
65.3<br>
%<br>
61.3<br>
27 % of diabetes pop (T2) with recorded foot risk<br>
2012<br>
25831<br>
84.0<br>
%<br>
81.1<br>
28 % of diabetes pop (T1) current smokers<br>
2012<br>
1006<br>
23.5<br>
%<br>
21.6<br>
Smoking<br>
29 % of diabetes pop (T2) current smokers<br>
2012<br>
6353<br>
20.7<br>
%<br>
18.0<br>
30 % of diabetes pop (T1) obese (BMI&gt;=30)<br>
2012<br>
859<br>
23.9<br>
%<br>
25.5<br>
Obesity<br>
31 % of diabetes pop (T2) obese (BMI&gt;=30)<br>
2012<br>
15805<br>
56.2<br>
%<br>
55.4<br>
&amp;<br>
hypertension<br>
32 % of diabetes pop (T1) with SBP &lt;= 140mmHg<br>
2012<br>
3090<br>
81.6<br>
%<br>
80.7<br>
33 % of diabetes pop (T2) with SBP &lt;=140mmHg<br>
2012<br>
22941<br>
77.8<br>
%<br>
77.2<br>
34 % of diabetes pop (T1) with HbA1c &gt; 75mmol/mol<br>
2012<br>
1310<br>
33.3<br>
%<br>
39.3<br>
Metabolic<br>
35 % of diabetes pop (T2) with HbA1c &gt; 75mmol/mol<br>
2012<br>
3836<br>
13.4<br>
%<br>
15.5<br>
complications<br>
36 % of diabetes pop (T1) with cholesterol &gt;5mmol<br>
2012<br>
1044<br>
31.7<br>
%<br>
30.3<br>
37 % of diabetes pop (T2) with cholesterol &gt;5mmol<br>
2012<br>
5142<br>
18.1<br>
%<br>
19.5<br>
38 % of diabetes pop (T1) with eGFR &lt;15<br>
2012<br>
22<br>
0.6<br>
%<br>
0.6<br>
39 % of diabetes pop (T2) with eGFR &lt;15<br>
2012<br>
74<br>
0.3<br>
%<br>
0.3<br>
Microvascular<br>
40 % of diabetes pop (T1) with end-stage renal failure<br>
2012<br>
41<br>
1.0<br>
%<br>
1.2<br>
complications<br>
41 % of diabetes pop (T2) with end-stage renal failure<br>
2012<br>
184<br>
0.6<br>
%<br>
0.5<br>
42 % of diabetes pop (T1) with diabetic retinopathy<br>
2011<br>
1936<br>
53.4<br>
%<br>
57.5<br>
43 % of diabetes pop (T2) with diabetic retinopathy<br>
2011<br>
6290<br>
23.1<br>
%<br>
27.2<br>
44 % of diabetes pop (T1) with previous MI<br>
2012<br>
131<br>
3.1<br>
%<br>
3.6<br>
45 % of diabetes pop (T2) with previous MI<br>
2012<br>
3072<br>
10.0<br>
%<br>
10.1<br>
46 % of diabetes pop (T1) with previous cardiac revascularisation<br>
2012<br>
103<br>
2.4<br>
%<br>
2.5<br>
47 % of diabetes pop (T2) with previous cardiac revascularisation<br>
2012<br>
2332<br>
7.6<br>
%<br>
7.2<br>
Macrovascular<br>
48 % of diabetes pop (T1) with previous stroke<br>
2012<br>
94<br>
2.2<br>
%<br>
2.1<br>
complications<br>
49 % of diabetes pop (T2) with previous stroke<br>
2012<br>
1784<br>
5.8<br>
%<br>
5.3<br>
50 % of diabetes pop (T1) with previous foot ulcer<br>
2012<br>
336<br>
7.8<br>
%<br>
8.5<br>
51 % of diabetes pop (T2) with previous foot ulcer<br>
2012<br>
1933<br>
6.3<br>
%<br>
4.7<br>
52 % of diabetes pop (T1) with previous lower limb amputation<br>
2012<br>
24<br>
0.6<br>
%<br>
1.1<br>
53 % of diabetes pop (T2) with previous lower limb amputation<br>
2012<br>
141<br>
0.5<br>
%<br>
0.7<br>
`Worse' Area<br>
Scotland Average<br>
`Better' Area<br>
5</span><span class="ft4">th </span><span class="ft3">Percentile<br>
25</span><span class="ft4">th </span><span class="ft3">Percentile<br>
75</span><span class="ft4">th </span><span class="ft3">Percentile<br>
95</span><span class="ft4">th </span><span class="ft3">Percentile<br>
Note: T1 = Type 1 diabetes; T2 = Type 2 diabetes; n/a = data not available, or cannot be calculated; sr2 = directly<br>
Spine Chart Key:<br>
standardised rate per 100 population; % = percent. Only measures one and two are age adjusted. Differences in age<br>
Statistically significantly `worse' than National average<br>
composition of health board populations may partly explain differences in measures between boards. High level of<br>
recorded smoking in some boards may reflect the fact that smoking status has not been updated for those who have<br>
Statistically not significantly different from National average<br>
stopped smoking. All measures exclude those of `unknown' status in the denominator. Further details of diabetes<br>
Statistically significantly `better' than National average<br>
measure definitions are given in the main report for the 2012 Scottish Diabetes Survey.<br>
No significance can be calculated<br>
93<br>
Scottish Diabetes Survey Monitoring Group<br>
<hr>
<A name=94></a>Scottish Diabetes Survey 2012<br>
Orkney Health Board Spine Chart 2012<br>
Domain<br>
Indicator<br>
Period<br>
Number<br>
Measure<br>
Type &quot;National<br>
Average&quot;<br>
1<br>
Age/sex standardised prevalence of T1 diabetes<br>
2012<br>
119<br>
0.6<br>
sr2<br>
0.5<br>
2<br>
Age/sex standardised prevalence of T2 diabetes<br>
2012<br>
877<br>
3.8<br>
sr2<br>
4.3<br>
Prevalence<br>
Incidence<br>
3<br>
Crude prevalence of T1 diabetes<br>
2012<br>
119<br>
0.6<br>
%<br>
0.5<br>
&amp;<br>
4<br>
Crude prevalence T2 diabetes<br>
2012<br>
877<br>
4.4<br>
%<br>
4.3<br>
Mortality<br>
5<br>
Estimated % pop with undiagnosed diabetes<br>
2012<br>
264<br>
1.3<br>
%<br>
0.9<br>
6<br>
Crude mortality rate for all people with diabetes<br>
2012<br>
42<br>
4.0<br>
%<br>
3.6<br>
7<br>
% of diabetes pop with recorded BMI<br>
2012<br>
892<br>
90.9<br>
%<br>
89.2<br>
8<br>
% of diabetes pop (T1) with recorded HbA1c<br>
2012<br>
116<br>
97.5<br>
%<br>
87.1<br>
9<br>
% of diabetes pop (T2) with recorded HbA1c<br>
2012<br>
854<br>
97.4<br>
%<br>
92.8<br>
10 % of diabetes pop (T1) with recorded BP<br>
2012<br>
105<br>
88.2<br>
%<br>
85.2<br>
11 % of diabetes pop (T2) with recorded BP<br>
2012<br>
860<br>
98.1<br>
%<br>
94.6<br>
12 % of diabetes pop (T1) with recorded cholesterol<br>
2012<br>
99<br>
95.2<br>
%<br>
81.2<br>
13 % of diabetes pop (T2) with recorded cholesterol<br>
2012<br>
841<br>
95.9<br>
%<br>
91.6<br>
14 % of diabetes pop (T1) with a recorded smoking status<br>
2012<br>
111<br>
93.3<br>
%<br>
90.6<br>
15 % of diabetes pop (T2) with a recorded smoking status<br>
2012<br>
860<br>
98.1<br>
%<br>
95.9<br>
Quality<br>
16 % of diabetes pop (T1) with recorded creatinine<br>
2012<br>
107<br>
93.9<br>
%<br>
83.4<br>
of<br>
17 % of diabetes pop (T2) with recorded creatinine<br>
2012<br>
829<br>
94.5<br>
%<br>
93.7<br>
Recording<br>
18 % of diabetes pop (T1) with recorded microalbumin<br>
2012<br>
85<br>
74.6<br>
%<br>
60.7<br>
19 % of diabetes pop (T2) with recorded microalbumin<br>
2012<br>
742<br>
84.6<br>
%<br>
69.1<br>
20 % of diabetes pop (T1) with recorded eGFR<br>
2012<br>
90<br>
86.5<br>
%<br>
56.7<br>
21 % of diabetes pop (T2) with recorded eGFR<br>
2012<br>
820<br>
93.5<br>
%<br>
70.5<br>
22 % of diabetes pop (T1) with recorded eye screen<br>
2012<br>
103<br>
90.4<br>
%<br>
82.0<br>
23 % of diabetes pop (T2) with recorded eye screen<br>
2012<br>
822<br>
93.7<br>
%<br>
86.6<br>
24 % of diabetes pop (T1) with recorded pulses<br>
2012<br>
84<br>
70.6<br>
%<br>
55.9<br>
25 % of diabetes pop (T2) with recorded pulses<br>
2012<br>
576<br>
65.7<br>
%<br>
71.8<br>
26 % of diabetes pop (T1) with recorded foot risk<br>
2012<br>
93<br>
78.2<br>
%<br>
61.3<br>
27 % of diabetes pop (T2) with recorded foot risk<br>
2012<br>
742<br>
84.6<br>
%<br>
81.1<br>
28 % of diabetes pop (T1) current smokers<br>
2012<br>
20<br>
16.8<br>
%<br>
21.6<br>
Smoking<br>
29 % of diabetes pop (T2) current smokers<br>
2012<br>
108<br>
12.3<br>
%<br>
18.0<br>
30 % of diabetes pop (T1) obese (BMI&gt;=30)<br>
2012<br>
21<br>
22.6<br>
%<br>
25.5<br>
Obesity<br>
31 % of diabetes pop (T2) obese (BMI&gt;=30)<br>
2012<br>
477<br>
59.7<br>
%<br>
55.4<br>
&amp;<br>
hypertension<br>
32 % of diabetes pop (T1) with SBP &lt;= 140mmHg<br>
2012<br>
89<br>
84.8<br>
%<br>
80.7<br>
33 % of diabetes pop (T2) with SBP &lt;=140mmHg<br>
2012<br>
625<br>
72.7<br>
%<br>
77.2<br>
34 % of diabetes pop (T1) with HbA1c &gt; 75mmol/mol<br>
2012<br>
42<br>
36.2<br>
%<br>
39.3<br>
Metabolic<br>
35 % of diabetes pop (T2) with HbA1c &gt; 75mmol/mol<br>
2012<br>
151<br>
17.7<br>
%<br>
15.5<br>
complications<br>
36 % of diabetes pop (T1) with cholesterol &gt;5mmol<br>
2012<br>
23<br>
23.2<br>
%<br>
30.3<br>
37 % of diabetes pop (T2) with cholesterol &gt;5mmol<br>
2012<br>
171<br>
20.3<br>
%<br>
19.5<br>
38 % of diabetes pop (T1) with eGFR &lt;15<br>
2012<br>
0<br>
0.0<br>
%<br>
0.6<br>
39 % of diabetes pop (T2) with eGFR &lt;15<br>
2012<br>
2<br>
0.2<br>
%<br>
0.3<br>
Microvascular<br>
40 % of diabetes pop (T1) with end-stage renal failure<br>
2012<br>
2<br>
1.7<br>
%<br>
1.2<br>
complications<br>
41 % of diabetes pop (T2) with end-stage renal failure<br>
2012<br>
2<br>
0.2<br>
%<br>
0.5<br>
42 % of diabetes pop (T1) with diabetic retinopathy<br>
2011<br>
56<br>
53.8<br>
%<br>
57.5<br>
43 % of diabetes pop (T2) with diabetic retinopathy<br>
2011<br>
244<br>
30.6<br>
%<br>
27.2<br>
44 % of diabetes pop (T1) with previous MI<br>
2012<br>
5<br>
4.2<br>
%<br>
3.6<br>
45 % of diabetes pop (T2) with previous MI<br>
2012<br>
79<br>
9.0<br>
%<br>
10.1<br>
46 % of diabetes pop (T1) with previous cardiac revascularisation<br>
2012<br>
2<br>
1.7<br>
%<br>
2.5<br>
47 % of diabetes pop (T2) with previous cardiac revascularisation<br>
2012<br>
58<br>
6.6<br>
%<br>
7.2<br>
Macrovascular<br>
48 % of diabetes pop (T1) with previous stroke<br>
2012<br>
1<br>
0.8<br>
%<br>
2.1<br>
complications<br>
49 % of diabetes pop (T2) with previous stroke<br>
2012<br>
30<br>
3.4<br>
%<br>
5.3<br>
50 % of diabetes pop (T1) with previous foot ulcer<br>
2012<br>
7<br>
5.9<br>
%<br>
8.5<br>
51 % of diabetes pop (T2) with previous foot ulcer<br>
2012<br>
32<br>
3.6<br>
%<br>
4.7<br>
52 % of diabetes pop (T1) with previous lower limb amputation<br>
2012<br>
2<br>
1.7<br>
%<br>
1.1<br>
53 % of diabetes pop (T2) with previous lower limb amputation<br>
2012<br>
10<br>
1.1<br>
%<br>
0.7<br>
`Worse' Area<br>
Scotland Average<br>
`Better' Area<br>
5</span><span class="ft4">th </span><span class="ft3">Percentile<br>
25</span><span class="ft4">th </span><span class="ft3">Percentile<br>
75</span><span class="ft4">th </span><span class="ft3">Percentile<br>
95</span><span class="ft4">th </span><span class="ft3">Percentile<br>
Note: T1 = Type 1 diabetes; T2 = Type 2 diabetes; n/a = data not available, or cannot be calculated; sr2 = directly<br>
Spine Chart Key:<br>
standardised rate per 100 population; % = percent. Only measures one and two are age adjusted. Differences in age<br>
Statistically significantly `worse' than National average<br>
composition of health board populations may partly explain differences in measures between boards. High level of<br>
recorded smoking in some boards may reflect the fact that smoking status has not been updated for those who have<br>
Statistically not significantly different from National average<br>
stopped smoking. All measures exclude those of `unknown' status in the denominator. Further details of diabetes<br>
Statistically significantly `better' than National average<br>
measure definitions are given in the main report for the 2012 Scottish Diabetes Survey.<br>
No significance can be calculated<br>
94<br>
Scottish Diabetes Survey Monitoring Group<br>
<hr>
<A name=95></a>Scottish Diabetes Survey 2012<br>
Shetland Health Board Spine Chart 2012<br>
Domain<br>
Indicator<br>
Period<br>
Number<br>
Measure<br>
Type &quot;National<br>
Average&quot;<br>
1<br>
Age/sex standardised prevalence of T1 diabetes<br>
2012<br>
128<br>
0.6<br>
sr2<br>
0.5<br>
2<br>
Age/sex standardised prevalence of T2 diabetes<br>
2012<br>
881<br>
3.8<br>
sr2<br>
4.3<br>
Prevalence<br>
Incidence<br>
3<br>
Crude prevalence of T1 diabetes<br>
2012<br>
128<br>
0.6<br>
%<br>
0.5<br>
&amp;<br>
4<br>
Crude prevalence T2 diabetes<br>
2012<br>
881<br>
3.9<br>
%<br>
4.3<br>
Mortality<br>
5<br>
Estimated % pop with undiagnosed diabetes<br>
2012<br>
416<br>
1.9<br>
%<br>
0.9<br>
6<br>
Crude mortality rate for all people with diabetes<br>
2012<br>
30<br>
2.8<br>
%<br>
3.6<br>
7<br>
% of diabetes pop with recorded BMI<br>
2012<br>
676<br>
67.9<br>
%<br>
89.2<br>
8<br>
% of diabetes pop (T1) with recorded HbA1c<br>
2012<br>
125<br>
97.7<br>
%<br>
87.1<br>
9<br>
% of diabetes pop (T2) with recorded HbA1c<br>
2012<br>
829<br>
94.1<br>
%<br>
92.8<br>
10 % of diabetes pop (T1) with recorded BP<br>
2012<br>
89<br>
69.5<br>
%<br>
85.2<br>
11 % of diabetes pop (T2) with recorded BP<br>
2012<br>
622<br>
70.6<br>
%<br>
94.6<br>
12 % of diabetes pop (T1) with recorded cholesterol<br>
2012<br>
101<br>
88.6<br>
%<br>
81.2<br>
13 % of diabetes pop (T2) with recorded cholesterol<br>
2012<br>
805<br>
91.4<br>
%<br>
91.6<br>
14 % of diabetes pop (T1) with a recorded smoking status<br>
2012<br>
123<br>
96.1<br>
%<br>
90.6<br>
15 % of diabetes pop (T2) with a recorded smoking status<br>
2012<br>
877<br>
99.5<br>
%<br>
95.9<br>
Quality<br>
16 % of diabetes pop (T1) with recorded creatinine<br>
2012<br>
112<br>
93.3<br>
%<br>
83.4<br>
of<br>
17 % of diabetes pop (T2) with recorded creatinine<br>
2012<br>
848<br>
96.3<br>
%<br>
93.7<br>
Recording<br>
18 % of diabetes pop (T1) with recorded microalbumin<br>
2012<br>
97<br>
80.8<br>
%<br>
60.7<br>
19 % of diabetes pop (T2) with recorded microalbumin<br>
2012<br>
666<br>
75.6<br>
%<br>
69.1<br>
20 % of diabetes pop (T1) with recorded eGFR<br>
2012<br>
110<br>
96.5<br>
%<br>
56.7<br>
21 % of diabetes pop (T2) with recorded eGFR<br>
2012<br>
843<br>
95.7<br>
%<br>
70.5<br>
22 % of diabetes pop (T1) with recorded eye screen<br>
2012<br>
110<br>
91.7<br>
%<br>
82.0<br>
23 % of diabetes pop (T2) with recorded eye screen<br>
2012<br>
790<br>
89.7<br>
%<br>
86.6<br>
24 % of diabetes pop (T1) with recorded pulses<br>
2012<br>
106<br>
82.8<br>
%<br>
55.9<br>
25 % of diabetes pop (T2) with recorded pulses<br>
2012<br>
749<br>
85.0<br>
%<br>
71.8<br>
26 % of diabetes pop (T1) with recorded foot risk<br>
2012<br>
107<br>
83.6<br>
%<br>
61.3<br>
27 % of diabetes pop (T2) with recorded foot risk<br>
2012<br>
749<br>
85.0<br>
%<br>
81.1<br>
28 % of diabetes pop (T1) current smokers<br>
2012<br>
22<br>
17.2<br>
%<br>
21.6<br>
Smoking<br>
29 % of diabetes pop (T2) current smokers<br>
2012<br>
136<br>
15.4<br>
%<br>
18.0<br>
30 % of diabetes pop (T1) obese (BMI&gt;=30)<br>
2012<br>
34<br>
40.5<br>
%<br>
25.5<br>
Obesity<br>
31 % of diabetes pop (T2) obese (BMI&gt;=30)<br>
2012<br>
356<br>
60.1<br>
%<br>
55.4<br>
&amp;<br>
hypertension<br>
32 % of diabetes pop (T1) with SBP &lt;= 140mmHg<br>
2012<br>
75<br>
84.3<br>
%<br>
80.7<br>
33 % of diabetes pop (T2) with SBP &lt;=140mmHg<br>
2012<br>
475<br>
76.4<br>
%<br>
77.2<br>
34 % of diabetes pop (T1) with HbA1c &gt; 75mmol/mol<br>
2012<br>
29<br>
23.2<br>
%<br>
39.3<br>
Metabolic<br>
35 % of diabetes pop (T2) with HbA1c &gt; 75mmol/mol<br>
2012<br>
104<br>
12.5<br>
%<br>
15.5<br>
complications<br>
36 % of diabetes pop (T1) with cholesterol &gt;5mmol<br>
2012<br>
39<br>
38.6<br>
%<br>
30.3<br>
37 % of diabetes pop (T2) with cholesterol &gt;5mmol<br>
2012<br>
195<br>
24.2<br>
%<br>
19.5<br>
38 % of diabetes pop (T1) with eGFR &lt;15<br>
2012<br>
0<br>
0.0<br>
%<br>
0.6<br>
39 % of diabetes pop (T2) with eGFR &lt;15<br>
2012<br>
2<br>
0.2<br>
%<br>
0.3<br>
Microvascular<br>
40 % of diabetes pop (T1) with end-stage renal failure<br>
2012<br>
1<br>
0.8<br>
%<br>
1.2<br>
complications<br>
41 % of diabetes pop (T2) with end-stage renal failure<br>
2012<br>
6<br>
0.7<br>
%<br>
0.5<br>
42 % of diabetes pop (T1) with diabetic retinopathy<br>
2011<br>
64<br>
56.6<br>
%<br>
57.5<br>
43 % of diabetes pop (T2) with diabetic retinopathy<br>
2011<br>
218<br>
27.3<br>
%<br>
27.2<br>
44 % of diabetes pop (T1) with previous MI<br>
2012<br>
7<br>
5.5<br>
%<br>
3.6<br>
45 % of diabetes pop (T2) with previous MI<br>
2012<br>
63<br>
7.2<br>
%<br>
10.1<br>
46 % of diabetes pop (T1) with previous cardiac revascularisation<br>
2012<br>
5<br>
3.9<br>
%<br>
2.5<br>
47 % of diabetes pop (T2) with previous cardiac revascularisation<br>
2012<br>
39<br>
4.4<br>
%<br>
7.2<br>
Macrovascular<br>
48 % of diabetes pop (T1) with previous stroke<br>
2012<br>
2<br>
1.6<br>
%<br>
2.1<br>
complications<br>
49 % of diabetes pop (T2) with previous stroke<br>
2012<br>
33<br>
3.7<br>
%<br>
5.3<br>
50 % of diabetes pop (T1) with previous foot ulcer<br>
2012<br>
2<br>
1.6<br>
%<br>
8.5<br>
51 % of diabetes pop (T2) with previous foot ulcer<br>
2012<br>
6<br>
0.7<br>
%<br>
4.7<br>
52 % of diabetes pop (T1) with previous lower limb amputation<br>
2012<br>
1<br>
0.8<br>
%<br>
1.1<br>
53 % of diabetes pop (T2) with previous lower limb amputation<br>
2012<br>
2<br>
0.2<br>
%<br>
0.7<br>
`Worse' Area<br>
Scotland Average<br>
`Better' Area<br>
5</span><span class="ft4">th </span><span class="ft3">Percentile<br>
25</span><span class="ft4">th </span><span class="ft3">Percentile<br>
75</span><span class="ft4">th </span><span class="ft3">Percentile<br>
95</span><span class="ft4">th </span><span class="ft3">Percentile<br>
Note: T1 = Type 1 diabetes; T2 = Type 2 diabetes; n/a = data not available, or cannot be calculated; sr2 = directly<br>
Spine Chart Key:<br>
standardised rate per 100 population; % = percent. Only measures one and two are age adjusted. Differences in age<br>
Statistically significantly `worse' than National average<br>
composition of health board populations may partly explain differences in measures between boards. High level of<br>
recorded smoking in some boards may reflect the fact that smoking status has not been updated for those who have<br>
Statistically not significantly different from National average<br>
stopped smoking. All measures exclude those of `unknown' status in the denominator. Further details of diabetes<br>
Statistically significantly `better' than National average<br>
measure definitions are given in the main report for the 2012 Scottish Diabetes Survey.<br>
No significance can be calculated<br>
95<br>
Scottish Diabetes Survey Monitoring Group<br>
<hr>
<A name=96></a>Scottish Diabetes Survey 2012<br>
Tayside Health Board Spine Chart 2012<br>
Domain<br>
Indicator<br>
Period<br>
Number<br>
Measure<br>
Type &quot;National<br>
Average&quot;<br>
1<br>
Age/sex standardised prevalence of T1 diabetes<br>
2012<br>
1901<br>
0.5<br>
sr2<br>
0.5<br>
2<br>
Age/sex standardised prevalence of T2 diabetes<br>
2012<br>
18806<br>
4.3<br>
sr2<br>
4.3<br>
Prevalence<br>
Incidence<br>
3<br>
Crude prevalence of T1 diabetes<br>
2012<br>
1901<br>
0.5<br>
%<br>
0.5<br>
&amp;<br>
4<br>
Crude prevalence T2 diabetes<br>
2012<br>
18806<br>
4.6<br>
%<br>
4.3<br>
Mortality<br>
5<br>
Estimated % pop with undiagnosed diabetes<br>
2012<br>
3528<br>
0.9<br>
%<br>
0.9<br>
6<br>
Crude mortality rate for all people with diabetes<br>
2012<br>
813<br>
3.8<br>
%<br>
3.6<br>
7<br>
% of diabetes pop with recorded BMI<br>
2012<br>
18841<br>
91.9<br>
%<br>
89.2<br>
8<br>
% of diabetes pop (T1) with recorded HbA1c<br>
2012<br>
1781<br>
93.7<br>
%<br>
87.1<br>
9<br>
% of diabetes pop (T2) with recorded HbA1c<br>
2012<br>
18044<br>
95.9<br>
%<br>
92.8<br>
10 % of diabetes pop (T1) with recorded BP<br>
2012<br>
1666<br>
87.6<br>
%<br>
85.2<br>
11 % of diabetes pop (T2) with recorded BP<br>
2012<br>
18056<br>
96.0<br>
%<br>
94.6<br>
12 % of diabetes pop (T1) with recorded cholesterol<br>
2012<br>
1337<br>
78.7<br>
%<br>
81.2<br>
13 % of diabetes pop (T2) with recorded cholesterol<br>
2012<br>
17837<br>
94.9<br>
%<br>
91.6<br>
14 % of diabetes pop (T1) with a recorded smoking status<br>
2012<br>
1777<br>
93.5<br>
%<br>
90.6<br>
15 % of diabetes pop (T2) with a recorded smoking status<br>
2012<br>
18581<br>
98.8<br>
%<br>
95.9<br>
Quality<br>
16 % of diabetes pop (T1) with recorded creatinine<br>
2012<br>
1612<br>
88.3<br>
%<br>
83.4<br>
of<br>
17 % of diabetes pop (T2) with recorded creatinine<br>
2012<br>
18275<br>
97.2<br>
%<br>
93.7<br>
Recording<br>
18 % of diabetes pop (T1) with recorded microalbumin<br>
2012<br>
1210<br>
66.3<br>
%<br>
60.7<br>
19 % of diabetes pop (T2) with recorded microalbumin<br>
2012<br>
15657<br>
83.3<br>
%<br>
69.1<br>
20 % of diabetes pop (T1) with recorded eGFR<br>
2012<br>
1450<br>
85.3<br>
%<br>
56.7<br>
21 % of diabetes pop (T2) with recorded eGFR<br>
2012<br>
18213<br>
96.9<br>
%<br>
70.5<br>
22 % of diabetes pop (T1) with recorded eye screen<br>
2012<br>
1527<br>
83.6<br>
%<br>
82.0<br>
23 % of diabetes pop (T2) with recorded eye screen<br>
2012<br>
16195<br>
86.1<br>
%<br>
86.6<br>
24 % of diabetes pop (T1) with recorded pulses<br>
2012<br>
1130<br>
59.4<br>
%<br>
55.9<br>
25 % of diabetes pop (T2) with recorded pulses<br>
2012<br>
14649<br>
77.9<br>
%<br>
71.8<br>
26 % of diabetes pop (T1) with recorded foot risk<br>
2012<br>
1204<br>
63.3<br>
%<br>
61.3<br>
27 % of diabetes pop (T2) with recorded foot risk<br>
2012<br>
16120<br>
85.7<br>
%<br>
81.1<br>
28 % of diabetes pop (T1) current smokers<br>
2012<br>
450<br>
23.7<br>
%<br>
21.6<br>
Smoking<br>
29 % of diabetes pop (T2) current smokers<br>
2012<br>
3130<br>
16.6<br>
%<br>
18.0<br>
30 % of diabetes pop (T1) obese (BMI&gt;=30)<br>
2012<br>
371<br>
24.6<br>
%<br>
25.5<br>
Obesity<br>
31 % of diabetes pop (T2) obese (BMI&gt;=30)<br>
2012<br>
9609<br>
55.4<br>
%<br>
55.4<br>
&amp;<br>
hypertension<br>
32 % of diabetes pop (T1) with SBP &lt;= 140mmHg<br>
2012<br>
1291<br>
77.5<br>
%<br>
80.7<br>
33 % of diabetes pop (T2) with SBP &lt;=140mmHg<br>
2012<br>
13301<br>
73.7<br>
%<br>
77.2<br>
34 % of diabetes pop (T1) with HbA1c &gt; 75mmol/mol<br>
2012<br>
801<br>
45.0<br>
%<br>
39.3<br>
Metabolic<br>
35 % of diabetes pop (T2) with HbA1c &gt; 75mmol/mol<br>
2012<br>
2716<br>
15.1<br>
%<br>
15.5<br>
complications<br>
36 % of diabetes pop (T1) with cholesterol &gt;5mmol<br>
2012<br>
348<br>
26.0<br>
%<br>
30.3<br>
37 % of diabetes pop (T2) with cholesterol &gt;5mmol<br>
2012<br>
3236<br>
18.1<br>
%<br>
19.5<br>
38 % of diabetes pop (T1) with eGFR &lt;15<br>
2012<br>
8<br>
0.5<br>
%<br>
0.6<br>
39 % of diabetes pop (T2) with eGFR &lt;15<br>
2012<br>
57<br>
0.3<br>
%<br>
0.3<br>
Microvascular<br>
40 % of diabetes pop (T1) with end-stage renal failure<br>
2012<br>
38<br>
2.0<br>
%<br>
1.2<br>
complications<br>
41 % of diabetes pop (T2) with end-stage renal failure<br>
2012<br>
122<br>
0.6<br>
%<br>
0.5<br>
42 % of diabetes pop (T1) with diabetic retinopathy<br>
2011<br>
722<br>
50.7<br>
%<br>
57.5<br>
43 % of diabetes pop (T2) with diabetic retinopathy<br>
2011<br>
3600<br>
22.4<br>
%<br>
27.2<br>
44 % of diabetes pop (T1) with previous MI<br>
2012<br>
64<br>
3.4<br>
%<br>
3.6<br>
45 % of diabetes pop (T2) with previous MI<br>
2012<br>
2017<br>
10.7<br>
%<br>
10.1<br>
46 % of diabetes pop (T1) with previous cardiac revascularisation<br>
2012<br>
49<br>
2.6<br>
%<br>
2.5<br>
47 % of diabetes pop (T2) with previous cardiac revascularisation<br>
2012<br>
1317<br>
7.0<br>
%<br>
7.2<br>
Macrovascular<br>
48 % of diabetes pop (T1) with previous stroke<br>
2012<br>
39<br>
2.1<br>
%<br>
2.1<br>
complications<br>
49 % of diabetes pop (T2) with previous stroke<br>
2012<br>
1057<br>
5.6<br>
%<br>
5.3<br>
50 % of diabetes pop (T1) with previous foot ulcer<br>
2012<br>
139<br>
7.3<br>
%<br>
8.5<br>
51 % of diabetes pop (T2) with previous foot ulcer<br>
2012<br>
678<br>
3.6<br>
%<br>
4.7<br>
52 % of diabetes pop (T1) with previous lower limb amputation<br>
2012<br>
22<br>
1.2<br>
%<br>
1.1<br>
53 % of diabetes pop (T2) with previous lower limb amputation<br>
2012<br>
129<br>
0.7<br>
%<br>
0.7<br>
`Worse' Area<br>
Scotland Average<br>
`Better' Area<br>
5</span><span class="ft4">th </span><span class="ft3">Percentile<br>
25</span><span class="ft4">th </span><span class="ft3">Percentile<br>
75</span><span class="ft4">th </span><span class="ft3">Percentile<br>
95</span><span class="ft4">th </span><span class="ft3">Percentile<br>
Note: T1 = Type 1 diabetes; T2 = Type 2 diabetes; n/a = data not available, or cannot be calculated; sr2 = directly<br>
Spine Chart Key:<br>
standardised rate per 100 population; % = percent. Only measures one and two are age adjusted. Differences in age<br>
Statistically significantly `worse' than National average<br>
composition of health board populations may partly explain differences in measures between boards. High level of<br>
recorded smoking in some boards may reflect the fact that smoking status has not been updated for those who have<br>
Statistically not significantly different from National average<br>
stopped smoking. All measures exclude those of `unknown' status in the denominator. Further details of diabetes<br>
Statistically significantly `better' than National average<br>
measure definitions are given in the main report for the 2012 Scottish Diabetes Survey.<br>
No significance can be calculated<br>
96<br>
Scottish Diabetes Survey Monitoring Group<br>
<hr>
<A name=97></a>Scottish Diabetes Survey 2012<br>
Western Isles Health Board Spine Chart 2012<br>
Domain<br>
Indicator<br>
Period<br>
Number<br>
Measure<br>
Type &quot;National<br>
Average&quot;<br>
1<br>
Age/sex standardised prevalence of T1 diabetes<br>
2012<br>
185<br>
0.8<br>
sr2<br>
0.5<br>
2<br>
Age/sex standardised prevalence of T2 diabetes<br>
2012<br>
1070<br>
3.4<br>
sr2<br>
4.3<br>
Prevalence<br>
Incidence<br>
3<br>
Crude prevalence of T1 diabetes<br>
2012<br>
185<br>
0.7<br>
%<br>
0.5<br>
&amp;<br>
4<br>
Crude prevalence T2 diabetes<br>
2012<br>
1070<br>
4.1<br>
%<br>
4.3<br>
Mortality<br>
5<br>
Estimated % pop with undiagnosed diabetes<br>
2012<br>
698<br>
2.7<br>
%<br>
0.9<br>
6<br>
Crude mortality rate for all people with diabetes<br>
2012<br>
58<br>
4.4<br>
%<br>
3.6<br>
7<br>
% of diabetes pop with recorded BMI<br>
2012<br>
1028<br>
83.2<br>
%<br>
89.2<br>
8<br>
% of diabetes pop (T1) with recorded HbA1c<br>
2012<br>
180<br>
97.3<br>
%<br>
87.1<br>
9<br>
% of diabetes pop (T2) with recorded HbA1c<br>
2012<br>
1028<br>
96.1<br>
%<br>
92.8<br>
10 % of diabetes pop (T1) with recorded BP<br>
2012<br>
149<br>
80.5<br>
%<br>
85.2<br>
11 % of diabetes pop (T2) with recorded BP<br>
2012<br>
1012<br>
94.6<br>
%<br>
94.6<br>
12 % of diabetes pop (T1) with recorded cholesterol<br>
2012<br>
150<br>
90.9<br>
%<br>
81.2<br>
13 % of diabetes pop (T2) with recorded cholesterol<br>
2012<br>
977<br>
91.3<br>
%<br>
91.6<br>
14 % of diabetes pop (T1) with a recorded smoking status<br>
2012<br>
176<br>
95.1<br>
%<br>
90.6<br>
15 % of diabetes pop (T2) with a recorded smoking status<br>
2012<br>
1054<br>
98.5<br>
%<br>
95.9<br>
Quality<br>
16 % of diabetes pop (T1) with recorded creatinine<br>
2012<br>
171<br>
95.5<br>
%<br>
83.4<br>
of<br>
17 % of diabetes pop (T2) with recorded creatinine<br>
2012<br>
1038<br>
97.0<br>
%<br>
93.7<br>
Recording<br>
18 % of diabetes pop (T1) with recorded microalbumin<br>
2012<br>
133<br>
74.3<br>
%<br>
60.7<br>
19 % of diabetes pop (T2) with recorded microalbumin<br>
2012<br>
868<br>
81.1<br>
%<br>
69.1<br>
20 % of diabetes pop (T1) with recorded eGFR<br>
2012<br>
114<br>
69.1<br>
%<br>
56.7<br>
21 % of diabetes pop (T2) with recorded eGFR<br>
2012<br>
937<br>
87.6<br>
%<br>
70.5<br>
22 % of diabetes pop (T1) with recorded eye screen<br>
2012<br>
158<br>
88.3<br>
%<br>
82.0<br>
23 % of diabetes pop (T2) with recorded eye screen<br>
2012<br>
949<br>
88.7<br>
%<br>
86.6<br>
24 % of diabetes pop (T1) with recorded pulses<br>
2012<br>
143<br>
77.3<br>
%<br>
55.9<br>
25 % of diabetes pop (T2) with recorded pulses<br>
2012<br>
897<br>
83.8<br>
%<br>
71.8<br>
26 % of diabetes pop (T1) with recorded foot risk<br>
2012<br>
143<br>
77.3<br>
%<br>
61.3<br>
27 % of diabetes pop (T2) with recorded foot risk<br>
2012<br>
884<br>
82.6<br>
%<br>
81.1<br>
28 % of diabetes pop (T1) current smokers<br>
2012<br>
42<br>
22.7<br>
%<br>
21.6<br>
Smoking<br>
29 % of diabetes pop (T2) current smokers<br>
2012<br>
177<br>
16.5<br>
%<br>
18.0<br>
30 % of diabetes pop (T1) obese (BMI&gt;=30)<br>
2012<br>
32<br>
25.8<br>
%<br>
25.5<br>
Obesity<br>
31 % of diabetes pop (T2) obese (BMI&gt;=30)<br>
2012<br>
512<br>
56.6<br>
%<br>
55.4<br>
&amp;<br>
hypertension<br>
32 % of diabetes pop (T1) with SBP &lt;= 140mmHg<br>
2012<br>
117<br>
78.5<br>
%<br>
80.7<br>
33 % of diabetes pop (T2) with SBP &lt;=140mmHg<br>
2012<br>
740<br>
73.1<br>
%<br>
77.2<br>
34 % of diabetes pop (T1) with HbA1c &gt; 75mmol/mol<br>
2012<br>
71<br>
39.4<br>
%<br>
39.3<br>
Metabolic<br>
35 % of diabetes pop (T2) with HbA1c &gt; 75mmol/mol<br>
2012<br>
222<br>
21.6<br>
%<br>
15.5<br>
complications<br>
36 % of diabetes pop (T1) with cholesterol &gt;5mmol<br>
2012<br>
50<br>
33.3<br>
%<br>
30.3<br>
37 % of diabetes pop (T2) with cholesterol &gt;5mmol<br>
2012<br>
244<br>
25.0<br>
%<br>
19.5<br>
38 % of diabetes pop (T1) with eGFR &lt;15<br>
2012<br>
1<br>
0.6<br>
%<br>
0.6<br>
39 % of diabetes pop (T2) with eGFR &lt;15<br>
2012<br>
2<br>
0.2<br>
%<br>
0.3<br>
Microvascular<br>
40 % of diabetes pop (T1) with end-stage renal failure<br>
2012<br>
1<br>
0.5<br>
%<br>
1.2<br>
complications<br>
41 % of diabetes pop (T2) with end-stage renal failure<br>
2012<br>
3<br>
0.3<br>
%<br>
0.5<br>
42 % of diabetes pop (T1) with diabetic retinopathy<br>
2011<br>
88<br>
55.0<br>
%<br>
57.5<br>
43 % of diabetes pop (T2) with diabetic retinopathy<br>
2011<br>
229<br>
23.7<br>
%<br>
27.2<br>
44 % of diabetes pop (T1) with previous MI<br>
2012<br>
6<br>
3.2<br>
%<br>
3.6<br>
45 % of diabetes pop (T2) with previous MI<br>
2012<br>
100<br>
9.3<br>
%<br>
10.1<br>
46 % of diabetes pop (T1) with previous cardiac revascularisation<br>
2012<br>
2<br>
1.1<br>
%<br>
2.5<br>
47 % of diabetes pop (T2) with previous cardiac revascularisation<br>
2012<br>
81<br>
7.6<br>
%<br>
7.2<br>
Macrovascular<br>
48 % of diabetes pop (T1) with previous stroke<br>
2012<br>
2<br>
1.1<br>
%<br>
2.1<br>
complications<br>
49 % of diabetes pop (T2) with previous stroke<br>
2012<br>
49<br>
4.6<br>
%<br>
5.3<br>
50 % of diabetes pop (T1) with previous foot ulcer<br>
2012<br>
13<br>
7.0<br>
%<br>
8.5<br>
51 % of diabetes pop (T2) with previous foot ulcer<br>
2012<br>
58<br>
5.4<br>
%<br>
4.7<br>
52 % of diabetes pop (T1) with previous lower limb amputation<br>
2012<br>
1<br>
0.5<br>
%<br>
1.1<br>
53 % of diabetes pop (T2) with previous lower limb amputation<br>
2012<br>
5<br>
0.5<br>
%<br>
0.7<br>
`Worse' Area<br>
Scotland Average<br>
`Better' Area<br>
5</span><span class="ft4">th </span><span class="ft3">Percentile<br>
25</span><span class="ft4">th </span><span class="ft3">Percentile<br>
75</span><span class="ft4">th </span><span class="ft3">Percentile<br>
95</span><span class="ft4">th </span><span class="ft3">Percentile<br>
Note: T1 = Type 1 diabetes; T2 = Type 2 diabetes; n/a = data not available, or cannot be calculated; sr2 = directly<br>
Spine Chart Key:<br>
standardised rate per 100 population; % = percent. Only measures one and two are age adjusted. Differences in age<br>
Statistically significantly `worse' than National average<br>
composition of health board populations may partly explain differences in measures between boards. High level of<br>
recorded smoking in some boards may reflect the fact that smoking status has not been updated for those who have<br>
Statistically not significantly different from National average<br>
stopped smoking. All measures exclude those of `unknown' status in the denominator. Further details of diabetes<br>
Statistically significantly `better' than National average<br>
measure definitions are given in the main report for the 2012 Scottish Diabetes Survey.<br>
No significance can be calculated<br>
97<br>
Scottish Diabetes Survey Monitoring Group<br>
<hr>
<A name="outline"></a><h1>Document Outline</h1>
<ul><li>þÿ
<li>þÿ
<li>þÿ
<ul><li>þÿ
<li>þÿ
<li>þÿ
<li>þÿ
<li>þÿ
<li>þÿ
<li>þÿ
<li>þÿ
<li>þÿ
</ul><li>þÿ
<ul><li>þÿ
<li>þÿ
<li>þÿ
</ul><li>þÿ
<ul><li>þÿ
<li>þÿ
<li>þÿ
<li>þÿ
<ul><li>þÿ
<li>þÿ
<li>þÿ
</ul><li>þÿ
<ul><li>þÿ
</ul><li>þÿ
<ul><li>þÿ
<li>þÿ
<li>þÿ
<li>þÿ
</ul><li>þÿ
<ul><li>þÿ
<li>þÿ
</ul></ul><li>þÿ
<li>þÿ
<li>þÿ
<li>þÿ
<li>þÿ
<li>þÿ
</ul><hr>
</BODY>
</HTML>
